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Abstract 
Oxygen is an essential factor for life in many organisms. Oxygen concentrations vary widely 
across different human tissues, but in general, are much lower than the 21% oxygen in 
atmospheric air. In spite of this, most research continues to be based on the culture of cells 
in an air oxygen (21% O2) environment. This ignores the mounting evidence of the role of 
physiological oxygen levels in the maintenance of survival, proliferation, stemness, genetic 
and epigenetic changes. The positive benefits of low oxygen tension on the maintenance of 
properties of several cells including embryonic and mesenchymal stem cells are well 
established while data describing negative impacts via genomic stability are few and 
conflicting. The role of cytosine modifications in cancer cells in response to hypoxia is 
poorly understood either in vitro or in vivo. In this study, we aimed to determine the role of 
low oxygen in the regulation of DNA methylation marks (5mC and 5hmC) and their 
associated genes including DNMT1/3A/3B/3L and TET1/2/3 in different cell lines including 
human embryonic stem cells, human mesenchymal stem cells and cancer cells. In addition 
to above, we also sought to corroborate upon and extend previous studies describing the 
effect of reduced oxygen on a range of cellular aspects including proliferation, metabolic 
activity, stemness and differentiation. To achieve these aims we cultured cells in either air 
oxygen, a fully defined 2% O2 environment (Hypoxycool media, tri-gas workstation), or in 
a multiuser tri-gas incubator with handling in a standard biological safety cabinet. 
Routine culture of stem cells in physiological normoxia enhanced the functional profile of 
stem cell populations including proliferation, metabolic activity and stemness. In contrast, 
culture of cancer cells in reduced oxygen caused significant decreases in growth profiles (vs. 
air oxygen). Quantitative RT-PCR and Western blots results of cells cultured in reduced 
oxygen revealed significant transcriptional translational downregulation of DNMT3B and 
TET1 vs. air oxygen (except for TET1 in cancer cell lines cultured in 2% O2 where it 
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increased significantly), accompanied by significantly reduced in levels of 5mC and 5hmC 
(again except for 5hmC in cancer cell lines cultured in 2% O2 where significant increases 
were noted). Noteworthy was that the downregulation in gene expression of DNMT3B was 
associated with an increase in its CpG promoter methylation. Importantly, these changes 
observation was associated with increases HIF2A, at protein levels in most cell types 
investigated. The role of physiological oxygen in these changes was confirmed by 
transitioning cancer cell lines between 2% O2 and air oxygen and detailing the reversibility 
of both DNMT3B and DNMT3L expression at mRNA level and promoters CpG island 
methylation. Together these data suggest that the level of 5mC is reduced by HIF2A, via 
DNMT3B- mediated methylation.   
In conclusions, our cells display oxygen-sensitive methylation patterns where de novo 
methylation is linked to oxygen culture and correlates directly with transcriptional and 
translational regulation of the de novo methylase DNMT3B. Delineating cancer and stem 
cell biology under niche-like culture conditions will ultimately enhance our understanding 
of mechanisms of action promoting improvements to both tumour-targeting medicines and 
regenerative medicine applications. 
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Chapter 1: Introduction 
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1-Introduction 
Epigenetics research has recently been increases remarkably in an attempt to understand the 
mechanisms of gene expression, cellular development and disease. Epigenetics describe the 
heritable changes in gene function that occur without changes in the DNA sequence (Zhang 
et al., 2010; D’Urso and Brickner, 2014). The molecular basis of heritable epigenetics has 
been examined in a variety of organisms and there are many mechanisms by which 
epigenetics can control the process of gene expression, but generally these include: DNA 
methylation (chemical alteration of DNA); modifying the histone proteins related to DNA 
(histone modication) and chromatin remodelling. There is a complex interplay between these 
operations and they all act to regulate the activity of gene expression (Bird, 2007; Bossdorf 
et al., 2007; Gal-Yam et al., 2008). 
In parallel to the study of epigenetics progress has been made in the study of stem cells. It is 
the characteristics of these cells that provide hope and promise for the treatment of many 
diseases and disorders including cancer, Alzheimer’s disease, Parkinson’s disease, Cardiac 
regeneration, and diabetes amongst other diseases (Sager et al., 2007; Jung et al., 2012). In 
addition, stem cell research has played a significant role in promoting understanding of the 
basics of differentiation and growth, as well as the evolution of diseases such as cancer 
(Rubio et al., 2005). Stem cells are characterized by three key properties which makes them 
distinct from other cells. Firstly, stem cells have the capacity to divide and self-renew, unlike 
other cells in the body; secondly, stem cells are non–specialized cells; thirdly, stem cells can 
differentiate and turn into multiple types of specialized cells found within the body, such as 
blood cells, bone cells, etc. under physiological conditions and in response to activation of 
specific families of genes. Differentiation capacity is ultimately dependent on the potency 
and variety of stem cell under investigation. Researchers predominantly utilize two main 
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sorts of stem cells for research purposes: embryonic or pluripotent stem cells and adult stem 
cells such as mesenchymal stem cells (Polok and Bishop, 2006). 
The relationship between stem cells and their niche and the significant role that the niche 
plays in maintenance, self-renewal and differentiation is currently under examination. The 
niche itself refers to the unique local microenvironment where an individual population of 
stem cells reside. Stem cells react with their niche through adhesion molecules and 
subsequent biochemical signalling translated into transcriptional machinery that preserves 
the characteristics of stem cells. Greater understanding of the nature of stem cells and their 
niches are expected to offer alternative routes in the handling of different diseases such as 
malignant neoplastic disease (Iwasaki and Suda, 2009). It is also clear that oxygen tension 
is involved in the regulation of stem cell behaviour and that it is an essential part of the stem 
cell microenvironment (Ma et al., 2009). Recent investigations have demonstrated that 
hypoxic niches can play a part in maintaining the undifferentiated state of several stem cells, 
including embryonic, mesenchymal and cancer stem cells and as well as having strong 
effects on proliferation and differentiation (Mohyeldein et al., 2010). 
Despite improvements in diagnosis and treatment of cancer, it is still one of the major causes 
of death in the world alongside heart diseases. Cancer is a disease characterized by 
uncontrolled cellular proliferation and differentiation (Parkin et al., 1999; Alghamdi and 
Khorshid, 2012). It is well-recognized that the development and progression of many cancers 
are influenced by the interactions between cancer cells and their local tumour 
microenvironment. Clinical investigations have indicated that hypoxia is associated with 
several tumour types, especially solid cancers (De Veirman et al., 1014). On the other hand, 
it has been shown that hypoxia is responsible for reducing DNA repair processes and, 
consequently, increasing mutagenesis (Vaupel, 2004).  
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Recently, it has been reported that cancer appears to have both epigenetic and genetic basis 
(Sadikovic et al., 2008). In addition, the role of epigenetic mechanisms and their responses 
to carcinogens has been explored. Recent research has indicated that cancer cells display 
similar epigenetic modifications to those associated with the differentiation of a stem cell 
(Ortiz-Sa'nchez, 2014). Moreover, there is increasing evidence that hypoxia plays an 
essential part in gene regulation (Weston et al., 2010). Therefore, better understanding of 
epigenetics changes could trigger new approaches, to understanding how the local 
microenvironment can modify cells to trigger disease without initiating mutations as a key 
primary process of disease development. 
The figures pathways presented in this thesis are generic, exist in most cell types and all 
exceptions was listed. 
1.1 Epigenetics 
In 1942, the term epigenetics was used for the first time by Conrad Waddington to describe 
the interactions between genotype and phenotype during development. He had hypothesized 
that non–genetic factors participate in the process of development of embryogenesis 
(Waddington, 1942; Altun et al., 2010). Epigenetics was also used to answer questions that 
cannot be explained by genetics alone, such as why identical twins have different types of 
diseases, although they have the same DNA sequence? Also, why do all cells in the body 
have the same genetic information, but tissue and organs have different functions? (Jorde 
and Wooding, 2004; Altun et al., 2010). The term epigenetics has been outlined in numerous 
ways over the years. At this time, epigenetics is defined as “the heritable changes in 
phenotype or gene expression not caused by the alteration in the underlying DNA sequence” 
(Probst et al., 2009). The basis of molecular epigenetic modifications has been explored in 
many organisms (Bird, 2007). However, there are various mechanisms by which epigenetics 
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can regulate gene expression; but in general, they are divided into either chemical 
modulation of DNA (DNA methylation) and histone modifications (Allen et al., 2009). 
These mechanisms play an essential role as modifications can have significant impact on 
chromatin structure and transcriptional activity of genes. In contrast to genetic aberrations, 
epigenetic changes are a reversible phenomenon (Boultwood and Wainscoat, 2007). 
Furthermore, these mechanisms play a fundamental role in different biological processes 
such as in normal mammalian development, embryogenesis, cellular differentiation, and 
cancer biology (Dueñas-González, 2005; Wegman-Ostoisky et al., 2007). Principally, these 
alterations can work alone, or in combination, to generate conformational modifications 
(remodelling) of chromatin which influences its accessibility to transcriptional machinery, 
and which thereby regulates transcriptional capability (Narlikar et al., 2002). 
1.1.1 DNA methylation (5mC) 
The first described covalent modification of DNA and the most extensively studied 
epigenetic modification to date is DNA methylation (Lechner et al., 2010; Sharam et al., 
2010; Dawson and Kouzarides, 2012). In mammalian cells, DNA methylation (5mC) refers 
to the covalent modification of the cytosine base that primarily occurs in the context of a 
CpG dinucleotide within the DNA sequence (i.e. a cytosine immediately followed by a 
guanine) through the addition of a methyl group at 5-carbon position on the cytosine 
nucleotide (Issa, 2012). In general, the epigenetic mark (5mC) can alter the regulatory 
function of these regions without changing the Watson-Crick base pairing of cytosine 
(Schübeler, 2015). This process can alter the biophysical characteristics of DNA and cause 
two effects; blockage of recognition sites of DNA by DNA-binding proteins (MBD) as well 
as allowing other proteins to bind leading to activation or inhibition of the target gene 
(Damelin and Bestor, 2007; Prokhortchouk and De fossez, 2008). However, the distribution 
of CpG dinucleotides in mammals is not uniform within the genome instead being 
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concentrated within small stretches of DNA known as CpG islands. Remarkably, many CpG 
islands are found associated with gene promoter regions such as housekeeping genes and 
tissue-specific genes as well as developmentally regulated genes. Furthermore, in contrast 
to non-island associated CpG sites, which are almost always methylated (approximately 
70%), the CpG sites within promoter associated CpG islands are usually methylation free 
(Suzuki and Bird, 2008; Zhu et al., 2008). The methylation within CpG islands regions often 
serves a key function in a variety of cellular processes including transcriptional silencing, 
genomic imprinting and X-chromosome inactivation (Sadikovic et al., 2008; Sharam et al., 
2010; Kanwal and Gupta, 2012). Mohn et al reported that methylation of CpG islands 
delivers stable silencing of relevant genes which is necessary for normal development and 
cell differentiation (Mohn et al., 2008). An inability to maintain DNA methylation, thereby 
causing aberrant methylation patterns resulting in under-expression and overexpression of 
certain proteins is a hallmark phenotype of a range of diverse diseases including cancer 
(Sharam et al., 2010; Tellez-plaza et al., 2014). 
1.1.2 5-Hydroxymethylcytosine (5hmC) 
A further mechanism thought to be involved in the regulation of DNA methylation patterns 
is the active demethylation of 5mC to 5‑hydroxymethylcytosine (5hmC) by the ten-eleven 
translocation family of deoxygenases (TETs) (Williams et al., 2011; Putiri et al., 2014). 
Historically, 5hmC was first reported in DNA mammals in the early 1970s but its function 
as an epigenetics mark was not discovered until 2009, when researchers noticed a significant 
quantity of 5hmC in Purkinje neurons and brain tissue (Penn et al., 1972; Kriaucionis and 
Heintz, 2009). Recently, several potential roles of 5-hydroxymethylcytosine (5hmC) in 
different organs have been explored (Tellez-Plaza et al, 2014, Fong et al., 2018). In general, 
5hmC is formed by oxidation of the methyl group in 5mC, by either TET1, TET2 or TET3 
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(Tan and Shi, 2012) as shown in Figure 1.1. However, following on from 5hmC detection 
in embryonic stem cells researchers have suspected that 5hmC may help determine 
development fate and be associated with the maintenance of transcriptional regulation and 
differentiation in ES cells as well as regulation of gene expression in the central nervous 
system (Li et al., 2013). Genome wide identification studies of ESCs have located high 
concentrations of 5hmC at transcription start sites (TSSs) of CpG-rich promoters (Williams 
et al., 2011; Ecsedi et al., 2018). Furthermore, global decreases in 5hmC level have been 
noted in many neoplasia including colon, prostate and breast through changes in the level of 
TETs expression (Ko et al., 2010; Haffner et al., 2011; Uribe-Lewis et al., 2015). Reports 
have now shown that the location of DNA methylation within a gene and its type are essential 
in determining its function. Importantly, it has observed that 5mC and 5hmC always co-
exist, but they have different regulatory functions at gene promoters (Williams et al., 2011; 
Xu et al., 2011). For example, 5mC is often associated with repression transcription whereas 
5hmC is involved in increased gene expression (Mariani et al., 2014). The role of the “sixth 
base” in the epigenetic control of gene regulation and disease development is under 
investigation (Chen et al., 2012; Ecsedi et al., 2018). This study will refer to 5mC and 5hmC 
collectively as DNA methylation and individually as cytosine methylation (5mC) and 
cytosine hydroxymethylation (5hmC). 
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Figure 1.1 Chemical structures of 5-methylcytosine (5mC) and its oxidation products 
5-hydroxymethylcytosine (5hmC). DNA methylation occurs at cytosine bases when a 
methyl group is added at the 5' position on the pyrimidine ring by a DNA methyltransferase 
(DNMTs). Demethylation of 5mC to 5‑hydroxymethylcytosine (5hmC) occurs by ten-
eleven translocation family of deoxygenases (TETs).  
 
1.1.3 Regulation of DNA methylation 
Three catalytically active members of methyltransferase enzymes (DNMTs) are directly 
involved in establishing and maintaining the cytosine methylation patterns in mammals 
including DNMT1, DNMT3A and DNMT3B (Cheng and Blumenthal, 2008). Functionally, 
these enzymes have been further categorised into two different classes as shown in Figure 
1.2. DNMT1, which is involved in the maintenance of heritable epigenetic marks during cell 
division, and DNMT3A and DNMT3B, which work in co-ordination with DNMT1 and are 
responsible for de novo methylation, typically during early development (Gopalakrishnan et 
al., 2008). DNMT1 is mainly produced during the S phase of the cell cycle and possesses a 
strong affinity for the hemimethylated DNA genome (Robertson et al, 2000; Dhe-Paganon 
et al., 2011). The importance of normal formation and maintenance of DNA methylation 
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patterns during growth and development have been confirmed in several gene targeting 
experiments (Sadikovic et al., 2008). Mouse homozygous mutants deficient in DNMT1 
expressed a lethal phenotype, resulting in stunted development, and gross morphological 
abnormalities where consequentially the embryos did not survive past mid-gestation (Li et 
al., 1992).  
DNMT3A and DNMT3B are both highly expressed during embryonic development and 
down-regulated post-differentiation (Turek-Plewa and Jagodzinski, 2005; Athanasiadou et 
al., 2010). Further evidence of the importance of DNMT3A and DNMT3B in de novo 
methylation was observed in mutation studies in embryonic stem cells (ESCs). Double 
mutant ESCs [Dnmt3A-/-, Dnmt3B-/-] showed a complete lack of de novo methylation 
(Okano et al., 1999). In addition, inactivation of both DNMT3 enzymes in mice results in 
embryonic lethality (Jones and Baylin, 2002). In addition to these two groups of enzymes, 
two further kinds of DNMT like proteins, particularly, DNMT2 and DNMT3L are also 
associated with DNA methylation. DNMT3L is homologous to DNMT3A and DNMT3B 
and it has been documented that DNMT3L specifically recognizes non-methylation histone 
and acts as a cofactor involved in the methylation of DNA by both enzymes (DNMT3A and 
DNMT3B) (Wienholz et al., 2010). Furthermore, a recent study has shown that DNMT3L 
takes part in maternal methylation imprinting and that the absence of DNMT3L in mice leads 
to defects in methylation of Oocytes and Spermatogenesis (Suetake et al., 2004).  
On the other hand, it has been reported that 5hmC is involved in the regulation of DNA 
methylation by acting as a guardian of CpG islands (maintaining them as DNA methylation 
free) (Williams et al., 2012). The fact that 5hmC is enriched at promoter regions and 
transcription start sites (TSSs) suggests that 5hmC may be derived from pre-existing 5mC 
being converted to 5hmC specifically at CpG islands (Williams et al., 2012). Le et al found 
in bacteria that 5hmC can be converted back to 5mC through removal of a formaldehyde 
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group from 5hmC by the DNMT enzymes (Le et al., 2011). However, consistent with the 
role of TETs in converting 5mC into 5hmC in vivo, TET1 knockout mESCs have decreased 
levels of 5hmC accompanied by a slight increase in global level of 5mC (Dawlaty et al, 
2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 De novo and maintenance DNA methylation during replication in 
mammalian cells. Maintenance methylation activity is necessary to preserve DNA 
methylation after every cellular DNA replication cycle. De novo methylation is catalysed by 
DNMT3A/B during semi-conservative replication, the resultant daughter DNA strands are 
hemi-methylated. DNMT1 is involved in the maintenance of heritable epigenetic marks 
during cell division and possesses a strong affinity for hemimethylated DNA genome. The 
actions of the de novo methyltransferases are regulated by DNMT3-like protein (DNMT3L) 
which can stimulate or repress the activity of these enzymes. 
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1.1.4 DNA methylation regulates gene expression 
DNA methylation plays an essential role in the repression and promotion of gene expression. 
The mechanism by which methylation represses gene expression is yet to be established but 
it is suggested that gene promoters are unmethylated to allow transcription factors to bind to 
their binding site (Chen et al., 2011). In line with this idea, Philips et al reported that the 
levels of methylation vary near the transcription sites depending on cell type. In addition, 
this change in extensive methylation patterns at gene promoters correlates with reductions 
in gene expression (Philips, 2008). However, there are two potential mechanisms for the 
regulation of gene expression by DNA methylation as shown in Figure 1.3. Firstly, some 
transcription factors are unable to bind to their binding site if it contains methylated cytosine. 
Secondly, induced gene silencing through recruitment of methyl CpG binding domain 
(MBD) proteins which interact with a cytosine methyl group leading to alteration of the 
chromatin activity via complex development with other particles such as histone 
modification enzymes including histone deacetylates (HDACs) and histone methyl 
transferases (HMTs) (Fuks et al., 2001; Fatemi and Wade, 2006; Klose and Bird, 2006). 
MBDs constitute a family of five methyl-binding proteins which are known as epigenetic 
methyl signature readers which include MeCP2, MBD1, MBD2, MBD3 and MBD4 (Fatemi 
and Wade, 2006). In addition, it has been reported that most of the MBD family members 
associate with large protein complexes containing nucleosome remodelling activity and 
histone deacetylation activity (HDACs) that are involved in the process of transcription 
silencing through modification of chromatin components (Fatemi and Wade, 2006). On the 
other hand, little information is known about the role of 5hmC as a gene expression regulator, 
but it has reported that 5hmC is involved in regulation of gene expression through altering 
chromatin structure or recruitment or displacement of other DNA binding proteins that affect 
transcription (Fong et al., 2008). Zhang et al reported that 5hmC is involved in gene 
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regulation through inhibition of the binding of methyl CpG binding proteins 2 (MBP2) at 
CpG sites (Zhang et al., 2012). In line with this idea, TETs may be involved in gene 
regulation through adjusting DNA methylation levels at promoter regions and this finding is 
supported by fact that both TETs and 5hmC localise to TSSs in mESCs (Williams et al., 
2011). However, Wu et al reported that 5hmC at promoter regions is associated with gene 
repression while within the gene was associated with active gene transcription (Wu et al., 
2011). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Regulation of gene expression by DNA methylation. DNA methylation can 
alter the biophysical characteristics of DNA and cause two effects; blockage of recognition 
site of DNA by DNA-binding proteins as well as allows other proteins to bind leading to 
activation or inhibition of the target gene in these regions. 
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1.2 Stem cells 
Stem cells are defined as undifferentiated or unspecialised cells that can differentiate and 
generate more specialised cells. Stem cells can be divided into two main types: embryonic 
stem cells from the embryo and adult stem cells from adult tissue. Stem cells have the 
capacity to self-renew and differentiate into one or more types of specialized cell in the body 
(Polok and Bishop, 2006). Stem cells are classified according to their capacity for 
differentiation as shown in Figure 1.4. Examples are: 
• Totipotent stem cells are found only in early progeny of the zygote (1-3 days). These 
cells have ability to differentiate into all types of specialized cells found within the 
body and the placenta and subsequently develop into a complete organism (Mitalipov 
and Wolf, 2009).  
• Pluripotent stem cells are derived from the undifferentiated inner cell mass (ICM) of 
the blastocyst (5-14 days). These cells can differentiate into cell types representative 
of the three germ layers (endoderm, mesoderm and ectoderm) such as, embryonic 
stem cells (Mitalipov and Wolf, 2009). 
• Multipotent stem cells. These cells have the basic characteristics of all stem cells. 
These cells can differentiate into multiple cell types in a single germ layer. An 
example is the multipotent blood stem cell (Hematopoietic) which can differentiate 
into roughly 11 cell types found within blood such as red blood cells, white blood 
cells or platelets (Bianco, 2011). 
In addition to those above unipotent stem cells represent another group of stem cell with 
the capacity to differentiate into only one specific cell type (Nii et al., 2014). 
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Figure 1.4 Schematic diagram illustrating the stem cell hierarchy. Embryonic stem cells 
(ESCs) are pluripotent and have the capacity to differentiate into cells of all three dermal 
layers, that is, endoderm, mesoderm and ectoderm. Adult stem cells are multipotent, and 
have a more restricted ability to differentiate, being committed to a specific lineage (Hayes 
et al., 2012). 
 
1.2.1 Human pluripotent stem cells 
1.2.1.1 Human embryonic stem cells  
The therapeutic potential of stem cells holds great promise in treating many human diseases 
due to their unique properties. Human embryonic stem cells (hESCs) are derived from the 
undifferentiated inner cell mass (ICM) of the blastocyst (Watt and Driskell, 2010). ESCs are 
pluripotent and are characterized by their potential to replenish themselves (self-renew) and 
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their ability to differentiate into cell types representative of the three germ layers (endoderm, 
mesoderm and ectoderm) and form any of the over 200 different cell types found in the body 
(De Wert and Mummery, 2003; Watt and Driskell, 2010). Thus, they have been considered 
to have brought great hope to the field of regenerative medicine therapy, tissue 
transplantation and drug discovery (Ho et al., 2012; Nii et al., 2014). In 1998, the first human 
embryonic stem cell lines were developed successfully in plastic laboratory culture dishes 
by Thomson and colleagues (Thomson et al., 1998). Study of undifferentiated hESCs with 
electron microscopy has shown that hESCs have a high ratio of nucleus to cytoplasm, 
prominent nucleoli, indistinct cell membranes and free ribosomes (Oh et al, 2005). In 
addition, hESCs are characterized by the expression of a set of cell surface markers such as 
SSEA-4, SSEA-3, TRA-1-60 as well as TRA1-80 and to lack expression of a lactoseries 
oligosaccharide antigen, SSEA-1 that is expressed upon differentiation, and expression of 
transcription factor OCT-4 (Vazin and Freed, 2010). 
Maintenance of pluripotency and self-renewal is an important feature of hESCs and 
understanding the mechanisms involved in hESCs differentiation in vitro is essential for 
further understanding of the development of functional cells. The OCT-4, SOX-2 and 
NANOG transcription factors are important regulators that govern the self-renewal of hESCs 
through activation or repression of gene expression (Boyer et al., 2005; Galvagni and Neri, 
2015). During mammalian development, OCT-4 is an essential regulatory molecule that is 
implicated in the initial cell fate decision (Loh et al., 2006). Indeed, overexpression of OCT-
4 in hESCs pushes differentiation towards primitive endoderm and mesoderm whereas 
disruption of OCT-4 leads to dedifferentiation toward the trophectoderm (Matin et al., 2004). 
In addition, it is reported that OCT-4 interacts with SOX-2 and both are involved in gene 
activation and repression in vivo. NANOG is essential to block differentiation and can 
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preserve the pluripotent state of ESCs during embryonic development (Boyer et al., 2005, 
Saunders et al., 2013). 
1.2.1.2 Induced pluripotent stem cell  
Induced pluripotent stem cells (iPSCs) have been added to the field of stem cells with similar 
embryonic stem cells characteristics including morphology, proliferation ability as well as 
the expression of ESCs specific cell surface antigens (SSEA-3, SSEA-4, TRA-1-60 and 
TRA1-80) (Mitalipov and Wolf, 2009). Induced pluripotent stem cells are adult cells that 
have been genetically reprogrammed to an embryonic stem cell–like state via transduction 
of four defined factors (OCT-4, SOX-2, Klf4 and c-Myc) (Takahashi and Yamanaka, 2006; 
Takahashi et al., 2007). Mouse iPSCs were first reported in 2006, and human iPSCs were 
first reported in late 2007 (Takahashi and Yamanaka, 2006; Takahashi et al., 2007). Human 
iPSCs express the endogenous genes (OCT-4, SOX-2 and NANOG) and can generate cells 
characteristic of all three germ layers (Salci et al., 2015). 
1.2.2 Adult stem cells  
Adult stem cells (ASCs), which also includes fetal and somatic stem cells, are found in 
tissues such as bone marrow, blood, liver, skin and muscle amongst other tissues and are 
present as undifferentiated cells amongst other differentiated cells (Fujimaki et al., 2013). 
Adult stem cells within tissues have the ability to support repair and differentiate into other 
representative specialized cell types (Kondo, 2010). The typical role of an adult stem cell is 
to maintain and replenish their tissue of origin throughout an individual’s life (Fujimaki et 
al., 2013).  
In general, adult stem cells can be classified depending on (1) The ability to differentiate 
into different cell types where adult stem cells can have two kinds of cell potency including 
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multipotent stem cells such as, human mesenchymal stem cells (hMSCs) and unipotent stem 
cells such as muscle stem cells (Meirelles, 2009). (2) The germ layer they come from, for 
example, endoderm layer makes up pancreas, lung, intestine and liver while ectoderm layer 
gives rise the skin, nervous system, hair and mammary glands. On the other hand, muscle, 
mesenchymal stem cells and circulatory system generated from mesoderm layer (Haasters 
et al., 2009).  
1.2.2.1 Mesenchymal stem cells  
Bone marrow (BM) is the most common source for isolation of mesenchymal stem cells, but 
other tissues such as adipose tissue, compact bone, liver, intestinal tract, kidney, and 
umbilical cord blood have also been utilised as a source for isolation of mesenchymal stem 
cells (Gao et al., 2014). Mesenchymal stem cells (MSCs) are a specific rare population of 
adherent cells that constitute about 1 in 10,000 of bone marrow mononucleated cells. These 
cells are characterized by the ability to produce single cell colonies, and their capacity to 
adhere to tissue culture plastic. These colonies are termed the CFU-F (Colony Forming Unit–
fibroblast) (Wang and Wagers, 2011). The first descriptions of human mesenchymal stem 
cells (hMSCs) were discovered by Friedenstein and colleagues in the early 1970s as a non-
hematopoietic stem cell. It was established that hMSCs were able to differentiate into a range 
of lineages including osteoblasts (bone cells), chondrocytes (cartilage cells) and adipocytes 
(fat cells) (Friedenstein et al., 1968; Karystinou et al., 2009). Furthermore, several recent 
studies have observed that hMSCs can differentiate into other lineages such as myocytes and 
neurons (non-mesenchymal lineages) (Bossolasco et al., 2005). In addition to multipotency, 
one of the main properties of MSCs is their inability to self-renew and that the maintenance 
of the non-differentiated state is lost over several cell divisions (Sethe et al., 2006). In vitro, 
BM-derived MSCs can be cultured easily and can be expanded to relatively high numbers 
for use in different applications (Bernardo et al., 2007). In general, hMSCs have three 
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primary functions linked to their potential therapeutic use including tissue repair via 
molecule secretion, tissue replacement through multipotent properties, and their 
immunomodulatory functions (Devine et al., 2003; Ryan et al., 2005). By contrast, 
information about hMSCs in vivo is very poor for two reasons, rarity in different tissues as 
well as the difficulty of isolating a large quantity and high purity of hMSCs (Boguest et al., 
2005). However, MSCs usually exist in a very low concentration within a given tissue. In 
order to distinguish them from other cell populations, it is possible to exploit the cell surface 
markers which are unique for each cell type. These are proteins molecules, also known as 
“receptors” that coat the surface of all cells, and are able to bind to other cells, surfaces or 
proteins. CD (cluster of differentiation) markers are commonly used to identify stem cell 
types in bone marrow, but additionally a number of antibody-binding receptors, antigens, 
can also be used (Chippendale et al., 2011). However, the International Society for Cellular 
Therapy has defined minimal guidelines for MSCs characterisation including; plastic 
adherence, multi-lineage differentiation into fat, bone, and cartilage, together with a surface 
expression of stem cell markers (CD73, CD90, and CD105), with lacking expression of 
haematopoietic markers (CD34, CD45, CD11a, CD19 or CD79a, CD14 or CD11b and 
histocompatibility locus antigen (HLA)-DR) (Dominici et al., 2006).  It must also be 
considered that many different cell types may have a number of markers in common, so in 
order to isolate a specific stem cell population contained within the highly heterogeneous 
bone marrow, or to further separate the sub-populations of the adherent fraction, a 
combination of different markers must be used (Chippendale et al., 2011).  
1.2.3 The role of DNA methylation in stem cell regulation 
DNA methylation plays a major role in the regulation of stem cell differentiation and is 
essential for maintenance of stem cell characteristics (Huang et al., 2013). hESCs have been 
shown to have unique DNA methylation marks when compared to DNA methylation status 
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of both differentiated cells and cancer cells (Bibikova et al., 2006; Altun et al., 2010). 
However, high expression levels of the de novo methyltransferase enzymes (DNMT3A and 
DNMT3B) occur during development especially in undifferentiated cells which reduce 
during cellular differentiation (Li et al., 2007; Totonchi et al., 2017). In addition, the 
pluripotency-associated genes such as OCT-4 and NANOG become methylated (silenced) 
to allow stem cell to differentiate into specific lineages (Gopalakrishnan et al., 2008; Pelosi 
et al., 2011). Moreover, as differentiation continue, the global DNA methylation decreases 
but the fundamental methylation profile is maintained by DNMT1 (Ludwig et al., 2014). 
The significance of methylation on the genes that associate with pluripotency is dependent 
on the stages of embryogenesis and on specific cell types. For example, promoter regions of 
DNA can be hypomethylated in mouse ES cells but are hypermethylated in trophoblast ES 
cells (Gopalakrishnan et al., 2008). Furthermore, Ho et al found that some genes were 
unmethylated in ESCs with no transcriptional, but that these genes could be supressed by 
DNA methylation during differentiation (He et al., 2018). Changes in DNA methylation are 
important for stem cell differentiation as methylated DNA alters the interaction between 
transcription factors and their binding sites (TFBSs) on DNA (Chen et al., 2011) or by 
formation of complex with other molecules such as histone modification enzymes that alter 
chromatin activity (Hutnick et al., 2009). 
However, knockout of DNMT leads to loss ESCs the ability to differentiate while retaining 
the ability to replenish themselves (self-renewal). These results suggested that DNMTs play 
a prominent epigenetic role in pluripotency (Okano et el., 1999; Hu and Rosenfeld, 2012). 
In addition, another DNA methylation mechanism is involved in regulation of hESCs 
pluripotency; TETs enzymes (Moore et al., 2012). It has reported that global 5hmC levels 
significantly changed during lineage commitment of pluripotency stem cells into neural cells 
(Kim et al., 2014). On the other hand, knockout of TET1 in mESCs results in reduced levels 
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of 5hmC and an associated slight increase in global 5mC level (Dawlaty et al., 2011). 
Recently, Samadian et al found that the expression of TET1 was significantly upregulated 
during embryonic stem cells (ESC) derivation. Moreover, they also demonstrated that 
maintaining DNA methylation at low levels was essential to establish the ground-state of 
pluripotency during the early days of ESC derivation (Samadian et al., 2018).  
1.3 Cancer: Genetics versus Epigenetics   
Despite significant progresses in diagnostics and treatment methods and ongoing basic 
research of cancer disease, it is still the major cause of death in the worldwide alongside 
cardiac diseases (Parkin et al., 1999; Han et al., 2017). Traditionally cancer has been viewed 
as a disease characterised by the accumulation of genetic mutations, resulting in a multistep 
process of tumour pathogenesis (Hanahan and Weinberg, 2011; You and Jones, 2012). Loss 
or gain of function mutations of tumour suppressor genes and/or oncogenes respectively 
contribute to the development of a multitude of cancer hallmarks, including sustained 
proliferation, resistance to cell death and the ability to metastasise (Bertone et al., 2004; 
Cheng et al., 2005; Hanahan and Weinberg, 2011). Nonetheless, genetic alterations in cancer 
alone does not seem to present a complete explanation of the complexities of carcinogenesis 
and the acquisition of tumour heterogeneity (Sadikovic et al., 2008; Kanwal and Gupta, 
2012). Recently, it has been reported that cancer appears to have both an epigenetic and 
genetic basis, which is thought to interact to potentiate tumourigenesis (Baylin and Herman, 
2000; Baylin and Jones, 2011). Whilst the genetic aetiology of cancer has been well 
researched, the role of epigenetic alterations in response to changes within the tumour 
microenvironment is poorly understood (Baylin and Jones, 2011). Notably, targeting 
epigenetic mechanisms may present a significant potential for clinical translation, as despite 
the heritability of epigenetic marks, the ability to reverse these changes presents new 
opportunities for therapeutic strategies, highlighting the importance of understanding cancer 
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epigenetics (Jacqueline and Wainscoat, 2007; Kanwal and Gupta, 2012; Kagohara et al., 
2018). 
1.3.1 Role of DNA methylation in cancer 
Tumour initiation and progression have been known to be aided by the DNA methylation of 
the CpG islands of the promoter region of tumour suppressor gene which is the best studied 
epigenetic modification in cancer, and this is present in about 70% of all mammalian 
promoters (Dawson and Kouzarides, 2012). However, during tumour initiation and 
progression, cancer cells are marked by major disruptions in their DNA methylation profiles, 
displaying a complete reversal to the normal methylation patterns observed in healthy cells 
(Sadikovic et al., 2008; Sharma et al.,2010). This includes hypermethylation of CpG islands 
in gene promoter regions and global hypomethylation, resulting in alterations of key genes 
and downstream signalling pathways (Sadikovic et al., 2008; Sharma et al.,2010; You and 
Jones, 2012).  
In cancer, hypermethylation in gene promoter regions has been implicated in tumorigenesis 
through the epigenetic silencing of key tumour suppressor genes (Sadikovic et al., 2008; 
Sharma et al.,2010). Many tumour suppressor genes silenced by DNA hypermethylation 
have been well characterized, these include: BRCA1, RASSF1A, CCBE1, OPCML, 
MGMT, HOXA9, and hMLH1 (Kawakami et al., 2011; Lonning et al., 2011; Gloss and 
Samimi, 2014; Dong et al., 2016). Chmelarova et al reported P53 promoter methylation in 
51.5% of ovarian cancer (Chmelarova et al, 2013). These genes are involved in various 
cellular processes such as DNA repair, cell cycle, cell adhesion, apoptosis and angiogenesis 
which are all important in cancer development, and the hypomethylation of repeated DNA 
sequences leading to over expression of tumour causing genes known as oncogenes, thereby 
causing genetic instability by promoting chromosomal re-arrangement as shown in Figure 
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1.5 (Liu et al., 2009; Sharma et al., 2010; Earp and Cunningham, 2015). Epigenetic silencing 
is thought to also contribute to tumour initiation acting as the second hit in Knudson's two-
hit hypothesis of tumour suppressor gene inactivation (Jones and Laird, 1999; Sharma et al., 
2010). Interestingly, the degree of hypomethylation is correlated with tumour grade, stage 
and aggressive clinical characteristics in many cancers such as liver and colon (Daskalos et 
al., 2009; Sunami et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Typical DNA methylation profiles in normal mammalian and cancer cells. 
A global DNA hypomethylation of the genome in cancer cells at repeated sequences is 
observed together with DNA hypermethylation at specific gene-promoter region, such as 
tumour suppressor genes with silencing the corresponding gene. This pattern may lead to 
genomic instability and/or loss of, or reduced, transcription and following expression. 
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In contrast, global hypomethylation is thought to play a significant role in tumorigenesis 
through the activation of proto-oncogenes (Sharma et al., 2010). Several genes have been 
identified including H-RAS, a gene involved in cell proliferation. Consequently, this in 
addition to the increase in genetic instability that is cause by global hypomethylation, all 
may potentially contribute to the development and progression of cancer (Sharma et al., 
2010). 
In addition, mutations and epigenetic dysregulation of TET1 have been linked to leukaemia 
(Ko et al., 2010). Additionally, TET1overexpression has been found to have an oncogenic 
role in acute myeloid leukemia (AML) with MLL gene re-arrangement (Huang et al., 2016). 
Hypermethylation of promoter TET1 was found to be associated with increased DNA 
methylation in most of its target genes (Ko et al., 2010). Hsu et al and Sun et al found that 
TET1 is an essential tumour suppressor in prostate and breast cancers (Hsu et al., 2012; Sun 
et al., 2013). Generally, cancer cells have lower levels of 5hmC vs. normal cells in various 
cancers. However, it still unknown whether the loss of 5hmC is a cause or a consequence of 
tumorigenesis. Scourzic et al suggested that abnormal patterns of DNA methylation during 
differentiation and ageing processes might be a factor in carcinogenesis (Scourzic et al., 
2015). 
1.4 Oxygen, niche and hypoxia 
Oxygen is one of the most important factors in the life of many organisms (Konigsberg et 
al., 2013). In mammals, oxygen plays a key role in regulation of many cellular functions 
such as cell metabolism, cell division and differentiation (Ivanovic, 2009; Konigsberg et al., 
2013). Oxygen concentrations vary widely across different human tissues, but in general, are 
much lower than the 21% oxygen in atmosphere air. However, in a manner which displays 
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dependence on the distance away from the vasculature, the oxygen tension can range from 
between 0.1% - 12% with an average of 2% O2 (Stamati et al., 2011; Jez et al., 2015). For 
example, oxygen level ranges from 0.5% to 7% in the brain (Hemphill et al., 2005). In the 
bone marrow ranges are between 0.5% to 4% (Chow et al., 2000) while in the eye it can vary 
from 1% to 5% (Yu and Cringle, 2005). The human embryo is initially developed in an 
environment (female reproductive tract) where the oxygen level is far lower than that of air 
oxygen condition (Adam et al., 2004). It is reported that oxygen tensions of 5-10% or lower 
enhances development of embryos from different species (Karja et al., 2004). In contrast, 
higher oxygen is found to be harmful to human embryos probably due to formation of 
reactive oxygen species (ROS) such as hydrogen peroxide and superoxide that causes DNA 
damage, alter gene expression and induce epigenetic modifications during embryonic 
development by affecting kinases and gene transcription (Yuan et al., 2003; Meintjes et al., 
2009; Donkena et al., 2010). However, in vitro it is reported that development of embryos 
depends on the quality of culture environment to which embryos are exposed to (Yuan et al., 
2003). Also, Forsyth et al found that reduced oxygen tension in the ranges 2-5% are 
associated with reduced telomere shorting and enhanced proliferation in culture primary 
mortal fibroblasts (Forsyth et al., 2006). 
However, the cell “niche” concept was first proposed by Schofield in 1978 and refers to the 
particular microenvironment where stem cells reside in vivo (Schofield et al., 1978; 
Papagiannouli and Lohmann, 2015). The stem cells can reside in perivascular niches which 
exhibit low oxygen tensions, even with cells that associate closely with blood vessels such 
as mesenchymal stem cells, found with bone marrow (ranges 1-7% O2), which is lower than 
the oxygen level in peripheral blood (Mohyeldin et al., 2010; Sheehy et al., 2012; Jing et al., 
2012). Recent reports have confirmed that the communication and interaction between stem 
cell niche elements and architecture including cells, the oxygen tension, blood vessels, 
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matrix glycoproteins and the three-dimensional space is important for stem cell self-renewal 
and differentiation (Mohyeldin et al., 2010). The stem cell niche maintains the cells primarily 
in a quiescent condition through inhibit of cell proliferation and maintenance of a low 
metabolic state via specific signals provision. However, when there is demand, cells respond 
to altered signals quickly via disruption of the homeostatic balance between symmetric and 
asymmetric divisions (Li and Neaves, 2006; Gattazzo et al., 2014). However, reduced 
oxygen can occur under many physiological conditions such as normal embryonic 
development and many human pathological conditions, including cancer (Semenza, 2010; 
Damaki et al., 2012). In addition, the discovery of the hypoxia inducible factor (HIF) as a 
major regulator of the cellular response to hypoxia opened new windows for researchers to 
investigate the critical role of this factor in regulation of many cellular processes by changing 
the transcriptional activity of genes and protein production (Adamaki et al., 2012). Normoxia 
is referred to air oxygen (21% O2) whilst physiological normoxia/hypoxia refers to a 
condition where the oxygen level inside the human body is significantly lower than that in 
the atmosphere (between 1% and 5%,) (Loicono and Shapiro, 2010; Zhi et al., 2018).   
1.4.1 Mechanism response to reduced oxygen (hypoxia) 
The mechanism of oxygen level driven modulation of cellular behaviours is linked to the 
Hypoxia inducible factors-1A (HIF1A). HIFs consists of three isoforms: HIF1A, HIF2A and 
HIF3A, whereas HIF-1β, also known as ARNT (aryl hydrocarbon receptor nuclear 
translocator), has only one isoform, HIF-1β. Three alpha subunits (HIF1A, HIF2A, and 
HIF3A) all bind to a common subunit HIF-1β (Gordan and Simon, 2007). In brief, under air 
oxygen (normoxia) HIFα is hydroxylated on two conserved proline (P402 and P564) 
residues by a prolyl-hydroxylases family member (PHD1, PHD2, and PHD3). HIFs are 
regulated by Von Hippel Lindau protein (pVHL) which marks hydroxylated HIFs for 
ubiquitination and degradation by proteasome 26S as shown in Figure 1.6. In contrast, under 
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hypoxic conditions hypoxia stabilises HIF1A because the hydroxylation by PHDs is 
prevented, resulting in accumulation of HIF1A in its stable form, translocation into the 
nucleus, and binding to the HIF-1β to form the active HIF dimer (Fandrey et al., 2006; Simon 
and Keith, 2008). HIF1A binds to a specific DNA sequence present in target gene promoters, 
known as the hypoxia responsive element (HRE), and activates a group of genes that 
promote adaptation and survival (Ke and Costa, 2006; Luo et al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Hypoxia inducible factors up-regulation pathway. In normal oxygen tension 
Von-Hippel Lindau (VHL) tumour suppressor protein (pVHL) binds to and target HIF for 
degradation by ubiquitination. On the other hand, in hypoxic condition pVHL does not bind 
to HIF, consequently its levels increase within the cell, where it then subsequently binds to 
downstream hypoxia response elements within the nucleus resulting in the upregulation of 
the expression of genes that facilitate its survival within hypoxic conditions. 
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1.4.2 Low oxygen regulates pluripotent embryonic stem cells 
The ability of stem cells to self-renew or differentiate depends on various micro-
environmental cues including support cells, oxygen tension, soluble growth factors, extra-
cellular matrix, and mechanical forces (Mohyeldin et al., 2010; Abdollahi et al., 2011). In 
the physiological setting, oxygen tension is much lower than the 21% O2 found in 
atmospheric air. In general and depending on the tissue type and where the cells reside, 
oxygen may vary from 12% in peripheral blood to virtually anoxic in deep areas of cartilage 
zones (Amorin et al., 2013). However, Ezashi et al were the first to demonstrate that hESCs 
spontaneous differentiation decreased in 3%-5% O2 vs. atmospheric oxygen (Ezashi et al., 
2005). Simultaneous to these reports it was noted that 2% O2 was more physiological and 
was optimal for undifferentiated hESC proliferation and reduced the spontaneous 
chromosomal abnormalities noted in early and late passage cultures (Forsyth et al., 2006; 
Ludwig et al., 2006). These observations were supported by Närvä et al who confirmed that 
low oxygen led to the maintenance of pluripotency, prevents spontaneous differentiation, 
and enhanced hESCs self-renewal (Närvä et al., 2013). In addition, continuous low oxygen 
tension culture of hESCs led to increase expression of SSEA-3 which is a surface antigen 
that decreases rapidly in response to differentiation (Närvä et al., 2013). Furthermore, it has 
been reported that hypoxia is involved in the activate regulation of molecular pathways 
which govern self-renewal including OCT-4 (Simon and Keith, 2008; Mohyeldin et al., 
2010). In contrast, other researchers have revealed that low oxygen may be a potent stimulus 
for differentiation into specific cell lines (Koay and Athanasiou, 2008). More information is 
needed to understand the optimal oxygen concentration required to stimulate differentiation 
versus maintenance of stemness (Koay and Athanasiou, 2008; Abdollahi et al., 2011). Many 
studies now suggest that hypoxia-inducible factors, HIF-1A and HIF-2A, are master 
regulators of the stemness properties of stem cells and as stimuli for stem cell differentiation 
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(Wenger, 2002; Fong and Takeda, 2008; Mimeault and Batra, 2013). In recent study, Zhi et 
al found that increased HIFs expression under low oxygen (10% O2) enhanced the stemness 
properties and significantly increased the proliferation ability of induced hepatic stem cells 
by quickening G1/S transition via p53-p21 signalling pathway (Zhi et al., 2018).  
1.4.3 The effects of physiological normoxia on mesenchymal stem cells  
The first experiments designed to test the impact of different oxygen concentrations were 
performed by Zwartouw and Westwood in 1958. They observed that the proliferation of cells 
was more rapid in hypoxia conditions when compared with the normoxic state (Zwartouw 
and Westwood, 1958). In mammals, mesenchymal stem cells can be found in perivascular 
niches that are associated closely with vascular structure. In general, the local oxygen level 
in different tissues where MSCs reside is very low. Therefore, it has been hypothesized that 
cultured MSCs in low oxygen tension leads to an improvement in MSCs survival and 
proliferation as well as in the maintenance of typical MSC features (Amorin et al., 2013). 
Many studies have shown that low oxygen culture of MSCs has a significant effect on their 
expansion, delayed senescence, and formation of colony forming units- fibroblasts (CFU-F) 
in contrast to air cultured (Hung et al., 2007; Potier et al., 2007; Berniakovich and Giorgo, 
2013; Kay et al., 2015). Opposite to these findings, other studies have reported that there is 
no difference in the growth rate of MSCs or multipotency when maintained in both lower 
oxygen level and atmospheric conditions (Malladi et al., 2006; Wang et al., 2011). However, 
similar arguments have been raised about the potential of hypoxia to impact on tri-lineage 
differentiation of MSCs. For example, Huang et al found that hypoxia state increased 
differentiation potential to all three lineages in rat MSCs (Huang et al., 2013). Other studies 
indicated that low oxygen tension reduced MSCs differentiation into osteogenic and 
adipogenic lineages (Volkmer et al., 2010; Yang et al., 2011). These contradictory results 
are largely due to the difference in oxygen concentration and cell type (Abdollahi et al., 
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2013). However, BM-MSC, culture in low oxygen (2% O2) for long term led to increase the 
expression of embryonic markers such as OCT-4 (Grayson et al., 2007). Wang et al reported 
that a 5% O2 but not 2% or 10% O2 enhanced the differentiation of adipose tissue-derived 
stem cells (ASCs) to form SMCs with typical functional of SMCs in vitro (Wang et al., 
2018). In addition, low oxygen conditions (2% O2) stimulated the bioactivities of MSCs such 
as proliferation, wound-healing and migration capacity via the HIF1A-GRP78-Akt axis 
pathway (Lee et al., 2017). Furthermore, many studies suggest that low oxygen enhances 
plasticity, survival, proliferation, engraftment, and genetic stability of MSCs (Haque et al., 
2013; Beegle et al., 2015; Huang et al, 2016). However, suitable oxygen tension, optimum 
incubation time, paracrine action, and the underlying mechanism need further investigation 
(Lee et al., 2017). 
1.4.4 Tumour Hypoxia 
 It is well-recognized that the development and progression of many cancers are influenced 
by the interactions between cancer cells and their local tumour microenvironment (Hockel 
and Vaupel, 2001). Oxygen levels in normal tissues are maintained under strict controls to 
ensure normal cellular function, however, oxygen tensions within tumours can range from 
physiological levels of ~7% to severely hypoxic tensions of <0.1% (Heddleston et al., 2010; 
Thirlwell et al., 2011). Hypoxia can arise under many pathological conditions including 
cancer when metabolic demands for oxygen exceeds supply as vascular formation cannot 
keep up with the rate of cancer growth (Semenza, 2010). A study of cancer cells under 
hypoxia conditions indicated abnormal cell proliferation, aberrant blood vessel formation 
via upregulation of angiogenic factors, and metastatic mechanisms (Majmunder et al., 2010; 
Watson et al., 2010). In addition, hypoxia alters cancer cell metabolism and contributes to 
therapy resistance by inducing cell quiescence. Enhancing or reducing the positive or 
negative hypoxic effects on cancer cells could be due to a number of complex intracellular 
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pathways interacting with each other such as HIF, PI3K, MAPK, and NFĸB signalling. 
These pathways can affect many cell processes including cell proliferation, survival, cell 
death, metabolism, migration, and genetic instability. In addition, the HIF pathway is needed 
in physiological processes and is involved in cancer biology by controlling hundreds of 
genes (Beatout et al., 2008; Muz et al., 2014). One such example is vascular endothelial 
growth factor (VEGF) which promotes angiogenesis (Hockel and Vaupel, 2001; Thirlwell 
et al., 2011). Interestingly, this pathway can also be activated as a result of DNA methylation 
within the VHL promotor region, which subsequently results in the transcriptional repression 
and the unopposed activation of HIF (Thirlwell et al., 2011). A recent study shown that 
induction of the HIF pathway by inhibition of the prolyl hydroxylase (PHD) family improved 
blood vessel abnormalities in hypoxic tumours and consequently improved the sensitivity to 
chemotherapeutic drugs by activation transcription of genes that involved in angiogenesis 
(Koyama et al., 2017). 
Furthermore, HIF1A is also involved in down-regulation of some genes such as DNA repair 
(REV3), mRNA processing (hnRNP H1) and cytoskeleton maintenance (Rho kinase) 
(Greijer et al., 2005). Raval et al reported that HIF1A and HIF2A could have opposing roles 
on the same hypoxic inducible genes. For example, HIF1A overexpression is involved in 
restricted tumour growth, whilst an increase of HIF2A expression pushed tumour 
progression (Raval et al., 2005). Recent reports have suggested that the hypoxia 
microenvironment is also involved in cancer progression via activated adaptive 
transcriptional programs that support many biological tumour features such as survival, 
motility, and tumour angiogenesis (Keith and Simon, 2007). Furthermore, genomic 
instability induced by tumour microenvironment, including hypoxia, leads to increased point 
mutations, gene amplification and fragile-site induction (Reynolds et al., 1996; Coquelle et 
al., 1997; Bindra et al., 2005; Luoto et al., 2013). 
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1.5 Hypoxia induces epigenetic marks in cancer 
It has been hypothesized that hypoxic microenvironments may influence alterations in DNA 
methylation, resulting in inappropriate silencing or activation of genes involved in the 
progression of cancer (Shahrzad et al., 2007). However, HIFs are involved in regulation of 
gene expression to hypoxia through interaction with specific DNA sequences known 
hypoxia response elements (HREs) within the DNA genome (Waston et al., 2010). 
Furthermore, DNA methylation can impact cellular adaptation to hypoxic conditions 
through regulation of gene expression (Robinsons et al., 2012). However, changes in DNA 
methylation can influence the control of HIF binding to target genes directly by methylation 
of a specific CpG dinucleotide within the consensus HRE (Rossler et al., 2004). On the other 
hand, recent evidence has suggested that hypoxia–induced gene specific DNA 
hypermethylation can impact upon genes that were previously active (Waston et al., 2010).  
Study by Waston et al revealed that cells maintained in limited oxygen (1%) displayed 
reduced global DNA methylation (Waston et al., 2009). However, in the absence of HIF1A 
the level of DNA methylation increased and was associated with significant increases in 
DNA methyltransferase (DNMT3B) expression (Waston et al., 2009). Further to this 
hypoxia-inducible transcription factor HIF1A is involved in regulation of the DNA 
methyltransferase enzymes DNMT1 and DNMT3B enzymes (Watson et al., 2014). In 
addition, studies have shown a decrease in 5mC levels following exposure of cancer cell 
lines to severe hypoxic conditions (Shahrzed et al., 2007). Similarly, a decrease in 5mC 
levels was observed in in vivo xenograft cancer cells following exposure to severe hypoxic 
conditions (Shahrzed et al., 2007). In addition, it has reported by Mariani et al that hypoxia 
increases global 5hmC levels, with accumulation of 5hmC density at canonical hypoxia 
response genes and that these are associated with TET1 upregulation in hypoxia condition 
(Mariani et al., 2014). In contrast, Thienpont et al reported that low oxygen causes DNA 
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hypermethylation by decreasing TET activity (Thienpont et al., 2016). Generally, the 
interaction of epigenetics and hypoxia occurs via four mechanisms (Watson et al., 2010):   
• Epigenetics controlling HIFs stabilization. 
• Controlling HIFs via regulation of transcription of hypoxia response elements 
(HRE).  
• Histone demethylase enzyme as HIFs Targets. 
• Significant global changes in histone modification and DNA methylation  
For example, as shown in Figure 1.7, silenced of PHD3 and VHL by promoter 
hypermethylation is possibly an important epigenetic mechanism that may involve in 
controlling HIFs stabilization (Hatzimichael et al., 2009). 
However, better understanding of the role of hypoxic microenvironment in the field of 
cancer research, especially in DNA methylation area will open new windows for the 
discovery new therapeutics targeting the cancer cells (Muz et al., 2015). 
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Figure 1.7 key interactions between important epigenetics mechanisms and hypoxia. 
This figure summarises the role of epigenetics in controlling HIFs stabilization. Silenced of 
PHDs and VHL by promoter hypermethylation led to induce upregulation of HIFs, drives 
the activation of several target genes. Hypoxic conditions modulate genes expression profile 
via several mechanisms, included global DNA methylation alterations, local CpG changes 
on HIFs target genes and histone modification.  
 
1.6 O2 distribution in the normoxic and hypoxic incubators 
It has become increasingly clear that cultivating cells in vitro not only temperature, humidity, 
and CO2 but also O2 needs to be controlled. However, the actual normoxic O2 concentrations 
are almost never correctly indicated but rather given as 21% O2, which the equal to the O2 
concentration of room air rather than incubator air. Moreover, the O2 concentration in the 
gas phase, it will never be what the (adherent) cells in a tissue culture dish experience, since 
  
34 
 
they are attached to the bottom of the dish. Importantly, O2 solubility in the aqueous phase 
is rather low (Wanger et al., 2015). The mechanism by which gases reach the bottom of the 
tissue culture dish or flask is by diffusion, which is almost always the limiting factor for 
cellular oxygenation. After moving the dish out of a normoxic incubator and exposing it to 
room air conditions, the environmental O2 supply acutely increases and a shallow O2 
gradient forms due to the poor O2 diffusion in unstirred medium, even in the absence of cells 
(Pettersen et al., 2005; Polak et al., 2015). However, the onset of hypoxic exposure is usually 
defined as the moment when the doors of the hypoxic incubator are closed, and it will take 
several minutes to several hours until the medium O2 concentration asymptotically 
approximates the desired value, even if the incubator would change the gas phase 
composition rapidly. Moreover, in the absence of cells reveals a duration of 38 minutes, 45 
minutes, and 60 minutes to fall below a O2 value of 1.2-fold of the input value if a cell culture 
dish is acutely switched from 20% O2 to 2%, 1%, or 0.2% O2 concentration, respectively. 
However, without stirring, this will result in little change in the overall O2 content since only 
the surface region releases O2. Gas exchange with room air occurs almost instantaneously, 
and it will take up to 1 hour until hypoxic conditions in the incubator’s gas phase are re-
established. It is always better to culture, harvest, and lyse the cells within hypoxic 
workstations (Jaakkola et al., 2001; Wanger et al., 2015).  
However, typical cell culture methods involve isolating cells from a physiological state and 
then analysing them in “bench-top conditions”. This creates stress for the cell and introduces 
unknown outcomes in cell expression and morphology. So, we used the physiological 
workstations to mimic ‘in-vivo’ conditions providing a continuous cell culture environment 
which eliminates cellular stress linked to variations in temperature, pH and oxidation. In 
addition, to address the differences between continuous vs semi-continuous low oxygen 
exposure, a pathological hypoxia model was also created by culturing cells in a hypoxia 
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incubator with intermittent air flushing due to open/shut phase of the incubator doors with 
all culture processing being performed under an atmospheric environment. 
1.6 Aims and Objectives 
The overall aims of this project are to: 
1. Investigate the effects of reduced oxygen on characteristics of cells including 
proliferation, expression of core pluripotency factors and HIFs.  
2. Investigate the effects of physiological normoxia on global DNA methylation (5mC 
and 5hmC) in cells.  
3. Assess the relationship between changes in global DNA methylation (5mC and 5hmC) 
patterns in response to oxygen modulation and the transcriptional expression of 
DNMTs/TETs. 
4. Investigate the effects of hypoxia on the local DNA methylation patterns at selected 
CpG sites within the promoter regions of DNMTs/TETs genes. 
 To test this hypothesis, this project will adopt an epigenetic approach to explore and identify 
epigenetics marks from hypoxic cancer cells, hPSCs and BM-hMSCs. 
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Chapter 2: Materials and Methods 
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2.1 Materials 
Table 2.1 List of materials, catalogue numbers and suppliers. 
Name Catalogue 
No. 
Supplier 
3-isobutyl-1-methylxanthine (IBMX) I7018 Sigma-Aldrich 
(3-(4,5-dimethylthiazol-2yl)-,5diphenyltetrazolium 
bromide 
M2128 Sigma-Aldrich 
Agarose BP1356-500 Fisher Scientific 
Alamar blue DAL1025 Fisher Scientific 
Alcian blue A3157 Sigma-Aldrich 
Alizarin red S A5533 Sigma-Aldrich 
Annealing buffer 979009 Qiagen 
Ammonium acetate A2706 Sigma-Aldrich 
Ascorbic acid phosphate A8960 Sigma-Aldrich 
Basic Fibroblast growth factor (bFGF) 100-18B Peprotech 
BCA Protein Assay Kit 23225 Fisher Scientific 
Bovine serum albumin (BSA) BP9703-100 Fisher Scientific 
4′,6-Diamidino-2-phenylindole (DAPI) D9542 Sigma-Aldrich 
DNeasy Blood & Tissue Kit 69504 Qiagen 
Dexamethasone D2915 Sigma-Aldrich 
Direct Load Wide Range DNA Marker D7058 Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) D2650 Sigma-Aldrich 
Donkey anti-goat IgG NL003 R&D system  
Donkey serum D9663-10ML Sigma-Aldrich 
Dulbecco’s Modified Eagle Medium (DMEM) – 
4.5 g/L glucose 
BE12-709F Lonza 
EDTA (0.5 M), pH 8.0 AM9260G Fisher Scientific 
Essential 8™ Medium A1517001 Life Technologies 
Ethanol (absolute) E0650/17 Fisher Scientific 
Ethidium bromide E1510 Sigma-Aldrich 
Ethylene diamine tetra-acetic acid (EDTA) BP2482-1 Fisher Scientific 
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EZ DNA Methylation-Gold™ Kit D5005  Zymo research 
FBS (foetal bovine serum) DE14-801F Lonza 
Fibronectin F0895 Sigma-Aldrich 
Flow cytometry staining buffer FC001 R&D system  
Gel Loading Buffer (0.05% bromophenol blue, 40% 
sucrose, 0.1 M EDTA, 0.5% SDS) 
G2526 Sigma-Aldrich 
Glycine G8898 Sigma-Aldrich 
Go Taq G2 Flexi DNA polymerase M7801 Promega 
Goat anti-mouse IgG NL557 R&D system  
Hepes free acid B30487-1KG VWR 
Human Pluripotent Stem Cell Marker Antibody 
Panel kit 
SC008 R&D system  
Indomethacin I7378 Sigma-Aldrich 
Insulin I9278 Sigma-Aldrich 
Isopropanol P/7500/17 Fisher Scientific 
Knockout DMEM 10389172 Fisher Scientific 
Leupeptin L8511 Sigma-Aldrich 
Live human stem cell imaging Kit SC023 R&D system  
L-Glutamine BE17-605E Lonza 
L-Proline P5607 Sigma-Aldrich 
Methanol M/3900/17 Fisher Scientific 
MethylFlash Hydroxymethylated DNA 5-hmC 
Quantification Kit  
P-1036 Epigentek 
MethylFlash Methylated DNA Quantification Kit  P-1034 Epigentek 
Non-essential amino acids NEAA BE13-114E Lonza 
Oil Red O O0625 Sigma-Aldrich 
Nonidet P-40 56741-
50ML-F 
Sigma-Aldrich 
One Step RT-PCR Kit 210210 Qiagen 
Paraformaldehyde P/0840/53 Fisher Scientific 
Pepstatin A P5318 Sigma-Aldrich 
Penicillin, streptomycin, amphotericin B BE17-745E Lonza 
Phenylmethylsulfonyl fluoride (PMSF) P7626 Sigma-Aldrich 
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Phosphate buffered saline (Mg2+ and Ca2+ free) BE17-516F Lonza 
Phycoerythrin conjugated antibodies 
CD14  
CD19 
CD34  
CD45 
HLA-DR 
CD73  
CD90 
CD105 
IgG1 
IgG2a 
130-098-167 
130-098-168 
130-098-140 
130-098-141 
130-098-177 
130-097-943 
130-097-932 
130-098-906 
130-098-845 
130-098-849 
 
 
 
 
Miltenyi biotec 
PyroMark Gold Q24 reagents 970802 Qiagen 
QIAshredder mini spin columns 79656 Qiagen 
Quantifast SYBR green RT-PCR kit 204154 Qiagen 
RNase A 19101  Qiagen 
RNeasy mini kit 74104 Qiagen 
Sodium Chloride S7653 Sigma-Aldrich 
Sodium deoxycholate 30970-25 g Sigma-Aldrich 
Sodium dodecyl sulphate SDD L4390 Sigma-Aldrich 
Sodium pyruvate S8636 Sigma-Aldrich 
Streptavidin sepharase 17-5113-01 GE Healthcare 
TE buffer   P7589 Invitrogen 
Transforming growth factor B3 (TGF-B3) 100-36E Peprotech 
Tris-Hepes NH 4-20% NH31-420 Nusep Ltd 
Triton X-100 9002-93-1 Sigma-Aldrich 
Trypan blue T8154 Sigma-Aldrich 
Trypsin 15090 Life Technologies 
Tween 20 66368 Analar 
Uplight substrate S83728 Interchim 
Vitronectin (VTN-N) recombinant human protein, 
truncated  
A14701SA Life Technologies 
β-glycerophosphate G9422 Sigma-Aldrich 
β-mercaptoethanol 10368072 Fisher Scientific 
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2.2 General cell culture techniques 
2.2.1 Cell culture conditions 
All cells were maintained in the following three oxygen conditions: 
• 21% O2-Standard cell culture (21%ST) 
• 2% O2-Pre-gassed media in a 2% O2 incubator (2%PG) 
• 2% O2-Pre-gassed media in a 2% O2 Workstation (2%WKS) 
21%ST cells were cultured in humidified air and 5% CO2 incubator and handled in a standard 
biological safety laminar flow cabinet. For reduced oxygen cells were grown in either a 
nitrogen-regulated tri-gas controlled incubator set at 2% O2, 5% CO2 (2%PG) or in a tri-gas 
incubator set at 2% O2 in the presence of 5% CO2 but handled in a hermetically sealed 
hypoxic workstation (2%WKS) (SCI-TIVE, Baker Ruskinn Ltd, UK). The cells were then 
observed regularly under inverted microscope (Nikon TS100, Japan) to ensure they were 
healthy and to check for confluency. Mycoplasma testing was performed across randomly 
selected cell lines by Guy Hilton technician team to ensure that there was no contamination. 
All cell lines were incubated at 37oC. Surprisingly, many epigenetics studies have focusing 
on short term hypoxic effects (24h and 3 days) and there are yet no reports deal with long 
term hypoxic effects.  However, all cell types that we used in this study were culturing at 
least for five passages under both hypoxic conditions (2%PG and 2%WKS) prior to 
experiments. 
2.2.2 Hypoxic media 
To maintain the oxygen level of the cells during the physiological oxygen culturing, cell 
culture media was deoxygenated to a 2% O2 level using a HypoxyCool unit (Baker Ruskinn 
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Ltd, UK). The unit was pre-set to deoxygenate the supplemented medium to predefined 
oxygen concentrations (2% O2). To maintain sterility, avoid the risk of contamination during 
gas exchange, and allow for the fast reduction of the dissolved oxygen levels within the 
media, the media bottles caps (ThermoFisher) were replaced with vented closure caps within 
a sterile hood before the bottles were placed within the HypoxyCool system (Figure 2.1). 
To monitor the big pH changes during the culturing our cell with different oxygen levels, we 
used the cell culture media contains phenol red as an indicator for pH changes that will turn 
yellow at low pH and purple at high pH level. However, the effect of reduce oxygen (3% 
O2) on the pH levels was evaluate in new study by using the pH-sensitive dye BCECF, the 
results showed that hypoxia has little effect (0.05) on steady-state pH level. Also, Jørgensen 
et al study showed no significant change in pH levels during chemical anoxia in mouse 
neocortical neurons in primary culture (Jørgensen et al., 1999). 
  
 
 
 
 
 
 
 
 
Figure 2.1 Media deoxygenation. A) The media bottles caps were aseptically replaced with 
vented closure caps before being placed into the Hypoxycool unit. The cycle parameters 
used to establish dissolved oxygen levels within the media were as defined by manufacturors 
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instruction. B) Oxygen deoxygenation within the media over time. Source: The Baker 
Company. 
 
2.2.3 Enzymatic sub-culture and expansion 
When cells had reached 80-90% confluence the media was aspirated, and cells washed with 
calcium and magnesium free PBS. After washing cells were exposed to either 1% 
Trypsin/PBS (Embryonic stem cells) or to 0.5mM of ethylene diamine tetra acetic acid 
(EDTA) (BM-hMSCs and Cancer cells) in PBS solution and culture vessels were incubated 
for 3-5 minutes at 37°C until cells began to detach. Following detachment 1ml of pre-
warmed media was added, and the cells removed by gently pipetting media up and down 
onto the plate surface to create a cell suspension. Cell suspensions were then centrifuged at 
1000 rpm for 3 minutes to pellet the cells, supernatant removed, and the pellet re-suspended 
in fresh supplemented media in preparation for seeding at the correct dilution or cells/cm2 as 
experimentally required. This procedure was performed for all cells cultured within the three 
different oxygen conditions; 21%ST, 2%PG and 2%WKS. 
2.2.4 Cryopreservation of cells 
Following detachment as described in Section 2.2.3 cells were re-suspended in 1ml 
cryopreservation solution comprising 10% dimethyl sulphoxide (DMSO) in fresh media and 
immediately transferred into a cryovial. The cryovial was then placed into a Mr Frosty 
container and then into a -80oC freezer overnight before transfer into a suitable liquid 
nitrogen vessel for long term storage. 
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2.3 Culturing and cell characterization of human pluripotent stem cells 
2.3.1 Cell lines, sub-culturing and expansion 
Two human ES cells (SHEF1, SHEF2) were obtained from the laboratory stock (Guy Hilton 
Research Centre) and used under approval from the UK Stem Cell Bank (UKSCB) 
(Aflatoonian et al., 2010). Human induced pluripotent stem cell line (iPS) (ZK2012L) was 
kindly provided by Professor. Susan Kimber and Dr. Zoher Kapacee, Faculty of Biology 
Medicine and Health, University of Manchester. The ZK2012L cell line was derived from 
human dermal fibroblasts (formerly in the Kimber lab). As per methods of Takahashi and 
Yamanaka, and Takahashi et al protocol (Takahashi and Yamanaka, 2006, Takahashi et al., 
2007), the human dermal fibroblasts were transduced with retroviruses carrying the genes 
encoding for Oct 4, Sox 2, Klf 4 and c-Myc for 24 h then re-plated on a plate seeded with a 
feeder layer of iMEFs. Twenty-five to thirty days after transduction, the colonies formed 
were manually dissected, re-plated (Cheng et al., 2014). Cells were routinely cultured in the 
defined, Xeno-free, E8 system (Life Technologies). Media was prepared by first slowly 
thawing 10ml Essential 8 Supplement (50X) at 2-8oC overnight which was then mixed with 
490ml Essential 8 basal media to prepare 500ml of complete Essential 8 (E8) basal medium. 
Cells were thawed rapidly in a water bath (37oC) with gentle agitation following removal 
from liquid nitrogen. Once thawed the contents of the cryovial were added to 4ml of 
complete Essential 8 (E8) basal medium, centrifuged at 1000 rpm for 3 minutes, and the 
supernatant removed. The cell pellet was then re-suspended in 2ml of medium and seeded 
into one well of a 6 well plate coated with vitronectin (VTN-N) Recombinant Human 
Protein, Truncated, Prototype; Life Technologies). Coating was performed by adding 60µl 
(rhVTN-N) to 6ml of Dulbecco’s phosphate-buffer saline (DPBS) without calcium and 
magnesium (Gibco) to prepare 5mg/ml working vitronectin solution and then 1ml was added 
to each well of a 6-well tissue culture plate followed by incubation at room temperature 1 
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hour before use. After incubation the vitronectin solution was discarded and 2ml of hPSCs 
culture media added. hPSCs were cultured within the three different oxygen conditions; 
21%ST, 2%PG and 2%WKS. hPSCs were fed with new Essential 8 basal medium every day 
and cells were sub-cultured enzymatically at confluence using 0.5mM EDTA as described 
in Section 2.2.3. 
2.3.2 Spontaneous differentiation 
hPSC were grown in 6-well vitronectin-coated culture plates in three conditions as described 
above for 48 hours in E8 medium before switching into spontaneous differentiation medium 
(Knockout DMEM, 10% FBS, 1% NEAA, 1% L-glutamine and β-mercaptoethanol) as 
described in previously work (Kumar et al., 2015). The medium was changed every three 
days. Differentiated cells were characterised at three different time points; days 5, 10 and 
20. 
2.3.3 Characterisation of human pluripotent stem cells 
 2.3.3.1 Immunocytochemistry 
Undifferentiated hPSC were seeded at a density of 3.5 x 104 cells/cm2 to each well of a 6 
well plate and maintained in Essential 8 basal Medium over 96 hours prior to 
immunocytochemistry. Cells were characterised using the unfixed live human stem cell 
imaging kit (R&D systems, UK). The medium was aspirated, washed twice with PBS before 
adding 1ml fresh Essential 8 basal media containing 1x concentration (1:50) of antibody 
(SSEA-4, TRA-1-60, and SSEA-1) followed by 30 minutes incubation at 37oC. Then, the 
antibody solution was removed, hPSCs washed with fresh media, and re-fed with fresh 
Essential 8 Medium. Labelled cells were immediately imaged using fluorescent microscopy 
(Nikon Eclipse Ti-S, Japan) with a Nikon digital slight DS-Qi1Mc camera.  
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2.3.3.2 Flow Cytometric analysis of cells (FACS) 
Approximately 5 x 105 cells were labelled with hPSC markers of pluripotency (SSEA-4, 
TRA-1-60 and SSEA-1) antibodies as described above. Media was aspirated, cells washed 
twice with PBS, and cells harvested with Trypsin-versene (EDTA) and centrifuged at 1000 
rpm for 3 minutes. The supernatant was removed, and the cell pellet washed in flow 
cytometry buffer twice with a centrifugation at 1000 rpm for 3 minutes on each occasion. 
The cell pellet was then re-suspended in FACS buffer ((PBS with 0.5% (w/v) BSA (Fisher 
Scientific) and 2mM EDTA (Fisher Scientific)) and run into the flow cytometer (Beckman 
Coulter Cytomics FC 500). At least 1-3 X 104 events were acquired, and the data analysis 
was carried out using flowing software version 2. The percentage of positive events were 
determined by using gates to exclude 99% of the appropriate control events. Data analysis 
was performed with Flowing Software and the expression of SSEA-4 determined in the FL1 
channel, while TRA-1-60 and SSEA-1 were in the FL2 channel. 
2.3.4 Evaluation of pluripotent markers expression in human pluripotent stem cells 
and their progeny 
Spontaneous differentiation of hPSCs was assessed using Human Pluripotent Stem Cell 
Marker Antibody Panel kit (R&D systems). Cells were seeded in 24 well-plates using E8 
medium coated with vitronectin before being transferred into spontaneous differentiation 
media as described in Section 2.3.2. 
Spontaneous differentiation was examined in undifferentiated cells (Day 0) and from 
spontaneous differentiation cells at three different time points; days 5, 10 and 20 under all 
conditions (21%ST, 2%PG and 2%WKS). Prior to fixation the cells were washed twice with 
PBS and fixed with 4% paraformaldehyde solution (in PBS). After 40 minutes incubation at 
room temperature, 0.1% Triton™ X-100 was added for 5 minutes to permeabilise 
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membranes. Fixed cells were then washed twice before incubation with blocking buffer (3% 
BSA, 10% normal donkey serum in PBS) for 1 hour at room temperature to block non-
specific antibody binding. After washing, the cells were incubated with primary antibodies 
for either mouse anti-human SSEA-4 monoclonal, goat anti-human Nanog, monoclonal 
mouse anti-human alkaline phosphatase (ALP), and goat anti-human OCT-4 at 1µg/100µL 
and incubated at 4°C overnight. Followed by incubation for 2 hours at room temperature 
with 5μg/ml of secondary antibody specific to either OCT-4 and NANOG (donkey anti-goat 
IgG (R&D Biosystems)) or SSEA-4 and ALP (goat anti-mouse IgG (R&D systems). Non-
specific staining of the nuclei was visualised with 4, 6-Diamidino-2-phenylindole (DAPI) at 
a dilution of 1:500 in PBS for 5-10 minutes. Cells were immediately imaged using a Nikon 
fluorescence microscope (Nikon TZ1; Leica, Germany). 
2.4 Isolation and culture of bone marrow mesenchymal stem cells  
Three human mesenchymal stem cell (hMSCs) lines were isolated and expanded from 
commercially sourced (Lonza, USA) whole human bone marrow aspirate (BMA) using the 
plastic adherence method described by previously published techniques (D’Ippolito et al., 
2003, Kay et al., 2015). T-75 tissue culture flasks were coated with 10ng/ml of fibronectin 
(Sigma) diluted in PBS and incubated at room temperature for a minimum of 1 hour. After 
that, the fibronectin solution was aspirated and 15ml of DMEM media supplemented with 
5% FBS, 1% L-glutamine, 1% NEAA and 1% PSA (Penicillin-Streptomycin-Amphotericin 
B) (100U/ml penicillin, 100μg/ml streptomycin, 0.25μg/ml amphotericin B) was added to 
each T-75 tissue culture flasks. The whole bone marrow was cultured at a density of 1 x 105 
mononuclear cells (MNCs)/cm2 in 75 cm2 tissue culture flasks and incubated for one week 
at 37°C in three different oxygen conditions as a described in Section 2.2.1. Then, a 50% 
media change was performed and antibiotic-free fresh DMEM culture medium was added. 
One week later, the whole media was removed, and 20ml of complete fresh media added. 
  
47 
 
Complete fresh media changes were carried out twice weekly. Once the cells reached 
confluence the media was removed, and the cells washed twice with PBS and cells detached 
using 3ml of trypsin/EDTA in PBS solution and the cells passaged as described in Section 
2.2.3. 
2.4.1 Characterisation of mesenchymal stem cells 
2.4.1.1 Tri-lineage differentiation 
In order to determine the differentiation potential of hMSCs, the cells were assessed at P2 
using multipotency differentiation media. MSCs were seeded at 2 x 104 cells/cm2 in 24 well 
plates in in complete culture media overnight to allow attachment and subsequently allowed 
to reach 80-90% confluency prior to being exposed to either osteogenic, adipogenic or 
chondrogenic differentiation media alongside controls. Media was changed twice weekly for 
20 days. 
2.4.1.1.1 Adipogenic differentiation 
Cells were cultured in DMEM media supplemented with 10% FBS, 1% L-glutamine, 1% 
NEAA and adipogenesis differentiation induced with 0.5μM dexamethasone, 10µg/ml 
insulin (Sigma-Aldrich), 100mM indomethacin (Sigma-Aldrich) and 0.5mM 3-isobutyl-1-
methylxanthine (IBMX).  
2.4.1.1.2 Osteogenic differentiation 
Cells were cultured in DMEM media supplemented with 10% FBS, 1% L-glutamine and 1% 
NEAA prior to transfer into osteogenic differentiation media consisting of 0.1mM 
dexamethasone (Sigma-Aldrich), 50μM ascorbic acid phosphate and 10mM β-
glycerophosphate. 
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2.4.1.1.3 Chondrogenic differentiation 
Osteogenesis differentiation was induced using 1% ITS (Sigma, UK), 50mM ascorbic acid 
(Sigma, UK), 40µg/ml L-proline (Sigma-Aldrich), 0.1mM dexamethasone, 10ng/ml TGF-
β3 (Sigma-Aldrich) and 1% sodium pyruvate (Sigma-Aldrich).  
2.4.1.2 Histological staining 
hMSC were cultured in differentiation media for 20 days prior to being washed twice with 
PBS. For adipogenic differentiation the cells were fixed using 4% Paraformaldehyde 
(Sigma) in PBS for 20 minutes before being washed with PBS. Chondrogenic and osteogenic 
differentiated cells were fixed in 95% methanol (Sigma-Aldrich) for 10 minutes. 
2.4.1.2.1 Oil Red O for Adipogenesis   
Oil Red O (Sigma-Aldrich) was prepared as a 0.5% solution in 99% isopropanol alcohol 
(Fisher Scientific) and fresh working solution prepared by mixing 3 parts of 0.5% Oil Red 
O stock solution and 2 parts of dH2O for 15 minutes and filtering with a 0.22μm syringe 
filter prior to use. Paraformaldehyde-fixed cells were stained in fresh working solution for 
10-15 minutes at room temperature. After that the stain was separated and cells washed twice 
with dH2O before imaging immediately using Olympus CKX41 microscope (Japan). 
2.4.1.2.2 Alizarin Red S for Osteogenesis 
Osteogenic differentiation of hMSC was performed using 2% (w/v) Alizarin Red S (Sigma-
Aldrich) to detect calcium deposits. Alizarin Red S (2g) was dissolved in 100ml distilled 
water, mixed and pH adjusted to 4.1 - 4.3 with 10% ammonium hydroxide and filtered before 
use. Cells were covered with staining solution and incubated at room temperature for 5 to 15 
minutes followed by washing gently under running tap water. Stained cells were observed 
microscopically (Olympic CKX41) before image capture using Image-Pro Insight software. 
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2.4.1.2.3 Alcian blue for Chondrogenesis 
In order to detect glycosaminoglycan production 1g Alcian blue was dissolved in 100ml of 
3% acetic acid, and pH adjusted to 2.5 with acetic acid and filtered before use. Alcian blue 
staining solution was added to cover fixed monolayers cells for and left for 15 minutes before 
the stain was removed and the cells washed gently under running tap water prior to stained 
cells being imaged.  
2.4.1.3 Flow cytometric analysis of cells 
To carry out FACS hMSC cells were first seeded in a T25 flask and maintained until 80-
90% confluence. After washing twice with 5ml PBS the cells were incubated with 2.5ml 
trypsin/EDTA for 3-5 minutes. Cells were checked microscopically before centrifugation 
for 5 minutes at 900 rpm. The supernatant was aspirated, and cells re-suspended with 5ml of 
flow cytometry buffer and centrifuged again before the cell pellet was re-suspended in 1ml 
FACS buffer. Cell count was carried out and 1 x 105 cells aliquoted into individual 1.5ml 
microcentrifuge tubes, centrifuged and the supernatant removed. A panel of antibodies were 
diluted in flow cytometry buffer (CD14, CD19, CD34, CD45, CD73, CD90 and CD105, 
HLA-DR, IgG1 and IgG2a isotype controls) and added to specific cell pellets and incubation 
at 4°C for 15 minutes in the dark. Cells were then washed with 1ml of FACS buffer and 
centrifuged at 900 rpm for 5 minutes. Supernatants were discarded, and the cell pellet re-
suspended in 300μl of FACS buffer and a minimum of 50000 events were recorded via 
analysis on the Beckman Coulter Cytomics FC 500 flow cytometer. Associated isotype 
controls (IgG1: CD19, CD73, CD90 and CD105, IgG2a: CD14, CD34, CD45, HLA-DR) 
were applied to establish positive and negative events with all experimental conditions 
measured. The data analysis was performed using flowing software (Version 2.5.1). 
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2.5 Cancer cell lines 
All cancer cell lines that used in this study were obtained from the laboratory stock of Guy 
Hilton Research Centre, Keele University. The cells were incubated at 37oC at three different 
oxygen tensions as described in Section 2.2.1 and detached and passaged as described in 
Section 2.2.3. The cells were then monitored daily to ensure that there was no contamination 
and to check for confluency. 
2.5.1 MG-63 human osteosarcoma cell line 
The adherent osteosarcoma cell line (MG-63) was originally derived from a fourteen -year 
old male patient with osteosarcoma (Billiau, 1975). The cells were maintained in T-75 flasks 
in DMEM media supplemented with 10% FBS, 1% NEAA and 1% L-Glutamine. These cells 
were incubated and passaged with 2.5% Trypsin at split ratios of 1:4 to 1:8.  
2.5.2 SH-SY5Y neuroblastoma cell line  
The adherent SH-SY5Y neuroblastoma cell line was derived from SK-N-SH which was 
originally isolated from a 4-year-old female with neuroblastoma bone marrow biopsy 
(Biedler et al., 1978). The cells were maintained in T-75 flasks in DMEM supplemented with 
10% FBS, 1% NEAA and 1% L-Glutamine. The cells were passaged with 2.5% Trypsin and 
replated at a split ratio of 1:4 to 1:8. 
2.5.3 COV362 human ovarian epithelial-endometroid carcinoma 
The adherent COV362 cells are a cell line derived from the pleural effusion of a human 
ovarian epithelial-endometroid carcinoma (Berg-Bakker et al., 1993 and Domcke et al., 
2013). Cells were cultured on uncoated T-75 flasks in DMEM media supplemented with 
10% FBS, 1% NEAA and 1% L-Glutamine. The cells were detached and passaged with 
2.5% Trypsin at split ratios of 1:4 to 1:8. 
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2.5.4 A549 human lung carcinoma 
The adherent human lung carcinoma cell line was originally isolated from a 58-year-old 
Caucasian male and first established in 1972 (Giard et al.,1973). Cells were cultured on 
uncoated T-75 flasks in DMEM media supplemented with 10% FBS, and 1% L-Glutamine. 
The cells were detached and passaged with 2.5% Trypsin at a split ratio of 1:3 to 1:6. 
2.5.5 Jurkat cells 
The non-adherent cell line was originally derived from the peripheral blood of a 14-year-old 
patient with relapsing Acute lymphocytic leukaemia (ALL) (Schneider et al.,1977; 
Mezencev et al., 2011). Jurkat cells were maintained in DMEM media supplemented with 
10% FBS, 1% NEAA and 1% L-Glutamine. The cell suspension from the T-75 flasks was 
transferred into a 50ml conical tube and was centrifuged at 1000 rpm for 3 minutes to pellet 
the cells. The pellet was re-suspended in 15ml of fresh supplemented DMEM. 5ml of cell 
suspension was then pipetted into three T-75 flasks, containing fresh supplemented media at 
a ratio of 1:3.  
2.5.6 IMR-90 human fetal lung fibroblast 
The non-cancer adherent IMR-90 cells (ATCC® CCL­186™) were isolated from lung tissue 
of a 16-week-old female Caucasian foetus. Cells were cultured on uncoated T-75 flasks in 
DMEM media supplemented with 10% FBS, 1% NEAA and 1% L-Glutamine. The cells 
were detached and passaged with 2.5% Trypsin at a split ratio of 1:3.  
2.6 Cell proliferation analysis 
To determine the effect of long-term physiological oxygen on the growth and viability of 
cells, three assays of cell proliferation were utilised; quantification of cells by cell counting, 
  
52 
 
the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and Alamar Blue 
cell proliferation assay. 
2.6.1 Cell counting 
Cells were trypsined with Trypsin/EDTA (Lonza) diluted in DPBS solution to obtain a single 
cell suspension. Following detachment, the cells were pelleted at 200 g centrifuged, the 
supernatant aspirated, and the cells re-suspended in 1ml medium. Next, cells suspension was 
diluted 1:1 in 0.4 Trypan blue (Sigma-Aldrich) and 5μl was loaded into the haemocytometer. 
All viable (unstained) cells within all 4 outer squares were counted under a microscope 
(Figure 2.2A). Total cell number was then determined by using the calculation shown in 
Figure 2.2B. Cells were counted in three independent experiments over 6 days under each 
condition at the same time for each day. 
 
 
 
 
 
 
 
Figure 2.2 Cell count. A. Schematic of the Haemocytometer used – all viable cells within 
the four-outer large square were counted B. Calculation to determine the total number of 
cells in suspension - Average of cell count multiply by 104 = conversion factor to determine 
number of cells per ml. n= the original volume the cell suspension and the Dilution factor = 
dilution factor with Trypan Blue (1:1 dilution). 
 
Cells/ml = Average of viable cells counted 
x 104 
 
Total cells = Cell/ml x n x dilution factor 
B
. 
A
. 
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2.6.2 MTT assay 
MTT (3-(4,5-dimethylthiazol-2yl)-2,5diphenyltetrazolium bromide) colorimetric assay was 
performed to evaluate cell metabolic activity. This assay quantifies the cells metabolic 
viability based on mitochondrial function by the action of the NAD(P)H dependent 
oxidoreductase enzyme conversion of the yellow MTT tetrazolium salt into purple formazan 
crystals. The concentration of formazan determined by the absorbance is directly 
proportional to number of viable cells. 1 x 104 cells/cm2 cells were cultured in 96 or 48 well 
plates (flat bottom) for 48 hours and used experimentally thereafter. Stock solution was 
prepared by dissolved 50mg MTT (Sigma) in 10ml of PBS, 150μl of culture media 
containing 15μl of MTT stock solution was added to each well followed by incubation for 4 
hours at 37oC within their respective culturing conditions, over 6 days. A 125µl aliquot was 
then removed and 50μl of Dimethyl sulfoxide (DMSO) added and the plates further 
incubated for 45 minutes at 37oC. As a negative control, 150μl of medium alone containing 
15μl of MTT stock solution was used. The absorption was measured with a micro-plate 
reader (BioTek, Synergy 2) at a 570 nm wavelength. 
2.6.3 Alamar blue assay 
Alamar blue is an alternative approach to MTT that measures both in vitro cell proliferation 
and cell viability. The Alamar blue assay (Fisher Scientific) converts resazurin (non-toxic 
reagent) to resorufin in viable cultured cells which in turn accumulates in the medium. The 
cellular mechanisms of resazurin conversion in viable cells are not clear, but the role of 
mitochondrial reductase by generating reducing equivalents such as NADH has been 
suggested (Sykes et al., 2009 and Rotoli et al., 2014). A density of 1 x 104 cells/cm2 were 
cultured in 96 well plates (flat bottom) for 48 hours and used experimentally thereafter. 
100μl of Essential 8 medium containing 10μl (ready-to-use solution) of Alamar blue reagent 
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was added directly to each 96-well plate followed by incubation for 4 hours in three different 
conditions at 37oC to allow cells to convert resazurin (blue color) to resorufin (pink color), 
and then the absorbance was measured at 570 nm wavelength. Data are presented as a mean 
± standard deviation (SD) of three triplicate experiments. 
2.7 DNA Methylation Analysis 
2.7.1 Cell pellet preparation 
The cell suspensions were generated as described in Section 2.2.3 and centrifuged at 3000 
x g for 3 minutes with 1ml culture medium, supernatant removed, and the pellet washed 
twice with PBS by centrifugation, before the final supernatant removed and pellets stored at 
-20oC. 
2.7.2 DNA extraction 
DNA was extracted using the DNeasy Blood and Tissue kit (Qiagen) according to 
manufacturer’s instructions. Cell pellets were thawed and re-suspended in 200μl PBS, 20 μl 
proteinase K and 200μl buffer AL. Contaminant RNA was eliminated by RNase A treatment 
(Qiagen), followed by vortexing and incubated at 56˚C in water bath for approximately 10 
minutes for lysing. After incubation, 200μl of 96% ethanol was added, mixed well, and 
pipetted into a DNeasy spin column in a 2ml collection tube and centrifuged at 8000 rpm for 
1 minute. The flow-through was removed leaving total DNA attached to the DNeasy column 
membrane and then the spin column transferred into a new 2ml collection tube, washed 
twice, with 500µl buffer AW1 and then with 500µl Buffer AW2, by centrifugation at 8000 
rpm and 13000 rpm for 1 and 3 minutes, respectively. Flow-through was discarded and the 
spin column placed into a new 2ml microcentrifuge tube and DNA eluted in 50μl DNase and 
RNase free water by centrifugation at 8000 rpm for 1 minute. This step was repeated twice 
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to increase the yield of extracted DNA. The integrity and concentration of DNA was 
determined by running 200ng DNA on 1% agarose gels using ethidium bromide staining 
with 1x electrophoresis buffer TAE at 100 V for 1 hour (Figure 2.3) and by 
spectrophotometrically analysis at 260 nm with a NanoDrop 2000/2000c (Thermo 
Scientific). Extracted DNA was stored at -20°C. 
 
 
 
 
 
 
 
Figure 2.3 Example agarose gel electrophoresis. The quality and integrity of genomic 
DNA (approximately 200 ng DNA) extracted from hESCs samples incubated in normoxic 
(21%ST) and hypoxic (2%PG and 2%WKS) oxygen conditions using standard gel 
electrophoresis. A: Undifferentiated cells; B: Differentiated cells (5 Days); C: Differentiated 
cells (10 Days); D: Differentiated cells (20 Days); M: DNA marker. Gel images were 
captured with Syngene Genesnap software. 
 
2.7.3 DNAs global methylation 
2.7.3.1 Elisa-based methods 
Quantification of total 5mC content within DNA isolated from cell lines was performed 
using the MethylFlashTM methylated DNA quantification Kit (Epigentek). In brief, the DNA 
sample is captured in a pre-coated 96-well ELISA plate, and the methylation status detected 
after several incubation steps with primary and secondary antibody before quantification of 
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methylated DNA by reading calorimetrically at A450 and the quantification of global DNA 
methylation derived from the absorbance measured (Kurdyukov and Bullock, 2016). 
2.7.3.2 5-Methylcytosine (5mC) 
The ELISA analysis was performed following manufacturer’s instructions; 100ng of 
genomic DNA for each sample (in triplicate) was used in the assay. First, a standard curve 
of methylated polynucleotide containing 50% of 5-methylcytosine as a positive control was 
generated using the five concentrations indicated into Table 2.2, and these were added to 
their respective wells. 
Table 2.2 Summary of the five-different concentration of the positive control used to 
generate the standard curve. 
Standards Concentration of Positive control 
1 0.5ng/μl 
2 1.0ng/μl 
3 2.0ng/μl 
4 5.0ng/μl 
5 10.0ng/μl 
 
100ng of genomic DNA for each sample was quantified as previously described in Section 
2.7.2 and diluted to a final volume of 10μl with distilled water. Binding solution (80μl) was 
added to each well of 48 well plates. 1μl of negative control buffer (an unmethylated 
polynucleotide), standard and the sample DNA was added to the respective wells and mixed 
well by pipetted several times to ensure the solution coated the bottom of the well (Figure 
2.4). The plate was the sealed with a Parafilm M and incubated for 90 minutes at 37oC. 
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Figure 2.4 A schematic of the 48 well plate. The negative control and standards were 
loaded in duplicates. The samples were loaded in the remaining wells. 
 
Then, the binding solution was removed, and the plate washed three times with 150μl of 1X 
wash buffer (prepared by diluted 10X wash buffer (ME1) diluted with 117ml of distilled 
water). Further, 50µl of a 1:1000 dilution of capture antibody was added to each well and 
incubated for 60 minutes at room temperature. After incubation the solution was removed 
before a further three washes with 150μl of wash buffer was performed again. Then 50µl of 
detection antibody (1:2000) was added to each well followed by incubation at room 
temperature for 30 minutes prior to the solution being removed and a further four washes 
with 150μl wash buffer. Next 50μl of enhancer buffer (diluted at a ratio of 1:5000) was added 
and samples incubated at room temperature for 30 minutes before removal and washed for 
five times, as above. Following washing, 100μl of developer solution (1:5000) was added 
and plates incubated at room temperature for 10 minutes in the dark. The developer solution 
acted as a chromogenic reagent which turned blue in the presence of sufficient methylated 
DNA. Following this 50μl of stop solution was added to stop the colorimetric reaction and 
the plate placed on a shaking frame to ensure that the reaction was completely stopped. 
  
58 
 
Absorbance was measured at 450 nm with a micro-plate reader (BioTek, Synergy 2) using 
the program Gen5 1.10.  
Standard curve was determined using linear regression (Figure 2.5) and the percentage of 
5mC in the total DNA calculated using the following formula: 
 
 
 
Where 2* are a normalization factors in the positive control to 100%, as the positive control 
contains only 50% of 5mC. S is the amount of input sample DNA in ng. 
2.7.3.3 5-Hydroxymethylcytosine (5hmC) 
Similar to the Methylated DNA Quantification kit protocol, 200ng amount of isolated DNA 
was quantified using the colorimetric MethylFlashTM Hydroxymethylated DNA 
Quantification Kit (Epigentek). Linear regression was performed on the standard curve 
generated from the positive controls and the total amount (Figure 2.5) and percentage of 
methylated (5hmC) DNA quantified using the following formula: 
 
5* is a factor to normalize 5hmC in the positive control to 100%, as the positive control 
contains only 20% of 5hmC. S is the amount of input sample DNA in ng. 
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Figure 2.5 Example standard curve of determination of DNA methylation by the 
immunoassay. A) Linear relationship between the absorbance and amount of 5-
methylcytosine. B) Linear relationship between the absorbance and amount of 5-
hydroxymethylcytosine. 
 
2.8 Gene expression analysis 
2.8.1 RNA extraction 
Cells were lysed with 350μl lysis buffer RLT supplemented with 10μl/ml β-mercaptoethanol 
to disrupt cells before being homogenized by passing the lysate through a Qiashredder spin 
column (Qiagen) via 2 minutes centrifugation at 17000 rpm. After homogenisation the lysate 
was stored at -80°C for subsequent RNA extraction. RNA was extracted followed to the 
manufacturer’s protocol using the RNeasy® Mini Kit (Qiagen). Frozen lysates were 
defrosted before being placed on ice and 1 volume of 70% ethanol added, mixed well, and 
the resulting solution passed through an RNeasy mini spin column placed in a 2ml collection 
tube to allow total RNA to bind to the column membrane and centrifuged at 8000 g for 15 
second before the flow through was discarded and the column membrane washed twice with 
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700µl of RW1 washing buffer and then with 500µl of RPE washing buffer by centrifugation 
at 8000 g for 15 seconds and 2 minutes, respectively. The last step was repeated by 
centrifuged the column again at 17,000 g for 1 minute to remove any residual fluid. Then the 
spin column was transferred into a new 2ml microcentrifuge tube and the membrane soaked 
with 25μl RNeasy-free water for two minutes prior to being centrifuged at 6000 g for 1 
minute. This step was repeated to increase the RNA concentration by transferring the RNA 
from the microcentrifuge tube back onto the RNase spin column and centrifuged again. Total 
RNA concentration was quantified using a NanoDropTM 2000/2000c Spectrophotometer 
(Thermo Scientific) and stored at -80°C until required. 
2.8.2 Reverse transcriptase polymerase chain reaction (RT-PCR) 
2.8.2.1 Primer sequences 
PCR primers were obtained from GenBank (http://www.ncbi.nlm.nih.gov/) and ordered 
from Invitrogen Ltd while primers for TET2, HIF1A, HIF2A and pluripotent genes were 
obtained from ThermoFisher-Scientific. Primer sequences and product sizes are listed in 
Table 2.3. 
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Table 2.3 Sequence of Primers used in RT-PCR. 
Primers Sequence 
Product 
size 
DNMT1 
F 5’CTCTCTCCGTTTGGTACATC 3’ 
245 
R 5’CTTTCCAAATCTTTGAGCCG 3’ 
DNMT3A 
F 5’AGAGCAGAGGACGAGC 3’   
192 
R 5’ATTATCGTGGTCTTTGGAGG 3’ 
DNMT3B 
F 5’TAATAAGTCGAAGGTGCGTC3’ 
198 
R 5’TCTGAAGCCATTTGTTCTCG 3’ 
TET1 
F 5’AGCTTACCAAAATCAGGTGG3’ 
221 
R 5’GCTGCTCATCTTGAGGAATA 3’ 
TET2 
F 5’CCACTACCCCAACCAAAGTAACA3’ 
272 
R 5’GTAGCTCTCCACTGCTACCAAAAA3’ 
 
TET3 
F 5’CTTTATGACTTCCCTCAGCG 3’ 
270 
R 5’ AGCCTTTATTTCCACCTCCT 3’ 
DNMT3L 
F 5’TGCTAGACAGACCCCATTTCCT 3’ 
274 
R 5’ATTGACCACTCAGGGCCATTG 3’ 
HIF1A 
F 5’CCACCTCTGACTTGCCTTTC 3’ 
702 
R 5’GCCGAGGGAATGGGCTTAC 3’ 
 
HIF2A 
F 5’GGCGTCTGAACGTCTCAAAG 3’ 
788 
R 5’GAGCCGCAGAAGTCTCCA 3’ 
OCT-4 
F 
5’CATAGCCTGGGGTACCAAAATGGGG 
3’ 
536 
R 
5’GCAATTTGCCAAGCTCCTGAAGCAG 
3’ 
SOX-2 
F 5’CCATCCACACTCACGCAAA 3’ 
204 
R 5’GCAAAGCTCCTACCGTACCACT 3’ 
NANOG 
F 5’TGCAGGACTGCAGAGATTC 3’ 
300 
R 5’GGTGGCAGAAAAACAACTGGC 3’ 
β-actin 
F 5’ GCCACGGCTGCTTCCAGC 3’ 
528 
R 5’AGCCATGCCAATCTCATCTT 3’ 
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2.8.2.2 RT-PCR reaction 
RT-PCR was performed on samples using the Qiagen® One step RT-PCR kit. Mix reaction 
was prepared according to Table 2.4. 
Table 2.4 RT-PCR reaction mixes components 
Reagents Volume/sample 
RT-PCR Buffer,5x 2.5μl 
dNTP mix (10mM) 0.5μl 
Forward primer (10mM) 1μl 
Reverse primer (10mM) 1μl 
RNase free water 3.5μl 
Q-Solution, 5x 2.5μl 
Template RNA (25ng) 1μl 
QIAGEN One-step RT-PCR enzyme mix 0.5μl 
TOTAL 12.5μl 
 
 
Reactions were performed in a thermal cycler programmed in accordance to the conditions 
given in Table 2.5. This programme was performed for all primers except DNMT3A which 
had a higher annealing temperature of 56°C. A negative control (without template RNA) was 
used in every experiment. 
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Table 2.5 Cycling conditions.  
 
2.8.2.3 Agarose gel electrophoresis 
PCR products were electrophoresed through a 2% agarose gel (4 g of agarose powder was 
dissolved in 200ml 1x TAE buffer) containing 1:40000 ethidium bromideplaced in an 
electrophoresis tank containing excess 1 x TAE buffer (Sigma) that completely covered the 
gel. PCR samples (6μl) were mixed with a 2μl aliquot of gel loading buffer and then pipetted 
into the correct well. The wide range DNA marker (Sigma) was loaded into the first well 
and second DNA ladder placed in the final well and then visualised on the GelDoc-It2Imager 
(UVP, California, USA). To ensure cDNA integrity the housekeeping gene, β-actin, was also 
amplified. All gels were run at 100 V for one hour (Figure 2.6). 
 
 
 
 
 
Step Time (mins) 
Temperature (°C) Number of 
cycles 
Reverse Transcriptase 30 50 1 
Initial PCR activation 15 95 1 
Denaturation 1 94 39 
Annealing 1 55 39 
Extension 1 72 30 
Final Extension 10 72 1 
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245bp 
B-actin 
192bp 
198bp 
221bp 
272bp 
270bp 
528bp 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Example agarose gel electrophoresis. Agarose gel (2%) showing validation of 
specific PCR products of expected size for each DNMTs, TETs, and housekeeping genes 
tested in the present study across three different oxygen conditions. Direct load wide range 
DNA ladder. Fragment size (base pairs (bp)) indicated. Gel images were captured with 
Syngene Genesnap software. 
 
2.8.3 Quantitative Polymerase Chain Reaction (qPCR) 
Relative gene expression was performed on 25ng of isolated RNA for each sample to 
measure the level of expression of the genes showed in Table 2.3. qRT-PCR was achieved 
using QuantiFast® SYBER® Green RT-PCR One-step kit (QIAGEN). Relative 
quantification of gene expression was measured using the 2-ΔΔCT method. Threshold cycle 
(Ct) is the cycle number that shows a detectable increase in fluorescence generated within 
the PCR cycle. The expression of the genes was normalised against the house-keeping gene 
B-actin (ΔCt). ∆∆Ct value was assessed as the difference between ∆Ct values of the gene of 
interest and the control sample. 
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First, a qPCR reaction mix for each primer was prepared in accordance with the reaction 
setup indicated in Table 2.6.  
 
The reaction mix was then added to a chilled 96 PCR plate (Sigma) and sealed with optical 
adhesive cover (Thermofisher) before the plate was then transferred to a Strata gene 
MX3005P real time thermal cycler. The following cycling programme was used in 
accordance to the thermal profile outlined in Table 2.7.  
 
Table 2.6 qPCR reaction mixes component 
Reagents Volume/Sample 
SYBER Green Master mix 6.25μl 
Forward primer  1.25μl 
Reverse primer  1.25μl 
QuantiFast® RT (DNA Polymerase) mix 0.125μl 
Template RNA (25ng) 1.0μl 
RNase free water 2.5μl 
TOTAL 12.375μl 
Table 2.7 Thermal profile setups. 
Step 
Time 
(min) 
Temperature 
(°C) 
Number of 
cycles 
Reverse Transcriptase 10 50 1 
Initial PCR activation 5 95 1 
Denaturation  10sec 95 40 
Primer extension and Fluorescent determination 30sec 60 1 
Pre-programmed melt curve and Fluorescent 
determination as temperature increased from 
60ᴼC to 95ᴼC 
1 95 1 
30sec 60 1 
30sec 95 1 
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2.9 Western Blotting 
2.9.1 Preparation of cell lysates 
The cells were grown as described in Section 2.2.1. Following two PBS washes cells were 
lysed with fresh lysis RIPA buffer ((150mM sodium chloride (NaCl, Sigma-Aldrich), 20mM 
Hepes (CalbioChem), 2mM EDTA (Sigma-Aldrich), 0.5% sodium deoxycholate (Sigma-
Aldrich), 120µM leupeptin (Sigma-Aldrich), 1% NP-40 (Sigma-Aldrich), 10µM pepstatin 
(Sigma-Aldrich), 1mM phenylmethanesulfonylfluoride fluoride (PMSF, Sigma-Aldrich) 
and 10µM pepstatin (Sigma-Aldrich). The cell lysate suspension was then pipetted into an 
Eppendorf tube, centrifuged at 10,000 g for 10 minutes at 4°C to remove insoluble materials 
and the total protein content in the supernatant measured using the BCA protein kit (Sigma-
Aldrich). 
2.9.2 Bicinchoninic acid (BCA) protein assay 
Firstly an albumin standard curve containing bovine serum albumin (BSA) was prepared at 
concentrations between 0.1 and 2mg/ml. BCA working reagent was prepared by mixed BCA 
reagent A containing bicinchoninic acid, sodium carbonate, sodium tartrate and sodium 
bicarbonate in 0.1 N sodium hydroxide with 4% copper (II) sulphate (BCA reagent B) in the 
ratio of 1:50. 10µl of each BSA standard or 5µl of each lysate (diluted in 5µl RIPA buffer) 
was pipetted into the 96 well plate cultures and then mixed with 100µl of the working 
reagent. Next, the 96 well plates were covered and incubated for 30 minutes at 37°C. 
Absorbance readings were taken in duplicate at OD 570 nm using a spectrophotometer. 
Determination of the protein concentration for each lysate was performed using linear 
regression by plotting the BSA standard OD 570 versus its concentration (Figure 2.7). 
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Figure 2.7 A representative standard curve of BSA protein assay. The standard curve of 
BCA assay using a serial dilution of BSA, the concentrations of unknown samples from cell 
lysate were determined from the interpolation of X-axis of the standard curve, data expressed 
as mean ± SD (n=3). Interpolation of x-axis was used for determination of protein 
concentrations of unknown samples. 
 
2.9.3 SDS-PAGE 
Samples were prepared for SDS-PAGE by added 5-15µg sample protein to NuPAGE buffer 
(Invitrogen) supplemented with 5% β-mercaptoethanol (Sigma-Aldrich) before denaturing 
at 80°C for 15 minutes. Each lane on the 4-20% NuView Tris-Glycine polyacrylamide 
gradient gel (Nusep) was washed by pipetting 6-8 times with hepes running buffer ((100 mM 
hepes, 100 mM Tris and 1% sodium dodecyl sulphate SDS (Sigma-Aldrich)) and placed in 
an XCell SureLock Mini Cell (Invitrogen). Hepes running buffer was also used for both the 
cathode and anode buffer to separate the denatured protein from each sample lysate. Sample 
protein was loaded to each lane on the gel and the PageRuler™ Plus Prestained Protein 
Ladder (Thermo Scientific) was used to estimate the size of immunodetected proteins on 
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each gel. The gel electrophoresis was run at 30 mA, 240 V, for 60 minutes or until the 
running reached the end of the gel.  
2.9.4 Western Blotting analysis 
Amersham Hybond P 0.45µm polyvinylidene difluoride (PVDF) membrane (GE Healthcare 
Life Sciences) and filter paper (Whatmann 3 MM) was soaked with transfer buffer (25mM 
Tris, 200mM glycine (Sigma-Aldrich), 0.075% SDS and 10% methanol) for 20-30 minutes. 
After electrophoresis, separated proteins were transferred to a Hybond membrane using a 
blotting assembly as described (Towbin et al., 1979) and power supply was set at 25 V for 
1.5 hours. Membrane blocking the was performed by incubation of the protein-blotted 
membrane at room temperature for 60 minutes with TBST buffer ((50mM Tris 
hydrochloride (Tris HCl, pH 7.4, Sigma-Aldrich), 150mM NaCl, and 0.1% Tween 20)) 
supplemented with 5% skimmed milk powder. The membrane was incubated in 5ml of 
diluting primary antibody at 4°C overnight with gentle rocking. Any unbound, excess 
antibody was removed by washing the membrane 3 times with TBST buffer and then 
incubating with 5ml of secondary antibody at room temperature for 1 hour with gentle 
rocking. Following on from washes the immunoreactivity bands were subjected to UpLight 
HRP chemiluminescent substrate solution (Uptima) and imagined using a FluorChem M 
Imager. Bands were quantified on ImageJ2 software when necessary. The antibodies and 
corresponding dilutions used are described in Table 2.8. 
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Table 2.8 List of human primary and secondary antibodies. 
Primary 
antibody 
 
Host 
Company/ 
Catalog N. 
 
Dilution 
Secondary 
antibody 
Company/ 
Catalog N. 
 
Dilution 
DNMT3B Mouse R&D System/ 
MAB7646 
2 mg/ml Anti-mouse 
IgG-HRP 
Cell 
Signaling/ 
70765 
1:1000 
TET1 Mouse ThermoFisher/ 
GT1462 
1:1000 Anti-mouse 
IgG-HRP 
Cell 
Signaling/ 
70765 
1:1000 
HIF1A Rabbit Novusbio/ 
NB100-479 
1:1000 Anti-rabbit 
IgG-HRP 
Cell 
Signaling/ 
70745 
1:1000 
HIF2A Rabbit Novusbio/ 
NB100-122 
1:750 Anti-rabbit 
IgG-HRP 
Cell 
Signaling/ 
70745 
1:1000 
GAPDH Mouse Merck/ 
 MAB374 
1:5000 Anti-rabbit 
IgG-HRP 
Cell 
Signaling/ 
70765 
1:1000 
 
 
2.10 Pyrosequencing  
Pyrosequencing is a sequence-based technology that can be used for measuring the level of 
DNA methylation across many CpG sites within genes of interest. The estimated of 
methylation status within the sequenced region of interest are built on the signal intensities 
for incorporated dGTP and dATT, which release visible light through enzymatic conversion. 
The amount of light produced is directly proportional to the number of bases incorporated 
and is detected by CCD sensors within the Pyrosequencing hardware. The quantitative 
results are generated as percentage values from the ratio of methylated to unmethylated 
cytosine residues within CpG region. In this study we used the bisulphite conversion and 
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standard pyrosequencing protocols to determine the methylation status of genes of interest. 
There are many steps in pyrosequencing assay as shown in Figure 2.8 and the details are 
described below. 
 
Figure 2.8 An overview of the procedure for the pyrosequencing assay for DNA 
methylation analysis. 
 
2.10.1 Sodium Bisulphite Modification of Genomic DNA 
Modification of genomic DNA was performed with EZ DNA Methylation-Gold™ Kit 
(Zymo Research) to convert unmethylated cytosine residues chemically to uracil and leave 
the methylated cytosine unchanged. DNA was extracted from cultured cells as described in 
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Section 2.7.2, and 500ng of gDNA for each sample was diluted in 20μl of DNases/RNase 
free water. Then 130μl of CT Conversion reagent was added to 20μl of the DNA dilution, 
mixed well, placed in a PCR tube and the thermal cycler run at 98oC for 10 minutes and 
thereafter 64oC for 2.5 hours. Samples were then incubated at 4oC for 20 hours before being 
mixed with 600μl M-Binding Buffer and transferred to a Zymo-SpinMT IC Column and 
centrifuged at 13000 g for 30 seconds. M-Binding buffer was removed by washing with 
100μl wash buffer and then 200μl M-Desulphonation Buffer added followed by incubation 
at room temperature for 15-20 minutes. Following on from centrifugation at 13000 g for 30 
seconds, 200μl washing buffer was added to remove desulphonation buffer and samples then 
centrifuged at 13000 g for 1 minute before being repeated twice, and the eluate was 
discarded. Next, the spin columns were transferred to 1.5ml microcentrifuge tubes and eluted 
in 21μl M-Elution Buffer centrifugation at 13000 g for 30 seconds. The sodium-bisulphite 
converted DNA was quantified by spectrophotometry (single-stranded DNA measurements 
ssDNA) and stored at -20oC in sterile tubes for future use. 
2.10.2 PCR Amplification 
Converted DNA (2-4μl) was used as template in PCR reactions. Primers were designed from 
the UCSC genome browser (http://genome.ucsc.edu/) and ordered from biomers.net GmbH 
(Germany). Forward or reverse primers were biotinylated at the 5’end to enable sequencing 
of the antisense strand of the PCR amplicon. Primer sequences and expected PCR product 
size are listed in Table 2.9.  
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Table 2.9 Pyrosequencing PCR primers. Forward and reverse primer sequences used for 
pyrosequencing are shown with their respective sequencing primers. The expected products 
size as well as the optimum annealing temperatures degree for each primer is also given. 
Gene name Annealing 
Temp (°C) 
Forward primer Reverse primer Sequencing 
primer 
Product 
size 
 
DNMT1 
 
61 
5’- 
TGGGGGAGGA
ATTAAA-3’ 
5΄- 
AACTTTCTCCC
CACACC-3΄ 
5΄- 
TTGTGTAG
AAATGGAA
-3΄ 
 
230 
 
DNMT3
A 
 
61 
 5΄- 
GGAGAGGGTG
AGAAGG-3΄ 
5΄- 
TATCCCCCCCC
CAATT-3΄ 
5΄- 
GTTTGTTG
TTAGGAGT-
3΄ 
 
196 
 
DNMT3
B 
 
61 
5΄- 
GGGGATAGGA
GAAGGG-3΄ 
5΄- 
TCCTCACCTCC
CTTAA-3΄ 
5΄- 
GTTTGTTG
TTAGGAGT-
3΄ 
 
80 
 
DNMT3
L 
 
60 
5΄- 
GGAGAGGAAT
AGAGTG-3΄ 
5΄- 
AAAAATAACC
CCTTCT-3΄ 
 
5΄- 
CCTCCATT
CCAATACA
-3΄ 
 
72 
 
TET1 
 
61 
5΄- 
GGGTTTAGGTT
GTGG-3΄ 
5΄- 
CCCCAACTCC
ACCTAC-3΄ 
5΄- 
TTTAAAGT
TGTGGGGA
T-3΄ 
 
 
81 
 
TET2 
 
61 
5΄- 
TGGTGAGGGGT
GTTAG-3΄ 
5΄- 
CCCTTTAAAAT
ACACT-3΄ 
5΄- 
CACTCCAC
CACCACT-
3΄ 
 
 
150 
 
TET3 
 
61 
5΄- 
TTGGGATAGGG
GTTAG-3΄ 
5΄- 
CCACTCCCTA
ATCTAT-3΄ 
5΄- 
GATAGGGG
GGGTTAGT-
3΄ 
 
 
88 
 
 
GoTaq®G2 Flexi DNA Polymerase kit (Promega) was used to amplify all samples in 25μl 
volumes containing 5μl 5x Flexi buffer, 0.2μl Taq DNA Polymerase, 2.5μl of 25mM MgCl2, 
1μl 20μ M/μl nucleotides, 1μl of each forward and reverse primer and 12.3μl molecular 
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grade water. Initial denaturation was performed with one cycle of 95°C for 5 minutes. Then, 
touch-down cycling was used for the first 14 cycles, where the temperature was reduced by 
0.5oC in each successive cycle. Next, 35 cycles of 95°C for 45 seconds, annealing at 55–
63°C for 45 seconds and elongation at 72°C for 30 seconds. followed by final elongation 
step with one cycle at 72°C for 5 minutes. Successful PCR amplification was 
electrophoresed through a 2% agarose gel as described in Section 2.8.2.3. 
 
Figure 2.9 PCR amplification products by electrophoresis on a 2% agarose gel. The 
products are directed toward bisulphite-converted DNA, and specific for the DNMT3L gene. 
The successful and specific amplification are suggested when the correct size and single 
band are presence. Negative control: no-template.  
 
2.10.3 Pyrosequencing 
PCR amplied DNA was used in pyrosequencing analysis to determine the percentage of 
methylation within genes of interest. PCR products were biotin–labelled, by mixing PCR 
products with 1μl of streptavidin-sepharose beads (GE Healthcare), 40μl of Binding buffer 
(Qiagen), and 19 μl of molecular grade water, and 40μl of Binding buffer (Qiagen) on a 
rotary shaker for 15 minutes to allow streptavidin beads to bind biotin-labelled strand. 
During the mixing step, the Q24 pyrosequencing plate was prepared by adding 25 μl of 
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Annealing buffer (Qiagen), and 0.08μl of the assay-specific sequencing oligonucleotide to 
each well (Table 2. 9).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10 An overview of principles of pyrosequencing reaction steps. A) gDNA is 
bisulphite converted, PCR amplified with one of the primers biotinylated and “captured” by 
the streptavidin-sepharose beads. The beads do not pass through the vacuum station filters 
and are preserved during the washing, the biotinylated strand is purified and annealed to a 
sequencing primer to yield only the target region of interest before they subject to 
Pyrosequencing. B) This figure shows the chemical reactions and enzymes involved in the 
producer of light. The incorporation of complementary base-pairs into the single-stranded 
template is catalysed by the polymerase enzyme within the provided enzyme mixture. 
Pyrophosphate (PPi) is released during this chemical reaction and converted to ATP by 
sulfurylase enzyme in the presence of adenosine 5´-phosphosulfate substrate (APS). ATP is 
a required to convert luciferin to oxyluciferin that is catalysed by luciferase enzyme, and as 
sequence results the light is produced. the apyrase enzyme removes any unincorporated 
nucleotides. C) Detection is built on the intensity of the light produced and then the ratio of 
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cytosines to thymines can be determined by using the Pyrosequencing software. This figure 
adapted from the Invitrogen Pyrosequencing™ guide. 
 
Samples were then removed from the shaker and transferred to the Pyromark Q24 Vacuum 
Workstation (Qiagen), cleaned with 70% ethanol to remove excess salts and solutes, 
denatured with NaOH solution (VWR) to leave the bead-bound strand of interest only, and 
purified with wash buffer (10mM Tris pH 7.6) to remove the unbiotinylated DNA strand of 
interest before the biotinylated strands was released into the Q24 pyrosequencing plate filled 
with annealing mix. The plate was heated at 80oC for 2 minutes on preheated heat blocks 
and then cooled for 3 minutes to allow annealing between the sequencing primer and the 
target DNA strands. Pyromark Gold Q24 reagents (Qiagen) including the four nucleotides 
and the substrate and enzyme mix were loaded into pyrosequencing dispensation cartridge. 
Volumes were determined with the PyroMark Q24 software and control samples with each 
assay confirmed consistency between plates. The sequencing data was analysed using the 
PyroMark software. 
2.11 Statistical analysis 
The experimental data were analysed using statistical software SPSS (IBM SPSS Statistics 
21). A comparison among three groups was assessed using a one-way analysis of variance 
(ANOVA). The threshold for which statistically significant was accepted as p<0.05. 
GraphPad Prism 5 (GraphPad Software, La Jolla, USA) was used for graphical displaying 
of data. Data are expressed as mean ± SD, each result represent a replicate of 3 independent 
experiments (n=3). 
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Chapter 3: Air oxygen culture of human 
bone marrow-derived mesenchymal stem 
cells drives DNA hypermethylation 
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3.1 Introduction 
Human bone marrow-derived mesenchymal stem cells (BM-hMSCs) are characterized by 
their multipotency and differentiation ability (Schwartz et al., 2002). Human bone marrow-
derived mesenchymal stem cells (BM-hMSCs) were the first MSCs isolated and since then 
they have been reported from a wide range of adult tissues, such as dental tissues, adipocytes, 
lung, muscle, and peripheral blood (Mimeault and Batra, 2006). Moreover, and due to the 
multipotency potential (osteoblast, adipocyte and chondrocyte) and immunosuppressive 
properties MSCs are widely used in many clinical applications and evaluated as a potential 
tool of stem cells for regenerative medicine (Wang et al., 2016). However, short term 
survival, early senescence, poor engraftment following transplantation, and genetic and 
epigenetic instabilities during ex vivo expansion are among the weaknesses of MSC-based 
regenerative therapies (Mastri et al., 2014). It has been established that a complex mixture 
of inter- and intracellular interactive signalling systems are involved in control of 
homeostasis, growth, and differentiation of MSCs in their niche (Haque et al., 2013; 
Kowalski et al., 2015). Among which, physiological normoxia is involved in many aspects 
such as regulation of stem cell behaviour, maintenance of stemness and metabolism 
(Mohyeldin et al., 2010; Narva et al., 2013). The prevalent oxygen level of the BM-hMSCs 
niche has been shown to be 1-2% O2, suggesting that physiological normoxia is a 
predominant characteristic (Park et al., 2010). Currently, increased consideration has been 
given to cell culture conditions and how this could alter data collection in vitro. Several 
studies have suggested that reduced oxygen culture conditions, reminiscent of physiology, 
(2–5% O2 concentration) enhance isolation and proliferation of BM-hMSCs with less 
accompanying DNA damage and genetic instability (Boregowda et al., 2012; Estrada et al. 
2012; Haque et al., 2013; Heywood and Lee, 2017). Notably, starkly reduced oxygen levels 
play a significant role in maintaining stem cell fate by regulating stability of the hypoxia-
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inducible factor (HIFs) transcription factors which in turn stimulate different genes (Hu et 
al., 2016; Wiafa et al., 2018). However, the precise role of low, physiological, oxygen 
conditions on stem cell biology are still under investigation (Simon and Keith, 2008). 
“Epigenetics is the study of heritable changes in gene expression that are not caused by 
changes in the DNA sequence” (Esteller, 2008; D’Urso and Brickner, 2014). There are many 
mechanisms by which epigenetics can control the process of gene expression such as DNA 
methylation and histone modification (Bird, 2007). However, many studies have suggested 
a strong link between DNA methylation and regulation of stem cell renewal and 
differentiation (Huang et al., 2013). In addition, DNA methylation has been shown to have 
different patterns in BM-hMSCs in aging and in long-term cultures, suggesting that DNA 
methylation is involved in regulation of replicative senescence and aging (Bork et al., 2010). 
Lineage-specific promoter hypermethylation results in a loss of BM-hMSCs ability to 
differentiation towards that lineage. However, the correlation between changes on CpG 
island methylation levels of BM-hMSCs and ability of these cells to differentiate during 
long-term culture is still not clear and further work is needed (Sørensen et al., 2010). The 
work of Shahrzad et al reports that low oxygen levels significantly influence changes in 
DNA methylation and result in a global reduction in DNA methylation in human colorectal 
and melanoma cell lines (Shahrzad et al., 2007). Also, it has suggested that reduced oxygen 
plays a role in the regulation of DNMT and TET expression through induction of the HIF 
pathway and this can catalyse changes in the levels of 5mC and 5hmC in a number of human 
cell lines (Wu et al., 2015; Chen et al., 2016). However, the role of physiological normoxia 
conditions in regulation of the level of 5mC and 5hmC and their enzymes (DNMT and TET, 
respectively) in BM-hMSCs have received very little attention. 
We have tested the hypothesis that epigenetic methylation marks (5mC and 5hmC) in human 
bone marrow-derived mesenchymal stem cells (BM-hMSCs) are altered in response to 
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specific environmental changes (physiological normoxia (2% O2) vs. air oxygen (21% O2)). 
Furthermore, we have investigated if these changes are in relation to changes in the 
expression of controlling DNMTs/TETs gene expression and translation. This was achieved 
by isolation and expanded hMSCs from human bone marrow aspirates by plastic adherent 
culture technique and by examining global patterns of 5mC and 5hmC and examining local 
patterns within the promoter regions of DNMTs/TETs genes. 
3.2 Methods 
3.2.1 Isolation and culture of human bone marrow-derived mesenchymal stem cells 
(BM-hMSCs) 
Three human mesenchymal stem cells (MSCs) (BMA-16, BMA-20 and BMA-25) were 
isolated and expanded from commercially sourced (Table 3.1) whole human bone marrow 
aspirate (BMA) using the plastic adherence method as described in Section 2.4. The cells 
were maintained in the following three conditions 21% O2 - Standard cell culture (21%ST); 
2% O2 - Pre-gassed media – 2% O2 incubation (2%PG) and 2% O2-Pre-gassed media, 
Workstation (2%WKS). To maintain the oxygen level of the cells during physiological 
oxygen culture, cell culture media was de-oxygenated to a predefined oxygen concentration 
(2% O2) as described in Section 2.2.2. 
Table 3.1 Donor details of human bone marrow aspirates 
No BMA label Donor description Supplier 
1 BMA-16 Human Bone Marrow, Male, Age-29 years Lonza, MD, USA 
2 BMA-20 Human Bone Marrow, Female, Age-50 years AllCells, LLC, SA 
3 BMA-25 Human Bone Marrow, Male, Age-27 years Lonza, MD, USA 
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3.2.2 Characterisation of mesenchymal stem cells 
hMSCs were seeded at 2 x 104 cells/cm2 in 24 well plates in complete culture media prior to 
being cultured in differentiation media for 20 days. Evaluation of differentiation potential of 
BM-hMSCs was as described in Section 2.4.1.1 and Section 2.4.1.2. Flow cytometry of 
differentiated hMSCs was as described in Section 2.4.1.3. 
3.2.3 Global 5mC and 5hmC analysis 
Total genomic DNA was isolated from hMSCs as described in Section 2.7.2, and 100ng and 
200ng of DNA was subjected to methylated DNA (5mC) and 5-hydroxymethylated DNA 
(5hmC) quantification assay (Colorimetric) respectively by using a MethylFlash 
quantification kit as outlined in Section 2.7.3. 
3.2.4 Quantitative real-time RT-PCR 
Total RNA was extracted from hMSCs as described in Section 2.8.1. Relative gene 
expression was carried out in triplicate samples by using the QuantiFast SYBR Green 
OneStep RT-PCR kit (Section 2.8.3). 
3.2.5 Protein analysis 
hMSCs were cultured and lysed as described in Section 2.9.1 before 30µg of total protein 
(Section 2.9.2) was subjected to Western Blot analysis using antibodies against DNMT3B, 
TET1, HIF1A and HIF2A as described in Chapter 2, Section 2.9.4.  
3.2.6 Pyrosequencing of sodium bisulphite-converted DNA 
Genomic DNA (500ng) was subjected to bisulphite conversion before pyrosequencing using 
a PyroMark Gold Q24 Reagents and PyroMark Q24 Software 2.0 (Full details in Chapter 
2, Section 2.10). 
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3.3 Results 
3.3.1 Characterisation of Bone Marrow-derived Mesenchymal Stem Cells (BM-
hMSCs) 
3.3.1.1 Differentiation of BM-hMSCs into mesenchymal lineage 
Confirmation of the ability of BM-hMSCs to undergo tri-lineage differentiation is essential 
to evidence a multipotent differentiation capacity allowing us to refer to these cells as stem 
cells. As mentioned in Section 2.4.1.1, hMSCs were exposed to either chondrogenic, 
adipogenic, or osteogenic differentiation media. As shown in Figure 3.1, hMSCs were 
positive for Alizarin Red staining for osteogenesis, Oil Red O staining for adipogenesis, and 
Alcian blue staining for chondrogenesis. Cells grown in control media stained weakly, if at 
all, with the respective tri-lineage differentiation dyes (Figure 3.1). 
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Figure 3.1 Classical Tri-lineage differentiation of hMSC cultured in air oxygen (21%ST) and physioxia (2%PG and 2%WKS). hMSC were 
seeded into Tri-lineage differentiation medium for 20 days, revealing adipocytes (Oil Red O-lipid droplet), osteoblasts (Alizarin Red-calcium 
deposits) and chondrocytes (Alcian blue–proteoglycans stain). The scale bar equal 100 μm for all images.  
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3.3.1.2 Immunophenotypic characterisation of BM-hMSCs by flow cytometry 
According to ISCT guidelines (Dominici et al., 2006), a panel of hMSC surface markers 
were used to determine the immunophenotype of hMSCs by FACS. Cells from each 
condition (21%ST, 2%PG and 2%WKS) were incubated with marker antibodies and the 
percentage of positive or negative events were determined relative to the relevant isotype 
control marker (IgG1 or IgG2a) (Figure 3.2A). The results indicated that hMSCs expressed 
CD90, CD73 and CD105 but lacked expression of CD14, CD19, CD45, CD34 and HLA-
DR surface markers. No significant differences between isolation conditions were observed 
(Figure 3.2B).  
(A) 
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(B) 
 
 
 
 
 
 
 
 
 
Figure 3.2 Immunophenotypic characterisation of BM- hMSCs. A) Overlay histograms 
of hMSCs by Flowing Software showed that the hMSCs in three oxygen conditions 
expressed were typically negative for (CD14, CD19, CD37, CD45, HLA-DR) and typically 
positive for (CD90, CD73 and CD105). The unfilled area represents isotype control IgG1 or 
IgG2a, grey area is antibody marker. B) The percentage positive event was quantified 
relative to the relevant isotype control marker; IgG1 (CD73, CD90, CD105, and CD19) or 
IgG2 (CD14, CD34, CD45, and HLA-DR). Y-axis indicates surface markers. X-axis 
indicates % of positive events. The values are mean (n=3) and the error bar indicate standard 
deviation (SD).   
 
3.3.2 Physiological normoxia induced expression of pluripotency markers in BM- 
hMSCs  
Reduced oxygen culture resulted in significantly enhanced mRNA levels of the pluripotency 
marker SOX-2 but no significance indicated for OCT-4 (POU5F1) or NANOG. The relative 
fold expression of SOX-2 was significantly increased in 2%WKS cultures compared to air 
oxygen 21%ST in BMA-16, BMA-20 and BMA-25 (2.0 ± 0.29, 2.3 ± 0.44 and 2.0 ± 0.54, 
respectively), and in 2%PG cultures compared to air oxygen 21%ST in BMA-20 and BMA-
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25 (2.2 ± 0.54 and 1. 8 ± 0.44, respectively) (Figure 3.3). OCT-4 expression was generally 
higher in low oxygen than air oxygen but was not significantly upregulated. In contrast, the 
level of NANOG was decreased in hMSCs following treatment with 2%PG and 2%WKS 
but no significant differences were noticed. The data from all three BM-MSCs (BMA-16, 
20 and 25) was merged to have as representative biological replicates and to avoid cell line-
specific biases as possible. Similar signficant increase was observed in SOX-2 level in cells 
cultured under 2%PG and 2%WKS (1.8 ± 0.36 and 2.1 ± 0.18, respectively) (Figure 3.3). 
The results also showed there was no significant change in the relative expression of OCT-
4 and NANOG in hMSCs cultured under reduced oxygen compared to air oxygen 21%ST 
(Figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Quantitative RT-PCR analysis of OCT-4 (POU5F1), NANOG, and SOX-2 
in response to reduce oxygen in three BM-hMSCs. Expression was normalized to the 
expression of β-actin. Y-axis indicates relative changes in 2^ΔΔCt of treated cell to untreated 
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cell. X-axis indicates pluripotency markers Data are presented as mean ± standard deviation 
(SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
 
3.3.3 Air oxygen induces DNA hypermethylation (5mC and 5hmC) in BM- hMSCs  
To examine the global DNA methylation (5mC and 5hmC) patterns in BM- hMSCs DNA 
was isolated from hMSCs (Passage1) after isolation and 21 days incubation in 21%ST, 
2%PG and 2%WKS. This DNA was then explored using an immunospecific method to 
determine global levels of 5mC and 5hmC. A reduced level of global DNA methylation in 
the total DNA extracted from all three hMSCs cultured in both reduced oxygen conditions 
(2%PG and 2%WKS) in comparison to oxygen air (21%ST) was noted (Figure 3.4 and 3.5). 
The level of 5mC in BMA-16 cells was significantly lower following incubation in 2%PG 
(0.67 ± 0.17, p<0.05) and 2%WKS (0.54 ± 0.08, p<0.01) in comparison to those cultured in 
21%ST (0.99 ± 0.10) (Figure 3.4A). Also, as shown in Figure 3.4A DNA methylation 
decreased significantly in BMA-20 in 2%PG, by a percentage change of 5-methylcytosine 
(0.36 ± 0.05, p<0.05), and in 2%WKS (0.25 ± 0.05, p<0.01) versus 21%ST (0.61 ± 0.015). 
BMA-25 cells cultured in 2%WKS showed significant reduction in 5mC content (0.37 ± 
0.06) in comparison to those cultured in 2%PG and 21%ST (0.64 ± 0.16 and 0.85 ± 0.06), 
respectively (Figure 3.4A). Also, the results of three BM-MSCs (BMA-16, 20 and 25) taken 
together showed significant reduction in global 5mC level in cells cultured under 2%WKS 
conditions (0.39 ± 0.15, p<0.05), but there were no significant differences was observed 
between the cells that cultured in 2%PG and 21%ST (0.56 ± 0.17 and 0.82 ± 0.2) (Figure 
3.4B).  
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Figure 3.4 Global changes of 5mC contents in BM- hMSCs. A) Three BM- hMSC lines 
were incubated in air oxygen (21%ST) and normoxia physiological conditions (2%PG and 
2%WKS). B) The results of three BM-MSCs (BMA-16, 20 and 25) taken together. The 
methylated DNA fraction in the total isolated DNA was measured using MethylFlashTM 
Methylated DNA quantification kit. Y-axis indicates 5-methylcytosine absorbance (450 
nm). X-axis indicates different oxygen culture conditions. Data are presented as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST).      
 
Similar significant reductions were observed in global 5hmC content in BMA-16 cells grown 
under 2%WKS condition 0.009 ± 0.002, p<0.05 in comparison to those cultured in 2%PG 
and 21%ST (0.16 ± 0.0036 and 0.016 ± 0.0008), respectively (Figure 3.5A). The level of 
5hmC in BMA-20 cells was decreased significantly following incubation in 2%WKS (0.009 
± 0.0015, p<0.01) in comparison to those cultured in 21%ST (0.017 ± 0.002) (Figure 3.5A). 
Also, as shown in Figure 3.5A 5hmC decreased in cells of BMA-25 grown in reduced 
oxygen versus 21%ST, but there were no significant differences was observed. Also, the 
results of three BM-MSCs (BMA-16, 20 and 25) taken together showed significant reduction 
in global 5hmC level in cells cultured under 2%WKS condition (0.009 ± 0.0007, p<0.05) 
versus 21%ST (0.019 ± 0.004) (Figure 3.5B). 
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Figure 3.5 Global changes of 5hmC contents in BM- hMSCs. A) Three BM- hMSCs were 
incubated in air oxygen (21%ST) and normoxia physiological conditions (2%PG and 
2%WKS). B) The results of three BM-MSCs (BMA-16, 20 and 25) taken together. The 
methylated DNA fraction in the total isolated DNA was measured using MethylFlashTM 
hydroxymethylated DNA quantification kit. Y-axis indicates 5-hydroxymethylation 
absorbance (450 nm). X-axis indicates different oxygen culture conditions. Data are 
presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen 
(21%ST). 
 
3.3.4 Expression changes of DNMTs and TETs genes by BM- hMSCs in response to 
reduced oxygen  
RT-qPCR was employed to examine whether the reduced levels of global DNA methylation 
(5mC and 5hmC) in response to physiological normoxia were in relation to changes in the 
expression of DNMTs/TETs genes. The results showed there was no significant change in 
the relative expression of DNMT3A in all three BM-hMSCs (Figure 3.6). The level of 
DNMT3B was decreased significantly in BMA-16 and 20 cells following treatment with 
2%WKS (0.43 and 0.38, P<0.01) respectively, and in BMA-16 and 25 cultured in 2%PG 
(0.57 and 0.6, P<0.05, respectively) versus 21%ST (Figure 3.6).The level of DNMT3B was 
decreased significantly in BMA-16 and 20 cells following treatment with 2%WKS (0.43 and 
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0.38, P<0.01) respectively, and in BMA-16 and 25 cultured in 2%PG (0.57 and 0.6, P<0.05, 
respectively) versus 21%ST (Figure 3.6).  
Similar significant reductions were observed in DNMT3L levels BMA-16 cells grown under 
2%PG and 2%WKS conditions (0.76, P<0.01 and 0.69, P<0.05), respectively versus 21%ST 
(Figure 3.6). Significant differences were also noted in expression levels of DNMT3L 
between BMA-20 cells cultured in 2%PG and 2%WKS (1.5 and 0.71, P<0.05) respectively. 
In addition, the level of DNMT1 was significantly higher in BMA-16 cells cultured in 
2%WKS (1.4, P<0.05) versus 21%ST.   
The results of three BM-MSCs (BMA-16, 20 and 25) taken together showed significantly 
less expression in DNMT3B in cells cultured under 2%PG and 2%WKS conditions (0.64 
and 0.59, P<0.01), respectively versus 21%ST, but there was no significant change in the 
relative expression of DNMT1, DNMT3A and DNMT3L (Figure 3.6). 
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Figure 3.6 RT-qPCR expression of the DNA methyltransferase (DNMTs) enzymes at 
RNA level in three BM-hMSCs. Quantification RNA of DNMTs isolated from BM- 
hMSCs following incubation in air oxygen (21%ST) and normoxia physiological culturing 
conditions (2%PG and 2%WKS). The expression was normalized to the expression of β-
actin. Y-axis represents relative changes in 2^ΔΔCt of treated cell to untreated cell. X-axis 
represents DNA methyltransferase enzymes. Data are presented as mean ± standard 
deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
Ten-eleven translocation methylcytosine dioxygenase 2 (TET2) displayed no significant 
changes in expression across in all three of the BM-hMSCs (Figure 3.7). TET1 expression 
was significantly reduced in BMA-16 cells in 2%PG and 2%WKS culture (0.7, P<0.05 and 
0.64, P<0.01), respectively, and in BMA-20 cultured in both reduced oxygen (2%PG and 
2%WKS) (0.48 and 0.39, P<0.01), respectively versus 21%ST (Figure 3.7). Similarly, 
significantly less expression of TET1 in BMA-25 cells grown under 2%PG (0.6, P<0.05) 
  
91 
 
versus 21%ST (Figure 3.7). Also, significant reductions in expression of TET3 in BMA-20 
cells cultured in 2%PG (0.62, P<0.05) were noted. In contrast, BMA-25 showed 
significantly greater levels of TET3 expression in cells cultured under 2%PG condition (1.5, 
P<0.05) versus 21%ST (Figure 3.7). In order to have as representative biological replicates 
and to avoid cell line-specific bias, the results of three BM-MSCs (BMA-16, 20 and 25) was 
merged together (Figure 3.7). The results showed significantly less TET1 expression in cells 
cultured under 2%PG and 2%WKS conditions (0.7 and 0.77, P<0.01), respectively versus 
21%ST, but there was no significant change in the relative expression of either TET2 or 
TET3 (Figure 3.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 RT-qPCR expression of the ten-eleven translocation methylcytosine 
dioxygenase (TETs) enzymes at RNA level in three BM-hMSCs. Quantification RNA of 
TETs isolated from BM- hMSCs following incubation in air oxygen (21%ST) and normoxia 
physiological culturing conditions (2%PG and 2%WKS). The expression was normalized to 
the expression of β-actin. Y-axis indicates relative changes in 2^ΔΔCt of treated cell to 
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untreated cell. X-axis indicates ten-eleven translocation methylcytosine dioxygenase 
enzymes. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs 
air oxygen (21%ST). 
 
3.3.5 Reduced DNMT3B and TET1 protein expression in BM-hMSCs cultured in 
physiological normoxia 
To confirm that the decrease in DNMT3B and TET1 transcription was accompanied by 
down-regulation of DNMT3B and TET1 at protein level we used Western Blot analysis on 
protein isolated from three BM-hMSCs cultured at day 21 in normoxia physiological 
conditions compared to cells maintained in air oxygen conditions. Profiling of protein 
expression showed that there was a downregulation of DNMT3B and TET1 in hMSCs 
cultured in reduced oxygen conditions in a broadly similar pattern to that observed with 
mRNA expression (Figure 3.8). 
 
 
 
 
 
Figure 3.8 Changes in DNMT3B and TET1 expression in BM-hMSCs, at protein levels 
measured by immunoblotting. Protein was isolated from three BM-hMSCs at day 21 
following incubation in air oxygen (21%ST) and normoxia physiological (2%PG and 
2%WKS) conditions. GAPDH was used as a control. 
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3.3.6 Oxygen induces changes in gene-specific promoter methylation in BM-hMSCs 
Section 3.3.3 showed that there were differences in the mean levels of DNA methylation 
between reduced oxygen and air oxygen conditions in BM-hMSCs. We also showed that 
low oxygen induced changes in BM-hMSCs of methylation machinery at both transcript and 
protein levels (Section 3.3.4 and 5). To confirm that these changes were consistent with 
methylation at promoter level, the DNA methylation status of seven gene promoters at the 
CpG level was determined using pyrosequencing (Section 2.10). The results showed there 
was significantly greater mean levels of DNMT3B promoter methylation in BMA-16 cells 
following isolation with 2%WKS (43%) when compared with air oxygen (13%) (Figure 
3.9). Similar results were observed in BMA-20 cultured in 2%PG and 2%WKS (38% and 
36%, respectively) when compared with the air oxygen (7%), and in BMA-25 cells following 
treatment with 2%PG and 2%WKS (42% and 46%) respectively, versus 21%ST (13%) 
(Figure 3.9). The combined analysis of three BM-hMSCs showed significantly greater 
DNMT3B promoter methylation levels in cells cultured under 2%PG and 2%WKS 
conditions (34% and 42%), respectively versus 21%ST (11%), but there was no significant 
change in the relative promoter methylation levels of DNMT1, DNMT3A and DNMT3L 
(Figure 3.9). 
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Figure 3.9 Mean levels of promoter methylation in physiological normoxia relative to 
air oxygen in three BM-hMSCs. A set of DNMTs genes promoter were evaluated using 
pyrosequencing. Y-axis represents DNA methylation levels at CpG regions. X-axis 
represents DNA methyltransferase enzymes. Data are presented as mean ± standard 
deviation (SD). n=3 *P<0.05, **P<0.01, ***P<0.001 vs air oxygen (21%ST). 
 
In addition, a significant increase in TET1 promoter methylation was noticed in BMA-16 
and BMA-20 cells cultured in 2%PG (13% and 20%, respectively) when compared to air 
oxygen (6% and 11%) (Figure 3.10). There was also a significant difference in the mean 
level of DNMT3B promoter methylation between 2%PG and 2%WKS in BMA-16 (5% and 
27%), respectively (Figure 3.10). In contrast, a significant increase in TET3 promoter 
methylation level was observed in BMA-25 cells cultured in 2%WKS (20%) versus 21%ST 
(4%) (Figure 3.10). No significant change in the methylation level of TET2 promoter was 
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seen across all three BM- hMSCs. Furthermore, when taken together we saw no significant 
change in the methylation levels of TET1, TET2 and TET3 (Figure 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Mean levels of promoter methylation in physiological normoxia relative to 
air oxygen in three BM-hMSCs. A set of TETs genes promoter were evaluated using 
pyrosequencing. Y-axis indicates DNA methylation levels at CpG regions. X-axis indicates 
ten-eleven translocation methylcytosine dioxygenase enzymes. Data are presented as mean 
± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
 
3.3.7 Reduced oxygen resulted in enriched HIF2A expression at protein level in BM-
hMSCs 
To identify the effects of reduced oxygen incubation on the HIFs expression profiles, 
transcriptional and protein levels of HIF1A and HIF2A in all three BM-hMSCs cultured in 
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different oxygen conditions were analysed with qPCR and Western blotting assays. The 
results showed there was significantly less relative gene expression of HIF1A (0.76 ± 0.11 
and 0.76 ± 0.10), respectively, in BMA-16 cells cultured in 2%PG and 2%WKS conditions 
when compared to those cultured in air oxygen (21%ST). In addition, the level of HIF2A 
(2.2 ± 0.54) was significantly elevated in BMA-16 cells following treatment with 2%PG 
(Figure 3.11A). Similarly, the level of HIF2A protein (2.4 ± 0.54 and 2.2 ± 0.43) was 
increased significantly in BMA-16 cells cultured under 2%PG and 2%WKS when compared 
with air oxygen. HIF1A protein was not detected in BMA-16 cells (Figure 3.11B). 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 HIFs expression in BMA-16 cells cultured in three different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
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Similarly, significantly less HIF1A gene expression (0.59 ± 0.09) was noted in BMA-20 
cells grown under 2%WKS condition when compared with the air oxygen (Figure 3.12A). 
In contrast, the level of HIF2A (2.04 ± 0.54) was increased significantly in BMA-25 cells 
cultured under 2%WKS. HIF2A protein (2.8 ± 0.7) was increased significantly in BMA-20 
cells cultured under 2%WKS when compared with air oxygen. HIF1A protein was not 
detected in BMA-20 cells (Figure 3.12B). 
 
 
 
 
 
 
 
 
 
  
  
Figure 3.12 HIFs expression in BMA-20 cells cultured in three different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
 
We noted significantly less relative gene expression of HIF1A (0.66 ± 0.18 and 0.59 ± 0.15), 
respectively in BMA-25 cells cultured in 2%PG and 2%WKS conditions in comparison to 
those cultured in air oxygen (21%ST). No significant changes in the gene expression levels 
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of HIF2A was noticed in BMA-25 cells (Figure 3.13A). A significant increase in HIF2A 
protein expression was noted in 2%PG and 2%WKS conditions in BMA-25 (2.2 ± 0.41 and 
2.1 ± 0.38) respectively, when compared with air oxygen (Figure 3.13B). No significant 
differences in the level of HIF1A protein were noted. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 HIFs expression in BMA-25 cells cultured in three different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
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3.4 Discussion 
Reduced oxygen is an important environmental factor that influences cells in different 
contexts. In the last two decades the number of studies exploring how culture conditions 
affect characteristics and functions of cells have increased considerably. However, MSCs 
exhibition biological responses to low oxygen in different ways. In addition, reduced oxygen 
significantly affects major MSCs characteristics such as growth rate, cell viability, 
differentiation, metabolism and apoptosis (Haque et al., 2013). Furthermore, extensive 
research in epigenetics marks over the last 10 years has shed light on the role of DNA 
methylation, revealing a profound impact of these marks on cells development and function 
(Tsagaratou et al., 2017).  
In this chapter, we tested and compared the changes in DNA methylation marks (5mC and 
5hmC) and their enzymes (DNMTs and TETs) in human bone marrow-derived 
mesenchymal stem cells (BM-hMSCs) cultured in three different oxygen conditions. In 
addition, we measured the characterisation and ability of BM-hMSCs to differentiate as well 
as their expression of pluripotent markers and HIFs. 
Our results demonstrated that the cells possessed the tri-lineage differentiation potential 
which is characteristic of MSCs (Figure 3.1). Also, along with these positive results of tri-
lineage differentiation, BM-hMSCs expressed CD73, CD90 and CD105 positively and 
lacked expression of CD14, CD19, CD34, CD45 and HLA-DR (Figure 3.2). Interestingly, 
surface expression of CD73, CD90 and CD105 are more than 95% in both reduced oxygen 
conditions (2%PG and 2%WKS), whereas the expression of these markers are slightly less 
than 95% under air oxygen (21%ST). This may be due to prolonged enzymatic time exposure 
during cell detachment (Brown et al., 2007; Temtem et al., 2009). However, our results 
showed there was no different between BM-hMSCs cultured in different oxygen conditions. 
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Our results agree with previous reports that demonstrated that MSCs cultured in either 
reduced oxygen or air oxygen displayed a typical MSCs profile with regular expression of 
surface markers overtime and no significant differences observed in cell surface (Holzwarth 
et al., 2010; Basciano et al., 2011). Moreover, Wang et al showed there was no significant 
differences in MSCs phenotypes before and after treatment with hypoxia (1% O2) for 24 
hours (Wang et al., 2015).  
We showed that reduced oxygen did not lead to significant changes in the mRNA levels of 
OCT-4 and NANOG. In contrast, the expression of SOX-2 was significantly increased in 
2% O2 cultures compared to air oxygen (Figure 3. 3). These results are in line with previous 
studied that showed the level of SOX-2 significantly increase in hMSCs cultured under low 
oxygen (5% O2), but not OCT-4 and NANOG (Ahmed et al., 2016). Similar results also have 
revealed that the level of pluripotency markers was increased significantly in low oxygen 
MSCs (D'Ippolito et al., 2006; Fehrer et al., 2007). However, OCT-4 and SOX-2, are 
naturally expressed in MSCs at low levels in early passages, and their levels gradually 
decline when the number of passages increases (Liu et al., 2009; Yoon et al., 2011). 
Therefore, increased levels of OCT-4 and SOX-2 might be involved in maintenance of 
stemness and in improving MSCs proliferation as well as differentiation capabilities (Han et 
al., 2014). 
RT-qPCR and Western Blot were used to investigate the effect of reduced oxygen tension 
on the expression of HIF1A and HIF2A subunits. Expression of HIF1A showed a bias 
toward significant down-regulation by low oxygen, whereas transcription of HIF2A was 
increased following long-term culture under reduced oxygen conditions (Section 3.3.7). 
These observations agree with other studies that have shown a significant decrease in mRNA 
expression of HIF1A after acute or chronic low oxygen incubation (Forristal, et al., 2010; 
Thienpont et al., 2016). In contrast, western blot and immunocytochemistry showed the 
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HIF1A protein expressed in reduced oxygen condition is maintained after 10 and 14 days 
reduced oxygen incubation (Chaven, et al., 2000; Westfall et al., 2008, Forristal, et al., 2010; 
Lin, et al., 2011). In addition, previous studies have shown that HIF2A was upregulated 
under hypoxic conditions compared with 21% oxygen following different time point 
incubation. These results were confirmed by western blot results in different studies 
(Grayson, et al., 2007; Forristal, et al., 2010; Lin, et al., 2011; Narva, et al.,2013). However, 
many studies showed that level of HIF1A was increased significantly in MSCs isolated from 
different sources (Holzwarth et al., 2010; Ranera et al., 2012; Choi et al., 2016). The 
inconsistency of response of HIFs to low oxygen tension are likely due to the variations in 
the experimental setup, including (a) the variability between MSCs: in particular source and 
species (b) the variation between the media composition; (c) subtle changes in the oxygen 
concentration used (10% to 1%); (d) as well as the capacity of these cells to adapt to reduced 
oxygen over extended periods of incubation and culture (Müller et al., 2006; Schallmoser et 
al., 2008; Holzwarth et al., 2010; Ahmed et al., 2016).  
Oxygen is an essential factor for several cellular processes in various organisms and, any 
alternative in its availability, can produce important changes at cellular quantities (Melvin 
and Rocha, 2012). Moreover, since the discovery that hypoxia is recognised by HIFs 
enzymes which work as master regulator of cellular adaptation to low oxygen tensions more 
consideration has been given to the cell culture conditions and how this could alter various 
epigenetic modifications as well as drive the early developmental stages via regulated the 
gene expression of cell-type specific (Hitchler and Domann, 2007; Cyr and Domann, 2011; 
Perez-Perri et al., 2011; Melvin and Rocha, 2012). To date there are a limited number of 
reports available describing the DNA methylation status in human MSCs, particularly under 
reduced oxygen tension. However, routine culture of hMSCs in physiological normoxia 
resulted in a significant decrease in levels of 5mC and 5hmC, accompanied by transcriptional 
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translational down-regulation of DNMT3B and TET1 in our hands (Figure 3.6,7 and 3. 8). 
Analysis of methylation status of specific gene promoters by measuring CpGs promoter 
methylation levels using a pyrosequencing technique indicated that low oxygen alters the 
DNMT3B promoter methylation levels, but not TET1 (Figure 3.9 and 3.10). Tsai et al 
reported that DNA methylation mediated by DNMT1 is required for the maintenance of BM-
MSC properties (Tsai et al., 2012). In addition, altered gene expression during senescence 
due to specific epigenetic changes is well established (Schellenberg et al., 2011; 
Schellenberg et al., 2014). Bentivegna et al revealed highly significant differences in CpGs 
methylation levels between early and late passages of BM-hMSCs in almost all 
chromosomes tested (Bentivegna et al., 2016). In addition, it has been reported that low 
oxygen MSCs decrease DNA methylation within the promoter regions of OCT-4 and 
NANOG and this reduction is associated with increased transcriptional levels of the OCT-4, 
NANOG, SOX-2 and SSEA-4 when compared with air oxygen condition (Tsai et al., 2010). 
However, while many researchers agree that reduced oxygen is a main factor that improves 
growth rate, reduce senescence as well as maintains stem cell characteristics of hMSCs 
(Grayson et al., 2007; Basciano et al., 2011; Tsai et al., 2011), data on the effect of low 
oxygen culture conditions on DNA methylation status are very limited. However, it has been 
reported that reduced oxygen caused inhibition of DNMT activity preventing DNA 
methylation in cancer cells (Shahrzad et al., 2007; Skowronsk et al., 2010). In addition, a 
recent study indicated that short-exposure (24 hrs) to severe hypoxic (1% O2), led to changes 
in the DNA methylation status of primary neuronal cells compared to the control group that 
were maintained long after the low oxygen tension was removed (Hartley et al., 2013). In 
contrast, increased DNA methylation has been demonstrated in chronic low oxygen tension 
studies (Whatson et al., 2009; Melvin and Rocha, 2012). The molecular mechanism behind 
these changes is still unclear, but several studies have revealed that promoter 
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hypermethylation prevents HIF binding to the hypoxia response element (HRE) DNA 
recognition sites, which leads to modulation of the expression of numerous genes that affect 
cellular survival and metabolism (Skowronski et al., 2010; Deaton and Bird, 2011). 
In conclusion, the effects of reduced oxygen in vitro cultivation on DNA methylation (5mC 
and 5hmC) functions are still poorly understood. However, to our knowledge, this is the first 
work that compares the DNA methylation (5mC and 5hmC) and their enzymes (DNMTs and 
TETs) of BM-hMSCs that were exposed to different oxygen tension. In this work we have 
demonstrated that 5mC and 5hmC levels in BM- hMSCs are sensitive to modulation via 
subtle alterations in the biophysical environment. 
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Chapter 4: Low oxygen modulates the 
epigenetic state of pluripotent stem cells and 
their differentiated progeny cells 
 
 
 
 
 
 
 
  
105 
 
4.1 Introduction 
Our results in chapter 3 showed that there were differences in the mean level of DNA 
methylation (5mC and 5hmC) between physiologic normoxia and air oxygen conditions in 
BM-MSCs. Also, low oxygen conditions affected BM-MSCs at gene and protein expression. 
It was therefore considered useful to investigate these effects in human pluripotent stem cells 
hPS cells. Human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) 
cells both share the unique and essential properties of pluripotent stem cells (hPS) cells 
which is that they can self-renew in culture and differentiate into multiple cell lineages 
(Tavakoli et al., 2009). These unique abilities give hPS cells a great potential in research, 
drug screening and therapies for many diseases (Tavakoli et al., 2009; Nii et al., 2014). 
Moreover, understanding the mechanisms involved in hPS cells differentiation in vitro is 
essential for further understanding of the development of functional cells (Boyer et al., 2005, 
Galvagni et al., 2015).  
Recently, and due to their pluripotency, ES cells have been used as an in vitro model system 
to study epigenetic changes during stem cell differentiation and early development. It has 
been reported that pluripotency is governed by a complex interaction between genetic and 
epigenetic basis (Loh, et al., 2008). Evidence illustrates that the epigenetic pattern of 
undifferentiated human ES cells unique when compared to differentiated and somatic cells 
(Bibikova et al., 2006; Fouse et al., 2008; Altun et al., 2010).  
DNA methylation (5mC) is generated by DNA methyltransferase (DNMT) enzymes by the 
addition of a methyl group at position C5 of cytosine bases within cytosine-phosphate-
guanine dinucleotides (CpG). Functionally, these enzymes have been categorised into two 
different classes; DNMT1, which is involved in the maintenance of heritable epigenetic 
marks during cell division, and DNMT3A and DNMT3B, which work in co-ordination with 
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DNMT1 and are responsible for de novo methylation (Okano et al., 1998; Cheng and 
Blumenthal, 2008; Dhe-Paganon et al., 2011). Recent studies have identified DNMT3L 
(DNA methyltransferase 3-like) as being highly expressed in human ES cells and interacting 
with DNMT3A and DNMT3B to stimulate their catalytic activity. However, the precise 
function of DNMT3L in these cells is not clear (Bourc'his, 2001; Margot et al., 2003). 
However, a high level of 5-hydroxymethylcytosine (5hmC) was observed in ES cells and 
some somatic cells suggesting that 5hmC may have a separate role from of 5mC in gene 
regulation (Tahiliani et al., 2009, Yu et al., 2012). DNA hydroxymethylation is mediated by 
three TET proteins; TET1, TET2 and TET3 which seem to be differentially expressed in 
tissues; TET1 being mainly expressed in ES cells and TET2 and TET3 expressed more 
universally (Tsagaratou et al., 2017). However, the biological role of 5hmC and the 
associated enzymes in cells has not yet been completely elucidated (Tan and Shi, 2012; 
Tellez-Plaza et al, 2014).  
Human ES cells are routinely cultured under air room oxygen tensions (21% O2) but are 
derived from embryos which reside in a 2–5% physiological normoxia environment 
(Forristal et al., 2010). However, the stem cell niche is involved in the regulation of stem 
cell behaviour through balanced mechanisms controlling production of stem cell and 
progenitor cells which act to maintain homeostasis (Voog and Jones, 2010; Papagiannouli 
and Lohmann, 2015). It has established that reduced oxygen tensions are beneficial for the 
maintenance of human ES cell pluripotency, reduced spontaneous differentiation, and 
improved genetic stability (Forsyth et al., 2006; Ludwig et al., 2006). Cell response to low 
oxygen tension is mediated by members of the hypoxia-inducible factors (HIFs). Many 
studies have revealed that both HIF1A and HIF2A are critical for self-renew and 
maintenance of the undifferentiated state of human ES cells (Gordan and Simon, 2007). In 
addition, evidence has suggested that epigenetic regulation controls the adaptation of stem 
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cells to changes in the physiological environment (hypoxia) and play a crucial role in 
maintenance of homeostasis (Waston et al., 2010; Robinsons et al., 2012). Recently, it was 
reported that DNA methylation-controlled HIFs activation through regulation of 
transcription of hypoxia response elements (HRE) and controlling the HIFs stabilization 
(Waston et al., 2014). 
Understanding the functional significance of genes involved in prevention of DNA 
methylation modification against changes in the physiological environment may help 
provide a better understanding of the major underlying mechanisms that cover the 
pluripotency of stem cells and cellular diversity, leading to improved efficacy and safety in 
the use of stem cells for applied and basic purpose in research, drug screening and therapy. 
The quality and status of cells are important before continuing with any further studies, the 
aim of this chapter was to determine the functional characterisation of hPS cells and their 
differentiation progeny and to study the role of two reduced oxygen conditions (2%PG and 
2%WKS) in regulation of epigenetic marks in human pluripotent stem cells (hPSCs). 
4.2 Aims 
1-Investigate the effects of reduced oxygen on characteristics of hES cells compared with 
air oxygen. 
2. Investigate the effects of physiological normoxia on global DNA methylation (5mC and 
5hmC) and examine local patterns within the promoter regions of specific genes in hPS cells 
and their differentiated progeny in comparison to air oxygen tensions. 
3. Assess the relationship between changes in global DNA methylation (5mC and 5hmC) 
patterns in response to oxygen modulation and the transcriptional expression of 
DNMTs/TETs. 
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4.3 Methods 
4.3.1 Human PSCs culture 
Human PSCs were cultured, maintained and expanded in xeno-free E8M under three oxygen 
conditions as described in Section 2.2.1 and Section 2.2.3. To maintain the oxygen level of 
the cells during physiological oxygen culture, cell culture media was deoxygenated to 
predefined oxygen concentration (2% O2) as described in Section 2.2.2. 
4.3.2 Spontaneous differentiation 
Spontaneous differentiation was performed as described in Section 2.3.2, and the evaluation 
of pluripotent markers expression in human pluripotent stem cells and their progeny was 
undertaken as shown in Section 2.3.4. 
4.3.3 Human pluripotent stem cells characterisation 
Undifferentiated hPS cells was seeded at a density of 3.5 x104 cells/cm2 in a 6 well plate and 
maintained in Essential 8 basal Medium over 96 hours prior to immunocytochemistry as 
described in Section 2.3.3.1. Flow cytometry of undifferentiated hPS cells was performed 
as described in Section 2.3.3.2. 
4.3.4 Measurement of cellular viability 
Changes in cellular viability following hypoxia treatment were assessed as outlined in 
Chapter 2, Section 2.6. 
4.3.5 Global 5mC and 5hmC analysis 
Total genomic DNA was isolated from the hPS cells and their differentiated progeny at 
different time points as described in Section 2.7.2. DNA, 100ng and 200ng, was subjected 
to methylated DNA (5mC) and hydroxymethylated DNA (5hmC) quantification assay 
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(Colorimetric), respectively, with the MethylFlash quantification kit as outlined in Section 
2.7.3.  
4.3.6 Quantitative real-time RT-PCR 
Total RNA was extracted from the hPS cells and their differentiated progeny at different 
time points as described in Section 2.8.1. Relative gene expression was carried out in 
triplicate samples by using the QuantiFast SYBR Green OneStep RT-PCR kit (Section 
2.8.3). 
4.3.7 Protein analysis 
Undifferentiated hPS cells and their differentiation cells were cultured on 6 well-plate and 
cells lysed as described in Section 2.9.1 before 30µg of total protein (Section 2.9.2) was 
subjected to western blot analysis using antibodies against DNMT3B, TET1, HIF1A and 
HIF2A as described in Chapter 2, Section 2.9.4.  
4.3.8 Pyrosequencing of sodium bisulphite-converted DNA 
500ng of genomic DNA was subjected to bisulphite conversion before pyrosequencing was 
achieved using a PyroMark Gold Q24 Reagents and PyroMark Q24 Software 2.0 (Full 
details in Chapter 2, Section 2.10). 
4.4 Results 
4.4.1 Effect of reduced oxygen on the proliferation of hPS cells  
A cell counting assay was used to determine proliferation of the hPS cells (ESCSs and 
hiPSCs) cultured in air oxygen (21%ST) and reduced oxygen conditions (2%PG and 
2%WKS). The number of cells seeded into multiple wells of a 6-well plate were counted 
daily using a counting chamber for 6 days. As shown in (Figure 4.1A, B, C), in both 
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conditions culture of physiological normoxia (2%PG and 2%WKS), there was a significant 
increase in cell proliferation between days 2 and 6 in comparison to those cultured in air 
oxygen (21%ST, p<0.05 or p<0.01). hPS cells cultured under 2%WKS condition had a 
higher proliferation rate (p<0.01) than those in 21%ST and this statistically significant 
increase in the cell count remained consistent in hPS cells cultured in 2%WKS conditions 
till day 6 of the experiment. The results also showed there was no difference in the 
proliferation rate between two reduced oxygen conditions (Figure 4.1A, B, C). The data 
from all three hPS cells (SHEF1, SHEF2, and hiPSCs) was combined, and the results showed 
there was increase in the proliferation rate of cells cultured under reduced oxygen conditions 
(2%PG and 2%WKS), but no significant differences were observed when compared to air 
oxygen conditions - probably because of the variability between three cell lines according to 
cell line-specific biases (Figure 4.1D). 
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Figure 4.1 Effect of reduced oxygen on the proliferation rate of hPS cells. A) SHEF1 B) 
SHEF2 C) hiPSCs line (ZK2012L) D) 3 hPSC line (SHEF1, SHEF2 and ZK2012L). Cell 
count experiments were conducted over 6 days after incubation in air oxygen (21%ST) and 
physiological normoxia conditions (2%PG and 2%WKS), with media changed every day. 
Y-axis indicates cell number x 106. X-axis indicates time (days). Data are shown as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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4.4.2 Reduced oxygen increases metabolic activity in hPS cells 
 MTT and Alamar blue assays were used to analyse the metabolic activity of hPS cells 
cultured in air oxygen (21%ST) and reduced oxygen conditions (2%PG and 2%WKS). 
Similar to above an increase in the number of viable cells quantified by MTT assay was 
noticed for hPS cells cultured in reduced oxygen conditions (Figure 4.2). SHEF1 displayed 
a significant increase in MTT at days 5 and 6 in both reduced oxygen conditions (p<0.01) 
(Figure 4.2A). ZK2012L cells showed significantly higher proliferation potential in in 
2%WKS than those cultured in air oxygen and 2%PG (p<0.01) whereas SHEF2 exhibited 
significant MTT increases in both reduced oxygen conditions (p<0.05) at day 5 and 6. 
(Figure 4.2B, C). The results also showed that cell viability of ZK2012L cells was increased 
significantly in 2%WKS as compared with 2%PG at day 5. The data from all three hPS cells 
(SHEF1, SHEF2, and hiPSCs) was combined, and the results showed there was increased in 
the metabolic activity of cells cultured under reduced oxygen conditions (2%PG and 
2%WKS), but there were no significant differences was observed when compared to air 
oxygen conditions (Figure 4.2D). 
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Figure 4.2 Effect of reduced oxygen on the viability of hPS cells. A) SHEF1 B) SHEF2 
C) hiPSCs line (ZK2012L) D) 3 hPSC line (SHEF1, SHEF2 and ZK2012L). MTT 
absorbance (570 nm) was measured over 6 consecutive days in hPS cells incubated under 
air oxygen (21%ST) and physiological normoxia conditions (2%PG and 2%WKS). Y-axis 
indicates MTT absorbance (570 nm). X-axis indicates time (days). Data are normalized to 
untreated controls and presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
 
Likewise, SHEF1 displayed a high significant increase in Alamar blue absorbance at day 5 
and 6 in both hypoxia conditions (p<0.01) (Figure 4.3A). SHEF2 exhibited significant 
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increases in both physiological normoxia conditions (p<0.05) at day 4, and thereafter 
(Figure 4.3B). ZK2012L cells displayed a high significant increase at day 5 and 6 (p<0.01) 
in both hypoxic cultured (Figure 4.3C). The data from all three hPS cells (SHEF1, SHEF2, 
and hiPSCs) was combined, and the results showed there was a significant increase in the 
Alamar blue absorbance of cells cultured under both reduced oxygen conditions between 
days 4 and 6 in comparison to those cultured in air oxygen (21%ST, p<0.01) (Figure 4.3D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Changes in cell viability of hPS cells cultured under reduced oxygen 
conditions. A) SHEF1 B) SHEF2 C) hiPSCs line (ZK2012L) D) 3 hPSC line (SHEF1, 
SHEF2 and ZK2012L). Alamar blue absorbance (570 nm) was conducted over 6 days after 
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incubation in air oxygen (21%ST) and physiological normoxia conditions (2%PG and 
2%WKS). Y-axis indicates Alamar blue absorbance (570 nm). X-axis indicates time (days). 
Data are normalized to untreated controls and presented as mean ± standard deviation (SD). 
n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
 
4.4.3 Characterisation of hPS cells following treatment with low oxygen tension 
The expression of pluripotency markers SSEA-4, TRA- 1-60 and differentiation markers 
SSEA-1 were then explored via a combination of immunocytochemistry and flow cytometry 
in undifferentiated hPS cells. As shown in Figure 4.4, live, unfixed cells displayed positive 
expression of the pluripotency surface markers SSEA-4 and TRA-1-60 and no expression of 
the SSEA-1 marker. This demonstrates that a typical hPS cells surface marker expression is 
retained in all oxygen conditions.  
 
 
 
 
 
 
 
 
 
 
  
116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Immunocytochemical staining of live, unfixed hPS cells. A) SHEF1 B) SHEF2 
C) hiPSC line (ZK2012L). Cells were seeded at a density of 35,000 cells/cm2 in 6-well plates 
in three different oxygen tensions and left for 96 hours. The left column shows phase-
contrast images, middle column shows fluorescent images and right column shows merged 
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images. bright-field for 4X objective and phase contrast for 10X and 20X objectives. The 
scale bar represents 100 µm.  
 
To further characterize pluripotency status, the expression of cell surface markers was 
quantified by flow cytometry (Figure 4.5). The results as a percentage of positive events 
showed that SHEF1 displayed 96.61 ± 3.41, 94.78 ± 8.31 and 97.36 ± 1.09 for SSEA-4; 
67.23 ± 10.56, 78.76 ± 10.68 and 88.41 ± 1.78 for TRA-1-60; and 2.23 ± 1.41, 5.15 ± 2.18 
and 6.44 ± 5.94 for SSEA-1, in three oxygen tension conditions (21%ST, 2%PG and 
2%WKS), respectively (Figure 4.5). SHEF2 displayed 84.76 ± 14.09, 87.29 ± 9.75 and 
96.02 ± 0.66 for SSEA-4; 62.71 ± 18.17, 67.53 ± 11.22 and 85.64 ± 1.26 for TRA-1-60; and 
7.12 ± 5.9, 7.84 ± 4.57 and 3.39 ± 0.77 for SSEA-1, in three oxygen tension conditions 
(21%ST, 2%PG and 2%WKS), respectively. hiPSC line (ZK2012L) displayed 86.54 ± 6.3, 
93.04 ± 6.02 and 86.4 ± 5.22 for SSEA-4; 53.48 ± 7.66, 76.84 ± 0.84 and 69.61 ± 9.8 for 
TRA-1-60; 9.5 ± 1.84, 4.53 ± 3.53 and 6.9 ± 3.92 for SSEA-1, in three oxygen tension 
conditions (21%ST, 2%PG and 2%WKS), respectively. These results demonstrated that 
three cell lines expressed the hPS cells markers at equivalent levels for the three oxygen 
tensions in which the cells were incubated.  
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Figure 4.5 Pluripotent marker expression of hPS cells. Pluripotent marker expression of 
hPS cells cultured under three oxygen tensions were tested by FACS analysis. A) Overlay 
histograms of hPS cells by Flowing Software. B) All cell samples were found to be positive 
for both SSEA-4 and TRA-1-60, and negative for SSEA-1 after each experiment at both 
reduced oxygen (2%PG and 2%WKS) and air oxygen (21%ST). Y-axis indicates surface 
markers. X-axis indicates % of positive events. Data are presented as mean ± standard 
deviation (SD). n=3. 
 
4.4.4 Evaluation of spontaneous differentiation of hPS cells  
Expression of OCT-4 and SSEA-4 along with NANOG and ALP were analysed by 
immunofluorescence in undifferentiated cells (day 0) and from spontaneous differentiation 
(5, 10 and 20 days) in hPS cells. The results showed that all markers (OCT-4, SSEA-4, 
B 
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NANOG and ALP) were expressed in high levels in undifferentiated hPS cells under all 
conditions tested (21%ST, 2%PG and 2%WKS). The results also showed that the expression 
of pluripotent markers decreased from 0 to 20 days in a time-dependent manner. SHEF1 in 
21%ST showed a reduction in OCT-4, SSEA-4, and ALP expression after 5 days, and 
NANOG after 10 days of differentiation. Also, 2%PG showed a notable reduction in OCT-
4 and NANOG after 5 and 20 days of differentiation, respectively, while SSEA-4, and ALP 
showed reduction at day 10 of differentiation. OCT-4 in 2%WKS condition was reduced 
after day 5 of differentiation, while expression of NANOG, SSEA-4, and ALP showed 
notable reduction in day 10 of differentiation (Figure 4.6). OCT-4, NANOG and ALP in 
SHEF2 showed remarkable reduction expression in day 10 of differentiation in 21%ST, 
2%PG, and 2%WKS, respectively, while expression of SSEA-4 showed notable reduction 
after 10 days in 21%ST, and in day 20 of differentiation in %PG and 2%WKS, respectively 
(Figure 4.7). hiPSC line (ZK2012L) showed remarkable reduction in OCT-4 and SSEA-4 
expression in day 10 of differentiation in 21%ST, 2%PG, and 2%WKS, respectively, and 
NANOG after 10 days in 21%ST and 2%PG, and in day 5 of differentiation in 2%WKS. 
ALP showed notable reduction in day 5 of differentiation in 21%ST, and after 10 of 
differentiation in 2%PG, and 2%WKS, respectively (Figure 4.8). In conclusion, 
undifferentiated hPS cells showed positive expression of OCT-4, SSEA-4, NANOG and 
ALP while the expression of these markers was reduced during cell differentiation with an 
increase in the size of the cells. 
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Figure 4.6 Immunofluorescence staining for pluripotency markers in undifferentiated and differentiating SHEF1 cells. Cells were seeded 
in 24 well-plates in three different oxygen tensions at selected time points (0, 5, 10 and 20 days). Red and green colour indicates antigen, blue 
DAPI. Each scale bar represents 100 µm. 
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Figure 4.7 Immunofluorescence staining for pluripotency markers in undifferentiated and differentiating SHEF2 cells. Cells were seeded 
in 24 well-plates in three different oxygen tensions at selected time points (0, 5, 10 and 20 days). Red and green colour indicates antigen, blue 
DAPI. Each scale bar represents 100 µm. 
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Figure 4.8 Immunofluorescence staining for pluripotency markers in undifferentiated and differentiating hiPSC line (ZK2012L) cells. 
Cells were seeded in 24 well-plates in three different oxygen tensions at selected time points (0, 5, 10 and 20 days). Red and green colour indicates 
antigen, blue DAPI. Each scale bar represents 100 µm.
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4.4.5 Reduced oxygen increased core pluripotency factors OCT-4 and SOX-2 in 
undifferentiated hPS cells 
hPS cell self-renewal and differentiation are regulated by a core group of genes known as 
pluripotency transcription factors such as OCT-4, NANOG and SOX-2 (Boyer et al., 2005; 
Wang et al., 2012). To identify whether the expression of this group of genes are directly 
regulated by oxygen at transcriptional level we isolated RNA from hPS cells and their 
differentiated cells cultured at three different oxygen conditions (21%ST, 2%PG and 
2%WKS). OCT-4 levels were increased in undifferentiated SHEF1, SHEF2 and ZK2012L 
in both reduced oxygen conditions (2%PG and 2%WKS) and significantly so in 2%PG and 
2%WKS in ZK2012L (1.84 ± 0.20 and 1.64 ±0.21, respectively) compared with air oxygen 
(Figure 4.9). In contrast, the level of OCT-4 was decreased in day 5, 10 and 20 after 
differentiation following treatment with 2%PG and 2%WKS but no significant differences 
were noticed except the cells that cultured in 2%PG for 20 days in SHEF1 and SHEF2 (0.33 
± 0.28 and 0. 0.30 ± 0.16, respectively), and 2%WKS in SHEF2 (0.38 ± 0.20) compared 
with air oxygen (Figure 4.9). The level of NANOG was decreased in undifferentiated 
SHEF1, SHEF2 and ZK2012L cells following treatment with 2%PG and 2%WKS but no 
significant differences were noticed except the cells that cultured in 2%PG in SHEF1 (0.51 
± 0.31), in comparison to those cultured in 21%ST (Figure 4.9). NANOG expression was 
increased in differentiated SHEF1, SHEF2 and ZK2012L cells grown in reduced oxygen 
conditions following treatment with reduced oxygen at day 10 and 20. Furthermore, Similar 
increased was observed in SOX-2 level in undifferentiated SHEF1, SHEF2 and ZK2012L 
cells and their differentiated cells that cultured under hypoxia conditions (2%PG and 
2%WKS), in comparison to those cultured in 21%ST (Figure 4.9).  
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The data from all three hPS cells (SHEF1, SHEF2, and hiPSCs) was combined, and the 
results showed there was a significant increase in the OCT-4 expression in cells cultured 
under 2%WKS (1.64 ± 0.13) in comparison to those cultured in air oxygen (21%ST) (Figure 
4.9). In contrast, the level of OCT-4 was decreased in day 5, 10 and 20 after differentiation 
following treatment with 2%PG and 2%WKS but no significant differences were noticed in 
comparison to cells cultured in air oxygen. As shown in Figure 4.9. The level of NANOG 
was decreased significantly in undifferentiated cells following treatment with 2%PG and 
2%WKS (0.57 ± 0.1 and 0.64 ± 0.11, respectively), and in day 5 after differentiation 
following treatment with 2%PG (0.63 ± 0.09) in comparison to those cultured in air oxygen 
(21%ST). Also, the results showed increased in expression of SOX-2 in cells cultured under 
reduced oxygen conditions (2%PG and 2%WKS), but there were no significant differences 
was observed except the cells that cultured in undifferentiated 2%WKS (2.0 ± 0.4) in 
comparison to those cultured in air oxygen (21%ST) (Figure 4.9). 
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Figure 4.9 Quantitative RT-PCR analysis of OCT-4 (POU5F1), NANOG, and SOX-2 in response to reduce oxygen in three cell lines of 
hPS cells. The expression was normalized to the expression of β-actin. Y-axis indicates relative changes in 2^ΔΔCt of treated cell to untreated cell. 
X-axis indicates time (days). Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST).       
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4.4.6 Reduced oxygen induces DNA hypomethylation in hPS cells and their 
differentiated progeny  
To examine the global DNA methylation (5mC and 5hmC) patterns in undifferentiated hPS 
cells and their differentiated progeny DNA was isolated from both undifferentiated hPS cells 
(day 0) and following 5, 10 and 20 days of differentiation in 21%ST, 2%PG and 2%WKS. 
This DNA was then explored using an immunospecific method to determine global levels of 
5mC and 5hmC. A decreased level of global DNA methylation in the total DNA extracted 
from all three pluripotent stem cells cultured and their differentiated progeny in both reduced 
oxygen conditions (2%PG and 2%WKS) in comparison to oxygen air (21%ST) was noted 
(Figure 4.10 and 4.11).  
Also, we noted that the level of global DNA methylation in spontaneous differentiation cells 
was decreased in a time-dependent manner. The level of 5mC in SHEF1 cells was decreased 
significantly in undifferentiated cells following incubation in 2%PG (0.82 ± 0.06, p<0.05) 
and 2%WKS (0.73 ± 0.07, p<0.01) in comparison to those cultured in 21%ST (1.01 ± 0.041), 
and in day 20 from spontaneous differentiation in 2%WKS (0.52 ± 0.09, p<0.05) whilst air 
oxygen was higher (0.72 ± 0.074) (Figure 4.10A). Also, as shown in Figure 4.10B DNA 
methylation decreased significantly in undifferentiated SHEF2 cells grown in 2%PG, a by 
percentage change in of 5-methylcytosine (0.74 ± 0.03, p<0.05), and in day 20 (0.51 ± 0.02, 
p<0.05) after differentiation versus 21%ST (0.84 ± 0.05 and 0.70 ± 0.08), respectively. 
SHEF2 cells cultured in 2%WKS showed significant reduction in 5mC content in 
differentiation cells in day 10 (0.50 ± 0.03, p<0.01) and 20 (0.4 1 ± 0.06, p<0.01). hiPSC 
line (ZK2012L) showed significant decreases <0.05, in global 5mC level when cultured in 
2%PG and 2%WKS oxygen excepting day 10 from differentiation (Figure 4.10C). Also, the 
results of three hPS cells (SHEF1, SHEF2 and hiPSCs) together showed decreased global 
5mC level in cells cultured under reduced oxygen conditions (2%PG and 2%WKS), but no 
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significant differences were observed except for the cells that were cultured in 2%WKS at 
day 20 from differentiation (0.46 ± 0.5) in comparison to those cultured in air oxygen (0.69 
± 0.5) (Figure 4.10D). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Percentage of 5mC in the total DNA extracted from hPS cells in response 
to reduce oxygen conditions. A) SHEF1 B) SHEF2 C) hiPSC line (ZK2012L) D) 3 hPSC 
line (SHEF1, SHEF2 and ZK2012L). hPS cells were incubated in air oxygen (21%ST) and 
normoxia physiological conditions (2%PG and 2%WKS) and the methylated DNA fraction 
in the total isolated DNA was measured using MethylFlashTM Methylated DNA 
quantification kit. Y-axis indicates 5-methylcytosine absorbance (450 nm). X-axis indicates 
time (days). Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST).       
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Similar significant reductions were observed in global 5hmC content in SHEF1 cells grown 
under reduced oxygen conditions 0.08 ± 0.006, p<0.05 and 0.06 ± 0.008, p<0.01 in day 0 
(2%PG and 2%WKS, respectively), and in day 10 and 20 in 2%WKS from differentiation 
(0.05 ± 0.01, p<0.05 and 0.04 ± 0.008, p<0.05), respectively, in comparison to those cultured 
in 21%ST (Figure 4.11A). In contrast, the presence of reduced oxygen did not significantly 
impact on 5hmC level in SHEF2 cells except the cells that cultured in 2%WKS in 
undifferentiation status (0.14 ± 0.02, p<0.05) (Figure 4.11B). On the other hand, there was 
a significant decrease (p<0.05) in the percentage of 5hmC in the total DNA extracted from 
hiPSCs cells cultured in 2%WKS conditions at day 0, 5 and 20 (0.13 ± 0.02; 0.06 ± 0.02 and 
0.057 ± 0.009), respectively, and in day 20 in 2%PG (0.06 ± 0.01) in comparison to those 
cultured in 21% ST (Figure 4.11C). Also, the results of three hPS cells (SHEF1, SHEF2 and 
hiPSCs) together showed decreased global 5hmC level in cells cultured under reduced 
oxygen conditions (2%PG and 2%WKS), but there were no significant differences was 
observed in comparison to those cultured in 21% ST (Figure 4.11D). 
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Figure 4.11 Percentage of 5hmC in the total DNA extracted from hPS cells in response 
to reduce oxygen conditions. A) SHEF1 B) SHEF2 C) hiPSC line (ZK2012L) D) 3 hPSC 
line (SHEF1, SHEF2 and ZK2012L). hPS cells were incubated in air oxygen (21%ST) and 
normoxia physiological conditions (2%PG and 2%WKS) and the methylated DNA fraction 
in the total isolated DNA was measured using MethylFlashTM hydroxymethylated DNA 
quantification kit. Y-axis indicates 5-hydroxymethylation absorbance (450 nm). X-axis 
indicates time (days). Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, 
**P<0.01 vs air oxygen (21%ST). 
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4.4.7 Expression of DNMTs and TETs genes by hPS Cells and their differentiated 
progeny in response to low oxygen level  
RT-qPCR was employed to examine whether the reduction in global DNA methylation 
(5mC and 5hmC) in response to physiological normoxia were in relation to changes in the 
expression of DNMTs/TETs genes. The results of SHEF1 cells showed there was no 
significant change in the relative expression of DNMT1, DNMT3A, TET2 and TET3 
excepting DNMT3A and TET3 expression in day 5 from differentiation in 2%WKS 
conditions (0.35 and 0.44, respectively), and in day 20 in 2%PG and 2%WKS (0.35 and 
0.43, respectively) in TET3 in comparison to those cultured in 21% ST (Figure 4.12). The 
level of DNMT3B was decreased significantly in undifferentiated cells following treatment 
with 2%PG and 2%WKS (0.37 and 0.52, respectively), and in all time course from 
spontaneous differentiation in 2%WKS (0.55, 0.50 and 0.51, respectively) (Figure 4.12). 
Similar significant reduction was observed in TET1 level in undifferentiated SHEF1 cells 
grown under 2%WKS conditions (0.51), and in day 5, 10 and 20 in 2%WKS from 
differentiation (0.54, 0.66 and 0.59, respectively). The level of DNMT3L was decreased 
significantly in undifferentiated cells following treatment with 2%PG and 2%WKS (0.49 
and 0.65, respectively), and in day 5 and day 20 from spontaneous differentiation in 2%WKS 
(0.55 and 0.67, respectively), and in day 10 in 2%PG and 2% WKS (0.48 and 0.53, 
respectively) in comparison to those cultured in 21% ST (Figure 4.12). 
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Figure 4.12 The RT-qPCR expression of the DNMTs and TETs after SHEF1 cells 
incubation under different oxygen level. RNA quantification of DNMTs and TETs 
isolated from SHEF1 cells following incubation in air oxygen (21%ST) and normoxia 
physiological culturing conditions (2%PG and 2%WKS). The expression was normalized to 
the expression of β-actin in the SHEF1 cells. Y-axis indicates relative changes in 2^ΔΔCt of 
treated cell to untreated cell. X-axis indicates time (days). Data are presented as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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Consistent results were observed for SHEF2 cells treated with physiological normoxia. 
Under 2%PG and 2%WKS significant reduction in DNMT3B expression was noticed in 
undifferentiated cells (0.44 and 0.22, respectively), and after 10 days from differentiation 
(0.49 and 0.64, respectively), and day 20 in 2%WKS (0.84) in comparison to those cultured 
in 21% ST (Figure 4.13). TET1 expression decreased in a pattern similar to that of 
DNMT3B expression. Furthermore, a significant decrease in the expression of DNMT3L 
was showed under 2%WKS conditions in undifferentiated cells (0.52), and after 20 days in 
2%PG and 2%WKS (0.40 and 0.72, respectively) (Figure 4.13). No significant change was 
noted in the expression of DNMT1, DNMT3A, TET2 and TET3 excepting DNMT3A and 
TET3 expression in undifferentiation cells and in day 20 from differentiation in 2%WKS 
conditions (0.26 and 0.70, respectively) in comparison to those cultured in 21% ST (Figure 
4.13). 
Similar significant reduction was observed in DNMT3B level in undifferentiated iPS cells 
grown under 2%PG and 2%WKS conditions (0.50 and 0.55, respectively), and in day 5 (0.34 
and 0.59, respectively) and day 20 (0.37 and 0.45, respectively) from differentiation in 
comparison to those cultured in 21% ST (Figure 4.14). The level of TET1 was decreased 
significantly in undifferentiated cells and day 10 after differentiation following treatment 
with 2%WKS (0.35 and 0.43, respectively), and in day 20 in 2%PG and 2%WKS conditions 
(0.13 and 0.4, respectively) (Figure 4.14). Significant decrease in the expression of 
DNMT3L was showed under 2%PG and 2%WKS conditions in undifferentiated cells (0.61 
and 0.59, respectively), and after 20 days (0.62 and 0.61, respectively) (Figure 4.14). No 
significant change in the expression of DNMT1, DNMT3A and TET2 excepting DNMT3A 
and DNMT1 expression in undifferentiation cells and day 5 from differentiation in 2%WKS 
conditions (0.36 and 0.48, respectively) in comparison to those cultured in 21% ST (Figure 
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4.14). In addition, TET3 expression increased significant only in undifferentiated cells in 
both reduced oxygen 2%PG and 2%WKS conditions (0.44 and 0.46, respectively) in 
comparison to those cultured in 21% ST (Figure 4.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 The RT-qPCR expression of the DNMTs and TETs after SHEF2 cells 
incubation under different oxygen level. RNA quantification of DNMTs and TETs 
isolated from SHEF2 cells following incubation in air oxygen (21%ST) and normoxia 
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physiological culturing conditions (2%PG and 2%WKS). The expression was normalized to 
the expression of β-actin in the SHEF2 cells. Y-axis indicates relative changes in 2^ΔΔCt of 
treated cell to untreated cell. X-axis indicates time (days). Data are presented as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 The RT-qPCR expression of the DNMTs and TETs after hiPSC line 
(ZK2012L) cells incubation under different oxygen level. RNA quantification of DNMTs 
and TETs isolated from ZK2012L cells following incubation in air oxygen (21% ST) and h 
normoxia physiological culturing conditions (2%PG and 2%WKS). The expression was 
  
144 
 
normalized to the expression of β-actin in the ZK2012L cells. Y-axis indicates relative 
changes in 2^ΔΔCt of treated cell to untreated cell. X-axis indicates time (days). Data are 
presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen 
(21%ST). 
 
The data from all three hPS cells (SHEF1, SHEF2, and hiPSCs) was combined, and the 
results showed there was a significant reduction in DNMT3B level in undifferentiated cells 
grown under 2%PG and 2%WKS conditions (0.46 and 0.44, respectively), and in day 20 
(0.67 and 0.40, respectively) from differentiation in comparison to those cultured in 21% ST 
(Figure 4.15).The level of TET1 was decreased significantly in undifferentiated cells 
following treatment with 2%WKS (0.48), and in day 5, 20 from differentiation (0.0.55 and 
0.57, respectively), and in day 10 in 2%PG and 2%WKS (0.60 and 0.37, respectively) 
(Figure 4.15). Significant decrease in the expression of DNMT3L was showed under 2%PG 
and 2%WKS conditions in undifferentiated cells (0.53 and 0.41, respectively), and after 20 
days following treatment with 2%WKS (0.41). No significant change in the expression of 
DNMT1, DNMT3A and TET2 excepting DNMT3A expression at day 10 from 
differentiation in 2%WKS conditions (0.79) was observed in comparison to those cultured 
in 21% ST (Figure 4.15). In addition, TET3 expression increased significant only in 
differentiated cells in 2%PG and 2%WKS conditions at day 5 (0.69 and 0.61, respectively), 
and day 20 (0.62 and 0.49, respectively), and after 10 days following treatment with 2%WKS 
(0.80) in comparison to those cultured in 21% ST (Figure 4.15). 
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Figure 4.15 The RT-qPCR expression of the DNMTs and TETs after 3 hPSC line 
(SHEF1, SHEF2 and ZK2012L) cells incubation under different oxygen level. RNA 
quantification of DNMTs and TETs isolated from 3 hPSC line following incubation in air 
oxygen (21% ST) and normoxia physiological culturing conditions (2%PG and 2%WKS). 
The expression was normalized to the expression of β-actin in the ZK2012L cells. Y-axis 
indicates relative changes in 2^ΔΔCt of treated cell to untreated cell. X-axis indicates time 
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(days). Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air 
oxygen (21%ST). 
 
4.4.8 Immunoblotting assay demonstrated reduced DNMT3B and TET1 protein 
expression 
 To confirm that the decrease in DNMT3B and TET1 transcription was accompanied by 
down-regulation of DNMT3B and TET1 at protein level, this was assessed using western 
blot analysis on protein isolated from undifferentiated hPS cells and their differentiated 
progeny cultured at day 20 in normoxia physiological conditions compared to cells 
maintained in air oxygen conditions. Profiling protein expression showed that there was a 
downregulation of DNMT3B and TET1 in hPS cells and their differentiated progeny 
cultured at day 20 in reduced oxygen conditions in a pattern similar to that of mRNA 
expression in hPS cell lines (Figure 4.16).  
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Figure 4.16 Changes in DNMT3B and TET1 expression in hPSCs, at protein levels 
measured by immunoblotting. A) SHEF1 B) SHEF2 C) hiPSC line (ZK2012L). Protein 
was isolated from undifferentiated hPS cells and their differentiated progeny cultured at day 
20 following incubation in air oxygen (21%ST) and normoxia physiological culturing 
conditions (2%PG and 2%WKS). GAPDH was used as a control. 
 
4.4.9 Gene-specific promoter methylation in hPS cells and their differentiated progeny 
Section 4.4.6 showed there were differences in the mean levels of DNA methylation between 
reduced oxygen and air oxygen conditions in hPS cells and their differentiated progeny. 
Also, the results showed that low oxygen induced the changes in hPS cells and their 
differentiated progeny at both transcript and protein levels (4.4.7 and 8). To confirmed that 
these changes were consistent with methylation at promoter level, DNA methylation status 
of seven genes promoter at CpGs levels was determined using pyrosequence assay. The 
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results of SHEF1 cells showed there were a significant increase in the mean level of 
DNMT3B methylation in undifferentiated cells following treatment with 2%PG and 
2%WKS (23% and 32%, respectively) compared with the air oxygen (11%), and in day 5 
and 20 from spontaneous differentiation in 2%PG and 2%WKS (23% and 25%, respectively) 
compared with the air oxygen (13% and 11%, respectively) (Figure 4.17). Also, there was 
a significant difference in the mean level of DNMT3B methylation between 2%PG and 
2%WKS in undifferentiated cells and day 20 from spontaneous differentiation. The level of 
DNMT3L methylation was increased significantly in undifferentiated cells and in day 10 
after differentiation following treatment with 2%WKS (86% and 89%, respectively) 
compared with the air oxygen (71% and 75%, respectively), and in day 20 in 2%PG and 
2%WKS conditions (85% and 90%, respectively) compared with the air oxygen (73%) 
(Figure 4.17). By contrast, there was no significant change in the methylation level of 
DNMT1, DNMT3A, TET1, TET2 and TET3 genes was observed (Figure 4.17).   
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Figure 4. 17 Mean levels of methylation in physiological normoxia relative to air oxygen 
in SHEF1 cells. A set of seven genes promoter were evaluated using pyrosequencing. Y-
axis indicates DNA methylation levels at CpG regions. X-axis indicates time (days). Data 
are presented as mean ± standard deviation (SD). *P<0.05, **P<0.01 vs air oxygen 
(21%ST). 
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Under 2%PG and 2%WKS a significant increase in DNMT3B methylation was noticed in 
undifferentiated SHEF2 cells (20% and 26%, respectively) compared with the air oxygen 
(9%), and after 5 and 20 days (20% and 27%, respectively) compared with the air oxygen 
(9% and 10%, respectively) (Figure 4.18). Also, there was a significant difference in the 
mean level of DNMT3B methylation between 2%PG and 2%WKS in day 20 from 
spontaneous differentiation (15% and 27%, respectively). Furthermore, a significant 
increase in the methylation of DNMT3L was showed under 2%PG and 2%WKS conditions 
in undifferentiated cells (87% and 89%, respectively) compared with the air oxygen (68%), 
and after 20 days in 2%PG and 2%WKS (82% and 87%, respectively) compared with the 
air oxygen (70%). No significant change in the methylation of DNMT1, DNMT3A, TET1, 
TET2 and TET3 was observed (Figure 4.18). 
Similar significant increase was observed in the mean level of DNMT3B methylation in 
undifferentiated hiPSC line (ZK2012L) cells grown under 2%WKS conditions and in day 5, 
10 and 20 from differentiation (26%, 19%, 13% and 25%, respectively) compared with the 
air oxygen, and in day 20 in 2%PG (5%, 4%, 5% and 8%, respectively), and in day 20 (28%) 
from differentiation (Figure 4.19). Also, there was a significant difference in the mean level 
of DNMT3B methylation between 2%PG and 2%WKS in undifferentiated cells and day 5 
and 10 from spontaneous differentiation. No significant change in the methylation of 
DNMT1, DNMT3A, DNMT3L, TET1, TET2 and TET3 was noticed (Figure 4.19). 
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Figure 4.18 Mean levels of methylation in physiological normoxia relative to air oxygen 
in SHEF2 cells. A set of seven genes promoter were evaluated using pyrosequencing. Y-
axis indicates DNA methylation levels at CpG regions. X-axis indicates time (days). Data 
are presented as mean ± standard deviation (SD). *P<0.05, **P<0.01, ***P<0.001 vs air 
oxygen (21%ST).  
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Figure 4.19 Mean levels of methylation in physiological normoxia relative to air oxygen 
in hiPSC line (ZK2012L) cells. A set of seven genes promoter were evaluated using 
pyrosequencing. Y-axis indicates DNA methylation levels at CpG regions. X-axis indicates 
time (days). Data are presented as mean ± standard deviation (SD). *P<0.05, **P<0.01, 
***P<0.001 vs air oxygen (21%ST). 
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The data from all three hPS cells (SHEF1, SHEF2, and hiPSCs) was combined, and the 
results showed there was a significant increase in the mean level of DNMT3B methylation 
in undifferentiated cells grown under 2%WKS conditions and in day 20 from differentiation 
(28% and 26%, respectively) compared with the air oxygen (Figure 4.20). Similar 
significant increase was observed in the mean level of DNMT3L methylation in 
undifferentiated cells grown under 2%WKS conditions and in day 5 and 20 from 
differentiation (85%, 86% and 88%, respectively). Furthermore, there was a significant 
difference in the mean level of DNMT3L methylation between 2%PG and 2%WKS at day 
5 from spontaneous differentiation. No significant change in the methylation of DNMT1, 
DNMT3A, TET1, TET2 and TET3 was found (Figure 4. 20). 
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Figure 4.20 Mean levels of methylation in physiological normoxia relative to air oxygen 
in 3 hPSC line (SHEF1, SHEF2 and ZK2012L) cells. A set of seven genes promoter were 
evaluated using pyrosequencing. Y-axis indicates DNA methylation levels at CpG regions. 
X-axis indicates time (days). Data are presented as mean ± standard deviation (SD). *P<0.05, 
**P<0.01, ***P<0.001 vs air oxygen (21%ST). 
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4.4.10 Reduced oxygen enriches HIF2A expression at protein level in hPS cells and 
their differentiated progeny 
To identify the effects of reduced oxygen incubation on the HIFs gene expression profiles, 
transcriptional and protein levels of HIF1A and HIF2A in all three hPSCs lines and their 
differentiated progeny cultured in three different oxygen conditions were analysed with 
qPCR and Western blotting assays. The results of SHEF1 cells showed there was significant 
downregulation in the relative gene expression of HIF1A in undifferentiated cells cultured 
in both hypoxic conditions (2%PG and 2%WKS), and in all time course points from 
spontaneous differentiation cells comparison to those cultured in air oxygen (21%ST). The 
level of HIF1A protein was increased in day 5 from differentiating cells following treatment 
with 2%PG and 2% WKS, in day 20 in 2%WKS but no significant change was noticed 
(Figure 4.21). In addition, the presence of low oxygen did not significantly impact on HIF2A 
gene expression in all time course points tested. In contrast, the level of HIF2A protein was 
increased significantly in undifferentiated SHEF1 cells cultured under 2%PG and 2%WKS 
(1.89 ± 0.31 and 1.92 ± 0.38, respectively) when compared with air oxygen, and in day 5 
from spontaneous differentiation in 2%PG and 2%WKS (2.9 ± 0.84 and 2.65 ± 0.65, 
respectively) and day 10 (2.06 ± 0.14 and 2.23 ± 0.65, respectively) (Figure 4.21). 
Similar significant reduction was observed in gene expression of HIF1A gene expression in 
undifferentiated SHEF2 cells grown under 2%PG conditions (0.78 ± 0.05), and in day 5, 10 
and 20 from differentiation in 2%PG (0.86 ± 0.08, 0.78 ± 0.09 and 0.67 ± 0.08, respectively) 
and 2%WKS (0.68 ± 0.05, 0.68 ± 0.12 and 0.67 ± 0.17, respectively) compared with the air 
oxygen (Figure 4.22). No significant change in the protein levels of HIF1A was noticed in 
SHEF2 cells and their differentiated progeny in all time course points tested. 
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Figure 4.21 The level of HIFs expression in SHEF1 cell line and their differentiated 
progeny cultured in three different oxygen conditions. A) The RT-qPCR expression of 
the HIF1A and HIF2A normalized to the expression of β-actin. B) Western blot analysis of 
HIFs normalized to the expression of GAPDH and to 1 for 2% oxygen. Data are presented 
as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). Data 
were 
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Furthermore, a significant up regulation in the HIF2A protein expression was showed under 
2%PG and 2%WKS conditions in day 10 of differentiation (2.69 ± 0.65 and 1.94 ± 0.22, 
respectively), after 20 days (2.56 ± 0.71 and 3.39 ± 0.62, respectively) compared with the 
air oxygen (Figure 3.16). Also, there was a significant difference in the level of HIF2A 
protein between 2%PG and 2%WKS in day 5 from spontaneous differentiation (2.05 ± 0.8 
and 0.5 ± 0.29, respectively). No significant change in the gene expression levels of HIF2A 
was noticed in SHEF2 cells and differentiated progeny (Figure 4.22). 
Under 2%PG and 2%WKS there was no significant changes in gene expression of HIF1A 
was noticed in undifferentiated hiPSC line (ZK2012L) and their differentiated progeny 
(Figure 4.23). HIF1A protein was not detected in hiPSC line (ZK2012L) and their 
differentiated progeny. There was a significant increase in gene expression of HIF2A in 
2%PG in undifferentiated hiPSC line (ZK2012L), and in day 5 spontaneous differentiation 
(1.4 ± 0.08 and 1.4 ± 0.1, respectively) compared with air oxygen. Furthermore, a significant 
increase in the protein level of HIF2A was showed under 2%PG and 2%WKS conditions in 
undifferentiated cells (1.89 ± 0.18 and 2.08 ± 0.5, respectively), and after 10 days (2.89 ± 
1.0 and 2.54 ± 0.32, respectively) and day 20 in 2%PG and 2%WKS (2.47 ± 0.7 and 3.48 ± 
0.7, respectively) compared with the air oxygen (Figure 4.23). There was a significant 
difference in the level of HIF2A protein between 2%PG and 2%WKS in undifferentiated 
cells. 
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Figure 4.22 The level of HIFs expression in SHEF2 cell line and their differentiated 
progeny cultured in three different oxygen conditions. A) The RT-qPCR expression of 
the HIFs normalized to the expression of β-actin. B) Western blot analysis of HIF1A and 
HIF2A normalized to the expression of GAPDH and to 1 for 2% oxygen. Data are presented 
as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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Figure 4.23 The level of HIFs expression in hiPSC line (ZK2012L) and their 
differentiated progeny cultured in three different oxygen conditions. A) The RT-qPCR 
expression of the HIFs normalized to the expression of β-actin. B) Western blot analysis of 
HIF1A and HIF2A normalized to the expression of GAPDH and to 1 for 2% oxygen. Data 
are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen 
(21%ST). 
  
160 
 
4.5 Discussion 
In the last two decades the number of epigenetics studies have increased significantly into 
how epigenetics marks affect the characteristics and function of cells. Among these 
epigenetics marks is DNA methylation (5mC and 5hmC). The role of DNA methylation 
(5mC) in regulation of cell behaviour and gene expression in several biological processes 
such as cell differentiation, development and tumorigenesis are well-studied, but the role of 
5-hydroxymethylated (5hmC) that has recently been detected in mammalian cells in 
maintenance of transcriptional regulation and differentiation are still being investigated 
(Chen et al, 2012). In addition, the effects of low oxygen tension on the morphology, 
proliferative and maintenance of the pluripotent state of human embryonic stem cells 
(hESCs) has been explored in many recent studies (Forsyth et al., 2006; Narva et al., 2013; 
Agrawal et al., 2016). In this chapter, we focussed on two parts, to test the hypothesis that 
the epigenetics marks (5mC and 5hmC) can be altered in response to a specific 
microenvironmental stressor such as reduced oxygen, and to investigate the effects of 
physiological normoxia on characteristics of pluripotent stem cells (hPS) cells. During all 
our experiments, special attention was taken to make sure that the cells were cultured under 
strictly controlled normoxia physiological conditions. 
In this study, our results showed that hypoxic conditions (2%PG and 2%WKS) increased the 
proliferation rate of hPS cells as compared with air oxygen and this finding is in line with 
previous studies which have demonstrated that the proliferation rate of hPS cells was 
increased under low oxygen culture (Forristal et al., 2010; Rajala et al., 2011). In addition, 
our MTT and Alamar blue results displayed similar effect to growth rate (Figure 4.2 and 
4.3), which indicates that hPS cells have the ability to grow better under low oxygen 
conditions and also might refer to the balance between proliferation and metabolic activity. 
However, many studies revealed that hPS cells maintained under low oxygen conditions 
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increased the proliferation rate, improved morphology, reduced chromosomal abnormalities, 
increased expression of pluripotency markers, and showed less spontaneous differentiation 
(Forsyth et al. 2006; Forristal et al. 2010; Narva et al., 2013). Accordingly, mimicking the 
specialized local microenvironment or ‘niches’ where stem cells reside in vivo (the 
physiological normoxia level) may be beneficial for the propagation of hPS cells in vitro 
(Mazumdar et al., 2010). On the other hand, analysing proliferation rate of hES cells cultured 
under three different low oxygen conditions revealed no significant differences in growth 
rate among different hypoxic conditions compared to air oxygen level (Ezashi et al., 2005). 
These variations of response of hPC cell lines to reduced oxygen may be due to the 
variability between cell lines in addition to different metabolic requirements of these cell 
lines. Also, the variation between culture conditions may influence the proliferation and 
differentiation of many cells (Sullivan et al., 2010; Redshaw and Loughna, 2012). 
Immunocytochemistry results of undifferentiated hPS cells showed that our three cell lines 
have typical characteristics of the surface antigen of hES and are distinct from mouse 
embryonic stem cells (Figure 4.4). Our results are agreeing with previous reports that 
demonstrated that the presence of a common set of pluripotency markers such as SSEA-
4(+), TRA-1-60(+) and SSEA-1(-) provides a valuable operational indication of hES cells 
(Adewumi et al., 2007; Tavakoli et al., 2009). To further characterize of the pluripotency 
status, the expression of cell surface markers was quantified by the flow cytometry. The 
results demonstrated that three cell lines expressed the hPS cells markers (SSEA-4 and TRA-
1-60), and there was no significant difference between low oxygen and air oxygen condition 
(Figure 4.5). However, many studies have demonstrated that cultured hPS cells under low 
oxygen level does not affect the expression of surface antigens SSEA-1, SSEA-4, TRA-1-
60 during normal passaging (Forsyth et al, 2006; Chen et al, 2009; Forristal et al., 2010; 
Narva et al., 2013). In fact, many laboratories are used SSEA-4, TRA-1-60 and TRA-1-81 
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as a good indicator to confirm the undifferentiated state of hESCs (Adewumi et al., 2007). 
Recent reports revealed that silencing of core pluripotency transcription genes such as OCT-
4, SOX-2 and NANOG lead to increased expression of SSEA-1 and decreased the expression 
of SSEA-3, TRA-1-60 and SSEA-4 markers as well as to induce differentiation and rapid 
loss of pluripotency of hPS cells (Matin et al., 2004; Fong et al, 2008; Narva et al., 2013). 
Routine culture of undifferentiated hPS cells in hypoxic conditions resulted in a significant 
increase in expression of OCT-4, SOX-2 and HIF-2 at transcriptional and protein level. 
There are several pathways and transcription factors involved in the maintenance of hESCs 
self-renewal, including OCT-4, NANOG, and SOX-2. These regulate self-renewal of hESCs 
by activating or repressing patterns of gene expression mediated by other transcription 
factors, but the molecular mechanisms underlying modulation of self-renewal and 
differentiation of hPS cells under low oxygen conditions remains unclear (Boyer et al. 2006; 
Pan et al. 2002). However, in vitro studies by Mazumder et al using reduced oxygen culture 
conditions (< 5% O2) revealed activation of Wnt signalling through HIF1A by enhancing β
‑catenin activation which in turn stimulated target genes. These studies observed that the 
growth rate of physiological normoxia ES cells was increased when compared with 
normoxic cells under induction of Wnt signalling condition (Mazumder et al., 2010). 
Similarly, Barbosa et al, using reduced oxygen mES cells culture revealed a significant role 
of GSK-3- mediated signalling in stimulation of the Wnt/β‑catenin pathway in regulation of 
the core of cell pluripotency transcription (e.g. OCT-4) as well as maintenance of mESCs 
self-renewal (Barbosa et al., 2012). The effect of HIFs in ESCs through Wnt/β‑catenin 
pathway was confirmed in another recent study (Sun et al., 2015). In addition, Silencing of 
HIF2A or HIF3A in low oxygen, leads to the decrease of OCT-4, SOX-2 and NANOG 
transcription factors (Forristal et al., 2010). On the other hand, silencing of core pluripotency 
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transcription factors OCT-4, NANOG and SOX-2 leads to induce differentiation and rapid 
loss of pluripotency (Matin et al., 2004; Fong et al., 2008).  
In the second part of this study, we examined the role of reduced oxygen in alteration of the 
global DNA methylation content (5-mC and 5-hmC) in hESCs and their differentiated cells. 
This was achieved with an ELISA-based colorimetric assay to estimate DNA methylation 
content directly and was complemented by determining the expression of DNA 
methyltransferase (DNMTs) and ten-eleven translocation methylcytosine dioxygenase 
(TETs) enzymes via RT-PCR assay and Western bloting. 
The results of a one-way ANOVA showed a significant effect of hypoxia on the global 5mC 
and 5hmC levels of hPS cells and their spontaneous differentiation (Section 4.4.6). These 
results suggested that physiological O2 concentrations induce changes in global DNA 
methylation and are consistent with previous evidence that indicated that the changes in both 
DNA methylation and hydroxymethylation play an important role in PSCs functions under 
physiological normoxia conditions (Waston et al., 2010; Mariani et al., 2014). However, two 
recent studies have demonstrated that global levels of both 5mC and 5hmC significantly 
decreased when hES cells underwent differentiation (Kim et al., 2014; Sun et al., 2014). 
Results by Mariani et al., showed that levels of 5hmC increased after treatment with 1% O2 
(hypoxia) in tumorigenic cell lines but not in nontumorigenic cells. Furthermore, 
quantitation of the global levels of 5mC and 5hmC by HPLC-MS/MS in SK-N-BE cells 
(neuroblastoma) exposed to 24, 48, or 72 hours of low oxygen demonstrated that global 
levels of 5hmC increased at 48 and 72 hours in reduced oxygen, whereas the global levels 
of 5mC remained unchanged at all timepoints (Mariani et al., 2014). In addition, cells 
maintained at lower oxygen levels (1%) revealed decreases in the global levels of DNA 
methylation, whereas in the absence of HIF1A, the global level of DNA methylation 
increased accompanied by an increase in DNA methyltransferase (DNMT3B) expression 
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(Waston et al., 2009; Waston et al., 2010). Changes in DNA methylation can impact the 
control of HIFs binding to target genes directly by methylation of a specific CpG 
dinucleotides within the hypoxia response elements (HRE) which are present in promoters, 
introns, and 3´ enhancers (Rossler et al., 2004; Waston et al., 2010). In addition, changes in 
DNA methylation are crucial for stem cell differentiation as methylated DNA alters the 
interaction between transcription factors and their binding sites (TFBSs) on DNA (Chen et 
al., 2011). Furthermore, Altun et al demonstrated that key transcription factors of embryonic 
stem cells which are involved in maintaining the ESCs in undifferentiated state are 
unmethylated in ESCs but methylated in differentiated cells (Altun et al., 2010).  
To test the hypothesis that changes of global DNA methylation (5mC and 5hmC) in response 
to reduced oxygen could be related to changes in expression of DNMTs/TETs, the 
expression of DNMTs and TETs enzymes at the mRNA and protein level were performed 
at undifferentiated and differentiated cells exposed to different oxygen conditions in four 
different time points (0, 5, 10 and 20 days). Our results showed a significant decrease in the 
expression of de novo methylation DNA methyltransferase DNMT3B and hydroxylases 
5mC DNA TET1 in response to low oxygen at transcription and protein level. Notably, this 
may correlate to the decrease in global 5mC and 5hmC level observed in hPS cells cultured 
in 2%PG and 2%WKS (Sections 4.4.7 and 4.4.8). In contrast, the expression of DNMT3B 
at promoter regions increased significantly under reduced oxygen in compared to air oxygen 
condition (Section 4.4.9). However, it has been reported that down-regulation of DNMTs 
under low oxygen were associated with global DNA hypomethylation in human colorectal 
cancer cell lines (Skowronski et al., 2010). Our results also agree with previous studies that 
showed that low oxygen upregulated the expression of DNMT1 and DNMT3A but not 
DNMT3B and induced genomic DNA hypomethylation in Hepatoma cells (Liu et al., 2011). 
In contrast, increased expression of DNMT1 and DNMT3D was associated with induced 
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global DNA hypermethylation when human cardiac fibroblast cells cultured in 1% hypoxia 
(Waston et al., 2014). In addition, the recent study showed that level of TET1 have tendency 
to decrease in normal fibroblasts cells (FB) cultured under low oxygen condition (Hattori et 
al., 2015). Furthermore, Thienpont et al demonstrated that level of TET1 which was down-
regulated in mESC cultured under low oxygen (physiological O2 concentration) led to 
decrease in the level of 5hmC (Thienpont et al., 2016). However not much is known about 
the mechanism of effect of reduced oxygen and the changes in methylation status. 
In conclusion, understanding the mechanisms involved in pluripotent epigenetic in vitro is 
essential for further understanding of the development of functional cells, with the potential 
for clinical translation into areas such as prognosis and treatment (Baylin and Jones, 2011). 
This study has highlighted the significant effect a hypoxic microenvironment can have on 
epigenetic changes within hPS cells and their differentiation progeny, and the downstream 
effects it can have on the physiological behaviour of cells including proliferation and 
metabolic activity. 
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Chapter 5: Tumour hypoxia reduces 
DNMT3B activity with accompanied DNA 
hypomethylation in human cancer cells 
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5.1 Introduction 
In the previous chapters, the results have highlighted the potential role of low oxygen tension 
in the induction of DNA hypomethylation in both pluripotent and multipotent stem cells. 
This chapter investigated the role of reduced oxygen in the modification of DNA methylation 
marks (5mC and 5hmC) in cancer cells. Despite improvements in diagnosis and treatment 
of cancer, it is still one of the major causes of death in the world alongside heart disease 
(WHO, 2015). Cancer is a disease characterized by uncontrolled cellular proliferation and 
differentiation (Parkin et al., 1999; Alghamdi and Khorshid, 2012). It is known to affect 
different organs or tissues in the body such as liver, lung, breast and ovaries etc. Traditionally 
cancer has been viewed as a disease characterised by the accumulation of genetic mutations, 
however extensive research into cancer epigenetics over the past decade has come to 
challenge this view (Hanahan and Weinberg, 2011; You and Jones, 2012).  
Several findings have shown that cancer appears to have both an epigenetic and genetic basis 
(Sadikovic et al., 2008; Baylin and Jones, 2012). Recent studies have revealed that epigenetic 
mechanisms are a main player in cancer-associated disorders and that the accumulation of 
epigenetic modifications could be a mechanism underlying these disorders (Sharma et al., 
2010; Wong et al., 2017). Dysregulation of the epigenetic machinery and subsequently the 
maintenance of epigenetic marks can result in inappropriate activation and/or inhibition of 
gene expression, contributing too many diseases, most notably cancer (Sharma et al., 2010). 
Among epigenetic alterations DNA methylation is that the most widely studied in mammals 
due to the increased availability of commercial genomics assays that are well-matched with 
different tissue samples (Kurdyukov and Bullock, 2016; Massie et al., 2017). DNA 
methylation patterns are established through the addition of a methyl group at the 5th carbon 
position of cytosine residues by DNA methyltransferases (DNMTs), to form 5-
methylcytosine (5mC). Currently, three ten-eleven translocations 1–3 (TET1–3) proteins 
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have been identified in many mammals. TET proteins are recently known have the ability to 
catalyze the conversion of 5mC into 5hmC, with distinct regulatory function (Kanwal and 
Gupta, 2012; Putiri et al., 2014; Green et al., 2016). 
In cancer, hypermethylation of promoter CpG islands of tumour suppressor genes (TSG) is 
one of the most common mechanisms leading to silence these genes during tumorigenesis 
(Sadikovic et al., 2008; Subramaniam et al., 2014). In contrast to genetic mutation cancer 
causes, the epigenetic codes in cancer are potentially reversible. For instance, DNA 
hypermethylation can be reversed by inhibition of DNMTs putatively leading to the 
reactivation of expression of tumour suppressor genes. This presents a potentially effective 
approach to the development of new therapeutic targets for cancer treatment (Fahy et al., 
2012; Yu et al., 2016). Subramaniam et al reported that inhibition of DNMT expression led 
to a decrease in tumour formation through the re-activation of the tumour suppressor genes 
(Subramaniam et al., 2014). On the other hand, it is established that the development and 
progression of a large number of cancers are influenced by the interactions between cancer 
cells and their local tumour microenvironment (Hockel and Vaupel, 2001). The oxygen 
tension within cancer tissues can range from physiological levels of ~2-7% to severely 
hypoxic tensions of <1% (Heddleston et al., 2010; Thirlwell et al., 2011). Despite this, cancer 
cells often survive and thrive within these conditions by several critical alterations that allow 
tumour cell survival, such as apoptosis inhibition, an angiogenic phenotype, and altered 
glucose metabolism (Fruehauf and Meyskens, 2007). However, it has been hypothesized that 
hypoxic microenvironments may influence alterations in DNA methylation, resulting in 
inappropriate silencing or activation of genes involved in the progression of cancer 
(Shahrzad et al., 2007). Watson et al study revealed that cells maintained in severe oxygen 
tension (1%) displayed reduced global DNA methylation (Waston et al., 2009). Similarly, a 
decrease in 5mC levels was observed in in vivo xenograft cancer cells following exposure to 
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severe hypoxic conditions (Shahrzad et al., 2007). In addition, it was reported that HIF1A 
regulated DNMT1 and DNMT3B expression in cardiac tissue fibrosis resulting in altered 
the DNA methylation level (Waston et al., 2014). In addition, there is increased evidence 
that hypoxia can induce changes in global deacetylation and alterations in acetylation and 
histone methylation in promoter regions that are related to hypoxia genes (Thirlwell et al., 
2011). Consequently, these studies highlight the significant correlation between hypoxia and 
the modification of DNA methylation in cancer. However, the DNA methylation pattern has 
been widely studied in cancer cells but the role of hypoxia in regulation of the methylation 
level and in particularly in regulation of the 5hmC level and TETs enzymes regulation is still 
under investigation (Chen et al., 2012).  
5.2 Amis 
In this chapter we aim to determine the role of hypoxia in the regulation of epigenetic marks 
in cancer cells. To examine this, we aim to: 
1. Investigate the effects of hypoxia on the proliferation, expression of core pluripotency 
factors and HIFs in cancer cells. 
2. Investigate the effects of hypoxia on global DNA methylation (5mC and 5hmC) in cancer 
cells. 
3. Assess the relationship between changes in global DNA methylation (5mC and 5hmC) 
patterns in response to oxygen modulation and the expression of DNMTs/TETs. 
4. Investigate the effects of hypoxia on the local DNA methylation patterns at selected CpG 
sites within the promoter regions of DNMTs/TETs genes in cancer cells 
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5.3 Methods 
5.3.1 Human cancer cell lines 
All cancer cell lines used in this study were obtained from the laboratory stock of Guy Hilton 
Research Centre, Keele University as described in Table 5.1. The cells were incubated at 
37oC at three different oxygen tensions as described in Section 2.2.1 and detached and 
passaged as described in Section 2.2.3. To maintain the oxygen level of the cells during 
physiological oxygen culture, cell culture media was deoxygenated to predefined oxygen 
concentration (2% O2) as described in Section 2.2.2. 
Table 5.1 Human cell lines used in this chapter 
Cell line Tumor type Reference 
A549 Lung carcinoma Giard et al., (1973) 
COV362 Ovarian cancer Berg-Bakker et al., (1993) 
MG-63 Osteosarcoma Billiau, (1975) 
SH-SY5Y Neuroblastoma Biedler et al., (1978) 
Jurkat T cell leukemia Schneider et al., (1977) 
IMR-90 Normal lung fibroblast ATCC® CCL­186™ 
                                                                     
 
5.3.2 Measurement of cellular viability 
Changes in cellular viability following hypoxia treatment were assessed as outlined in 
Chapter 2, Section 2.6.1 and 2.6.2. 
5.3.3 Global 5mC and 5hmC analysis 
Total genomic DNA was isolated from the cancer cells at different time points as described 
in Section 2.7.2. DNA, 100ng and 200ng, was subjected to methylated DNA (5mC) and 
hydroxymethylated DNA (5hmC) quantification assay (Colorimetric), respectively, with the 
MethylFlash quantification kit as outlined in Section 2.7.3.  
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5.3.4 Quantitative real-time RT-PCR 
Total RNA was extracted from the cancer cells and their differentiated progeny at different 
time points as described in Section 2.8.1. Relative gene expression was carried out in 
triplicate samples by using the QuantiFast SYBR Green OneStep RT-PCR kit (Section 
2.8.3). 
5.3.5 Protein analysis 
Cancer cells were cultured on 6 well-plate and cells lysed as described in Section 2.9.1 
before 30 µg of total protein (Section 2.9.2) was subjected to western blot analysis using 
antibodies against DNMT3B, TET1, HIF1A and HIF2A as described in Chapter 2, Section 
2.9.4.  
5.3.6 Pyrosequencing of sodium bisulphite-converted DNA 
500ng of genomic DNA was subjected to bisulphite conversion before pyrosequencing was 
achieved using a PyroMark Gold Q24 Reagents and PyroMark Q24 Software 2.0 (Full 
details in Chapter 2, Section 2.10). 
5.4 Results 
5.4.1 Effect of reduced oxygen on the proliferation of cancer cells 
Proliferation of the human cancer cells cultured in air oxygen (21%ST) and reduced oxygen 
conditions (2%PG and 2%WKS) was determined using a cell counting assay. The number 
of cells seeded into multiple wells of a 6-well plate were counted daily using a counting 
chamber for 6 days. Four cell lines (A549, COV362, MG-63 and Jurkat cells) showed a 
significant decrease in the proliferation rate of cells cultured under reduced oxygen 
conditions (2%PG and 2%WKS) in comparison to those cultured in air oxygen (p<0.05 or 
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p<0.01) (Figure 5.1). Also, A549 and Jurkat cells cultured under 2%WKS condition showed 
the lowest proliferation rate (p<0.01) in comparison to cells cultured in 2%PG and air oxygen 
at day 6 of the experiment. In contrast, the results showed there was increase in the 
proliferation rate of SH-SY5Y cells cultured under 2%WKS conditions when compared to 
those in 2%PG and 21%ST. In addition, the results of non-cancer cell line (IMR-90) showed 
there was no difference in the proliferation rate between cells cultured under reduced oxygen 
conditions or air oxygen (Figure 5.1). 
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Figure 5.1 Effect of reduced oxygen on the proliferation rate of cancer cells. Cell count 
experiments were conducted over 6 days after incubation in air oxygen (21%ST) and 
physiological normoxia conditions (2%PG and 2%WKS), with media changed every day. 
Y-axis indicates cell number x 106. X-axis indicates time (days). Data are shown as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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5.4.2 Reduced oxygen decreases metabolic activity in cancer cells 
MTT assay was used to analyse the metabolic activity of cancer cells cultured in air oxygen 
(21%ST) and reduced oxygen conditions (2%PG and 2%WKS). Similar to above a decrease 
in MTT was noticed for cancer cells cultured in reduced oxygen conditions in comparison 
to those cultured in air oxygen (Figure 5.2). A549 displayed a significant decrease in MTT 
at days 2 (p<0.01), 4, 5 and 6 in cells cultured under 2%PG condition (p<0.05), and at day 5 
and 6 in 2%WKS conditions (p<0.01 and p<0.05, respectively) in comparison to cells 
cultured in air oxygen (21%ST) (Figure 5.2). COV362 cells cultured in 2%PG and 2%WKS 
had a lower proliferation potential than those cultured in air oxygen (p<0.05), whereas MG-
63 exhibited significant MTT decreases in both reduced oxygen conditions (p<0.05) at day 
4, 5 and 6 in comparison to cells cultured in air oxygen (Figure 5.2). The results also showed 
that the cell viability of Jurkat cells was decreased significantly (p<0.05) in 2%WKS at days 
3 and thereafter, and at days 3 and 6 (p<0.05) in cells cultured in 2%PG in comparison to 
cells cultured in air oxygen. In contrast, the results showed the metabolic activity increased 
significantly (p<0.05) of SH-SY5Y cells cultured under 2%WKS conditions at days 3 and 
thereafter in comparison to cells cultured in air oxygen. Also, the results of non-cancer cell 
line (IMR-90) showed there was no difference in the metabolic activity between cells 
cultured under reduced oxygen conditions or air oxygen except the cells cultured in 2%WKS 
at days 5 and 6 (p<0.01 and p<0.05, respectively) in comparison to cells cultured in air 
oxygen (Figure 5.2). 
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Figure 5.2 Effect of reduced oxygen on the viability of cancer cells. MTT absorbance 
(570 nm) was measured over 6 consecutive days in cancer cells incubated under air oxygen 
(21%ST) and physiological normoxia conditions (2%PG and 2%WKS). Y-axis indicates 
MTT absorbance (570 nm). X-axis indicates time (days). Data are normalized to untreated 
controls and presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air 
oxygen (21%ST). 
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5.4.3 Hypoxia induces stem cell markers in cancer cell lines 
Stem cells are localized in a specialized microenvironment characterized by their low 
oxygen levels, which can regulate the balance among self-renewal, differentiation, and stem 
cell quiescence. In tumors, hypoxia is associated with aggressive disease course and poor 
clinical outcomes (Mohyeldin et al., 2010). In addition, several cancers have been shown to 
display gene expression signatures characteristic of human embryonic stem cells (hESC) 
(Mathieu et al., 2011). However, it is not well understood how cancer cells respond to 
reduced oxygen availability. Therefore, we analyzed the effect of low oxygen concentrations 
(2%PG and 2%WKS) on the expression of transcription factors OCT-4 (POU5F1), NANOG 
and SOX-2 in cancer cells. Reduced oxygen led to enhanced mRNA levels of pluripotency 
markers; OCT-4 and NANOG but not SOX-2 (Figure 5.3). However, the relative fold 
expression of OCT-4 was significantly increased in 2%WKS cultures compared to air 
oxygen 21%ST in A549, COV362, SH-SY5Y and Jurkat cells (2.24 ± 0.46, 1.8 ± 0.34, 1.7 
± 0.24 and 1.5 ± 0.18, respectively), and in 2%PG cultures compared to air oxygen 21%ST 
in A549 (2.1 ± 0.62) (Figure 5.3). NANOG expression was generally higher in low oxygen 
than air oxygen but was not significantly upregulated except in the non-cancer cell line 
(IMR-90) cultured in 2%PG and 2%WKS (1.4 ± 0.23 and 1.4 ± 0.22, respectively) compared 
to air oxygen 21%ST. In contrast, SOX-2 expression was generally lower in reduced oxygen 
than air oxygen but was not significantly down-regulated except in MG-63 cells cultured in 
2%PG (0.43 ± 0.21) compared to air oxygen as shown in Figure 5.3. 
We next investigated the effects of removed reduced oxygen stress at the transcriptional 
level. First, A594, COV362 and MG-63 cells were cultured in low oxygen condition 
(2%WKS) for five passages before the cells were returned to air oxygen condition and 
cultured for five passages again {2%WKS – air oxygen (21%ST)}. Our results showed that 
the relative fold expression of OCT-4 was significantly decreased in 2%WKS-21%ST 
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conditions (1.1 ± 0.31 and 0.94 ± 0.05, respectively) compared to 2%WKS cultures in A549, 
COV362 cells (2.24 ± 0.46, 1.8 ± 0.34) respectively. No significant change was observed in 
expression of NANOG and SOX-2 in cells that cultured in 2%WKS-21%ST conditions 
compared to other cultures conditions (Figure 5.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Quantitative RT-PCR analysis of OCT-4 (POU5F1), NANOG, and SOX-2 
in response to different oxygen conditions in cancer cells. The expression was normalized 
to the expression of β-actin. Y-axis indicates relative changes in 2^ΔΔCt of treated cell to 
  
178 
 
untreated cell. X-axis indicates pluripotency markers. Data are presented as mean ± standard 
deviation (SD). n=3 *P<0.05 vs air oxygen (21%ST). 
 
5.4.4 Analysis of global 5mC and 5hmC analysis 
5.4.4.1 Global 5- methylcytosine was decreased in cancer cells subjected to hypoxia  
Global DNA methylation (5mC) was explored by an immunospecific method in human 
cancer cell lines after incubation in different oxygen tensions. The level of 5mC in A549 
cells decreased significantly following incubation in 2%WKS (0.65 ± 0.05, p<0.05) in 
comparison to those cultured in 21%ST (0.91 ± 0.16) (Figure 5.4). Also, as shown in Figure 
5.4 DNA methylation decreased significantly in COV362 cells grown in 2%PG (0.61 ± 0.08, 
p<0.05) and in 2%WKS (0.59 ± 0.051, p<0.05) versus 21%ST (0.8 ± 0.09). In addition, MG-
63 cells cultured in 2%PG and 2%WKS showed significant reductions in 5mC content (0.67 
± 0.12 and 0.69 ± 0.06, p<0.05) respectively, in comparison to those cultured 21%ST (0.98 
± 0.14) (Figure 5.4). SH-SY5Y cells cultured in 2%PG and 2%WKS displayed similar 
reductions in 5mC level (1.3 ± 0.12 and 1.2 ± 0.05, p<0.05) respectively, in comparison to 
those cultured 21%ST (1.6 ± 0.12). In contrast, no significant change in DNA methylation 
level was observed in Jurkat cells and IMR-90 cells that cultured in hypoxia conditions 
compared to air oxygen culture condition (Figure 5.4). 
On the other hand, a significant increase was observed in 5mC levels in A549 cells that were 
cultured in the 2%WKS-21%ST condition approach (1.1 ± 0.03) in comparison to those 
cultured in 2%PG and 2%WKS conditions alone (0.65 ± 0.05 and 0.76 ± 0.09, p<0.05 and 
p<0.01), respectively (Figure 5.4). Similar significant difference was also noticed in 
COV362 cells cultured in 2%WKS-21%ST condition (0.89 ± 0.05, p<0.01) in comparison 
to those cultured in 2%PG and 2%WKS conditions. No significant change in DNA 
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methylation level was observed in MG-63 cells that returned to 2%WKS-21%ST condition 
compared to other oxygen culture conditions (Figure 5.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Global changes of 5-methylcytosine contents in human cancer cell lines. A 
set of cancer cell lines were incubated in different oxygen tensions. The methylated DNA 
fraction in the total isolated DNA was measured using MethylFlashTM Methylated DNA 
quantification kit. Y-axis indicates 5-methylcytosine absorbance (450 nm). X-axis indicates 
different oxygen culture conditions. Data are presented as mean ± standard deviation (SD). 
n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST).      
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5.4.4.2 Hypoxia induced DNA hydroxymethylation (5hmC) in cancer cells 
Next, we assessed the effect of varying oxygen concentrations on the levels of DNA 
hydroxymethylation (5hmC) in cancer cells. We observed a significant increase in global 
DNA hydroxymethylation (5hmC) in A549 cells following incubation in 2%PG and 
2%WKS (0.081 ± 0.026 and 0.11 ± 0.004, p<0.05, p<0.01) respectively, in comparison to 
those cultured in 21%ST (0.04 ± 0.015) (Figure 5.5). Also, DNA hydroxymethylation 
increased significantly in COV362 cells grown in 2%WKS (0.08 ± 0.011, p<0.05) versus 
21%ST (0.05 ± 0.02). In addition, SH-SY5Y cells cultured in 2%WKS showed significant 
increase in 5hmC content (0.14 ± 0.008, p<0.05) in comparison to those cultured 21%ST 
(0.11 ± 0.009) (Figure 5.5). In contrast, no significant change in DNA hydroxymethylation 
level was observed in MG-63, Jurkat cells and IMR-90 cells that cultured in hypoxia 
conditions compared to air oxygen culture condition (Figure 5.5). In addition, a non – 
significant decrease was observed in A549, COV362 and MG-63 cells that cultured in 
2%WKS-21%ST condition compared to other oxygen culture conditions (Figure 5.5). 
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Figure 5.5 Global changes of 5-hydroxymethylation contents in human cancer cell 
lines. A set of cancer cell lines were incubated in different oxygen tensions. The methylated 
DNA fraction in the total isolated DNA was measured using MethylFlashTM Methylated 
DNA quantification kit. Y-axis indicates 5-hydroxymethylation absorbance (450 nm). X-
axis indicates different oxygen culture conditions. Data are presented as mean ± standard 
deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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5.4.5 Expression of DNMTs and TETs by qPCR in tumour hypoxia 
5.4.5.1 Hypoxia decreases the expression of DNMT3B enzymes in cancer cells 
RT-qPCR was employed to examine whether the reduction in global DNA methylation 
(5mC) in response to hypoxia were in relation to changes in the expression of DNMT genes. 
The level of DNMT3B was decreased significantly in A549 cells following treatment with 
2%PG and 2%WKS (0.59 and 0.49, P<0.05) respectively, and in COV362 cultured in 2%PG 
(0.47, P<0.05) versus 21%ST (Figure 5.6). Similar significant reductions were observed in 
DNMT3B level in MG-63 cells grown under 2%PG, 2%WKS and 2%WKS-21%ST 
conditions (0.38, 0.18 and 0.33, P<0.01), respectively versus 21%ST (Figure 5.6). Also, 
significant differences were showed in expression of DNMT3B in SH-SY5Y cells cultured 
in 2%PG and 2%WKS (0.51 and 0.45, P<0.01) respectively, versus 21%ST. In addition, the 
level of DNMT3L was decreased significantly in SH-SY5Y cells cultured in 2%PG and 
2%WKS (0.47 and 0.36, P<0.01) versus 21%ST (Figure 5.6). IMR-90 cells displayed a 
significant increase in DNMT3B in cells cultured 2%WKS (0.63, P<0.05) versus 21%ST. 
In addition, the level of DNMT3A was increased significantly in MG-63 and Jurkat cells 
cultured in 2%WKS (0.46 and 0.70, P<0.05) respectively, versus 21%ST (Figure 5.6). No 
significant change was observed in DNMT3B expression in Jurkat and IMR-90 cells 
cultured in both hypoxia conditions in compared to air oxygen conditions. 
On the other hand, a significant difference was observed in DNMT3B in A549 cells cultured 
in 2%WKS-21%ST condition (1.3, P<0.01) in comparison to those cultured in 2%PG and 
2%WKS conditions (0.59 and 0.49, respectively) (Figure 5.6). Similar significant difference 
was also noticed in COV362 and MG-63 cells cultured in 2%WKS-21%ST condition (1.3 
and 1.6, p<0.01) in comparison to those cultured in 2%PG and 2%WKS conditions. In 
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addition, significant change in DNMT3L level was observed between 2%WKS-21%ST and 
2%WKS (1.2 and 0.67, p<0.05) in A549 cells (Figure 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6 The RT-qPCR expression of the DNA methyltransferase (DNMTs) enzymes 
at RNA level in cancer cells. Quantification RNA showed significant decrease in DNMT3B 
expression in cancer cells in response to hypoxia. The expression was normalized to the 
expression of β-actin. Y-axis indicates relative changes in 2^ΔΔCt of treated cell to untreated 
cell. X-axis indicates DNA methyltransferase enzymes. Data are presented as mean ± 
standard deviation (SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST).  
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5.4.5.2 Tumour hypoxia increased DNA hydroxymethylation by regulated TET1 
activity 
We also examined TETs mRNA expression by qPCR (Figure 5.7). We found that TET1 
appeared to be increased in the cancer cell lines cultured in 2%PG and 2%WKS compared 
to the air oxygen 21%ST. The level of TET1 was increased significantly in A549, COV362 
and SH-SY5Y cells following treatment with 2%WKS (2.1, 1.5 and 1.5, P<0.05), and in 
MG-63 cultured in 2%PG and 2%WKS (1.4, P<0.05 and 1.6, P<0.01) respectively, versus 
21%ST (Figure 5.7). In contrast, the level of TET1 was decreased significantly in non-
cancer cell line (IMR-90) following treatment with 2%WKS (0.51, P<0.05) (Figure 5.7). 
Similar significant reduction was observed in TET3 level in Jurkat cells grown under 2%PG 
and 2%WKS conditions (0.71 and 0.69, P<0.01), respectively versus 21%ST (Figure 5.7). 
In addition, a significant difference was observed in TET1 and TET3 in A549 cells cultured 
in 2%WKS-21%ST condition (1.1 and 0.88, P<0.05) respectively, in comparison to those 
cultured in 2%WKS conditions (Figure 5.7). Similar significant differences were noted in 
COV362 cells cultured in 2%WKS-21%ST in comparison to those cultured in 2%PG and 
2%WKS conditions. In addition, significant changes in TET2 level were observed between 
2%WKS-21%ST and 21%ST (0.59, p<0.05) in COV362 cells (Figure 5.7). No significant 
change was observed in TET2 and TET3 expression in cancer cells cultured in both hypoxia 
conditions in compared to air oxygen conditions. 
 
 
 
 
 
  
185 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 The RT-qPCR expression of the ten-eleven translocation methylcytosine 
dioxygenase (TETs) enzymes at RNA level in cancer cells. Quantification of mRNA 
showed a significant increase in TET1 expression in cancer cells in response to hypoxia. The 
expression was normalized to the expression of β-actin. Y-axis indicates relative changes in 
2^ΔΔCt of treated cell to untreated cell. X-axis indicates ten-eleven translocation 
methylcytosine dioxygenase enzymes. Data are presented as mean ± standard deviation 
(SD). n=3 *P<0.05, **P<0.01 vs air oxygen (21%ST). 
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5.4.6 Reduction in DNMT3B and increased TET1 protein expression in cancer cells 
subjected to hypoxia 
To confirm that the decrease in DNMT3B and TET1 transcription was accompanied by 
down-regulation of DNMT3B and TET1 at protein level we used western blot analysis on 
protein isolated from cancer cell lines in hypoxia conditions compared to cells maintained 
in air oxygen conditions. Profiling of protein expression showed that expression of 
DNMT3B and TET1 protein in cancer cells cultured in varing oxygen conditions in a broadly 
similar pattern to that observed with mRNA expression (Figure 5.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Changes in DNMT3B and TET1 expression in cancer cells, at protein levels 
measured by immunoblotting. Protein was isolated from cancer cells following incubation 
in varying oxygen tensions. GAPDH was used as a loading control. 
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5.4.7 Hypoxia induces DNMT3B promoter hypermethylation levels in cancer cells  
To confirm that the differences in mean levels of DNA methylation between different 
oxygen tensions at both transcript and protein levels in cancer cells (Figure 5.4.5) are 
consistent with methylation at promoter level, the DNA methylation status of seven gene 
promoters at the CpGs level was determined by using pyrosequencing. The results showed 
significantly greater mean levels of DNMT3B promoter methylation in A549 cells following 
DNA isolation from 2%PG and 2%WKS (25.25% and 27%, respectively) when compared 
with air oxygen (13.5%) (Figure 5.9). Similar results were observed in COV362 cultured in 
2%PG and 2%WKS (48.5% and 56%, respectively) when compared with air oxygen (8%), 
and in MG-63, SH-SY5Y and IMR-90 cells following treatment with 2%WKS (41.25%, 
26.75 and 23.25%) respectively, versus 21%ST (10.25%, 13% and 7%, respectively) 
(Figure 5.9).  
Interestingly, a significant difference in mean promoter methylation levels of DNMT3B in 
A549 and MG-63 cells cultured in 2%WKS-21%ST condition (16.75% and 15.25) 
respectively, was observed in comparison to those cultured in 2%WKS (Figure 5.9). 
Significant differences were also noticed in COV362 cells cultured in 2%WKS-21%ST 
(24%) in comparison to those cultured in 2%PG and 2%WKS conditions. We also observed 
a significant reduction in mean promoter methylation levels of DNMT3L in A549, COV362 
and MG-63 cells cultured in 2%WKS-21%ST (46.3%, 54% and 54.3) respectively, when 
compared to 21%ST (61%, 81.5% and 80.5%) (Figure 5.9). Similar significant differences 
were observed in mean promoter methylation levels of A549, COV362 and MG-63 cells that 
cultured in 2%WKS-21%ST when compared to both hypoxia conditions (2%PG and 
2%WKS). However, no significant change was observed in the relative promoter 
methylation levels DNMT1 and DNMT3L in cancer cells cultured in all oxygen conditions 
(Figure 5.9). 
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Figure 5.9 Mean levels of promoter methylation in hypoxia relative to air oxygen in 
human cancer cell lines. A set of DNMTs genes promoter were evaluated using 
pyrosequencing. Hypoxia induces DNMT3B promoter hypermethylation levels in cancer 
cells. Y-axis indicates DNA methylation levels at CpG regions. X-axis indicates DNA 
methyltransferase enzymes. Data are presented as mean ± standard deviation (SD). *P<0.05, 
**P<0.01, ***P<0.001 vs air oxygen (21%ST). 
 
We next investigated the effects of hypoxia at promoter methylation level of TETs. 
However, quantitative analysis of methylation percentage revealed no statistically 
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significant difference among four groups of oxygen excepted the mean promoter methylation 
levels of TET1 in A549 and MG-63 cells that returning to 2%WKS-21%ST condition when 
compared to hypoxia conditions as shown in Figure 5.10.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Mean levels of promoter methylation in hypoxia relative to air oxygen in 
human cancer cell lines. A set of TETs genes promoter were evaluated using 
pyrosequencing. Y-axis indicates DNA methylation levels at CpG regions. X-axis indicates 
ten-eleven translocation methylcytosine dioxygenase enzymes. Data are presented as mean 
± standard deviation (SD). *P<0.05, **P<0.01, ***P<0.001. 
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5.4.8 HIF2A protein expression by Western blotting was increased in cancer cells 
subjected to hypoxia 
To identify the effects of reduced oxygen incubation on the HIFs expression profiles, 
transcriptional and protein levels of HIF1A and HIF2A in human cancer cell lines cultured 
in different oxygen conditions were analysed with qPCR and Western blotting assays. 
Results showed there was significantly less relative gene expression of HIF1A (0.36 ± 0.13) 
in A549 cells cultured in 2%WKS-21%ST condition when compared to those cultured in air 
oxygen (21%ST), and when compared to 2%PG and 2%WKS (0.82 ± 0.17 and 0.71 ± 0.11, 
respectively). In contrast, no significant change was observed in the level of mRNA HIF2A 
expression in all oxygen conditions (Figure 5.11A). The protein level of HIF2A (2.3 ± 0.23 
and 2.4 ± 0.43, respectively) was significantly elevated in A549 cells following treatment 
with 2%PG and 2%WKS when compared to 21%ST (Figure 5.11B). In addition, a 
significant difference was observed in HIF2A in A549 cells that cultured in 2%WKS-21%ST 
condition (1.6 ± 0.38) in comparison to those cultured in 2%WKS conditions. No significant 
change in HIF1A protein was observed in all oxygen conditions (Figure 5.11B). 
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Figure 5.11 The level of HIFs expression in A549 cells cultured in different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
 
We noted significantly less relative gene expression of HIF1A (0.53 ± 0.19, 0.55 ± 0.06 and 
0.49 ± 0.13), respectively in COV362 cells cultured in 2%PG, 2%WKS and 2%WKS-
21%ST conditions in comparison to those cultured in air oxygen (21%ST). A significant 
increase in the gene expression levels of HIF2A was noticed in COV362 cells cultured in 
2%WKS (1.5 ± 0.27) in comparison to those cultured in air oxygen (21%ST) (Figure 
5.12A). In addition, a significant difference was observed in HIF2A in COV362 cells that 
cultured in 2%WKS-21%ST condition (0.79 ± 0.19) in comparison to those cultured in 
2%PG and 2%WKS conditions (1.4 ± 0.14 and 1.5 ± 0.27), respectively (Figure 5.12A). 
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A significant increase in HIF2A protein expression was noted in 2%PG and 2%WKS 
conditions in COV362 cells (2.24 ± 0.63 and 2.44 ± 0.36) respectively, when compared with 
air oxygen (Figure 3.12B). Also, a significant difference was observed in HIF2A in 
COV362 cells that cultured in 2%WKS-21%ST condition (1.3 ± 0.31) in comparison to 
those cultured in 2%WKS conditions (Figure 3.12B). HIF1A protein was not detected in 
BMA-20 cells.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12 The level of HIFs expression in COV362 cells cultured in different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
 
The results of MG-63 showed there was significantly less relative gene expression of HIF1A 
(0.46 ± 0.13 and 0.45 ± 0.14) respectively, in MG-63 cells cultured in 2%PG and 2%WKS 
condition when compared to those cultured in air oxygen (21%ST), and when compared the 
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2%PG and 2%WKS with 2%WKS-21%ST (0.8 ± 0.15) (Figure 5.13A). In contrast, no 
significant change was observed in the level of mRNA HIF2A expression in all oxygen 
conditions (Figure 5.13A). The protein level of HIF2A (2.03 ± 0.3) was significantly 
elevated in MG-63 cells following treatment with 2%PG when compared to 21%ST, and 
when the 2%PG compared with 2%WKS and 2%WKS-21%ST (1.8 ± 0.3 and 0.8 ± 0.21) 
respectively (Figure 5.13B). HIF1A protein was not detected in MG-63 cells. 
 
 
 
 
 
 
 
 
 
 
Figure 5.13 The level of HIFs expression in MG-63 cells cultured in different oxygen 
conditions. A) The RT-qPCR expression of the HIFs normalized to the expression of β-
actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 1 for 
2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, **P<0.01 
vs air oxygen (21%ST). 
 
Similarly, significantly less HIF1A gene expression (0.53 ± 0.2 and 0.58 ± 0.09, 
respectively) was noted in SH-SY5Y cells grown under 2%PG and 2%WKS conditions 
when compared with the air oxygen (Figure 3.14A). The level of HIF2A was increased in 
SH-SY5Y cells cultured under 2%PG and 2%WKS but no significant change was observed 
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when compared to air oxygen (Figure 3.14A). HIF2A protein (2.1 ± 0.12 and 2.05 ± 0.42, 
respectively) was increased significantly in SH-SY5Y cells cultured under 2%PG and 
2%WKS when compared with air oxygen (Figure 3.14B). No significant change in HIF1A 
protein was observed in all oxygen conditions. 
 
 
 
 
 
 
 
 
 
 
Figure 5.14 The level of HIFs expression in SH-SY5Y cells cultured in three different 
oxygen conditions. A) The RT-qPCR expression of the HIFs normalized to the expression 
of β-actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 
1 for 2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, 
**P<0.01 vs air oxygen (21%ST). 
 
In addition, there was no significant change in HIF1A and HIF2A at transcriptional and 
protein levels in Jurkat cells that cultured in different oxygen conditions (Figure 3.15A and 
B).  
 
 
  
195 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 The level of HIFs expression in Jurkat cells cultured in three different 
oxygen conditions. A) The RT-qPCR expression of the HIFs normalized to the expression 
of β-actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 
1 for 2% oxygen. Data are presented as mean ± standard deviation (SD). n=3.  
 
On the other hand, the results showed a significant reduction in gene expression in IMR-90 
cells that cultured in 2%PG and 2%WKS (0.5 ± 0.3 and 0.4 ± 0.3, respectively) when 
compared to those cultured in air oxygen (Figure 5.16A). Also, the level of HIF2A was 
increased in SH-SY5Y cells cultured under 2%PG and 2%WKS but no significant change 
was observed when compared to air oxygen (Figure 3.16A). The protein level of HIF1A 
and HIF2A (1.8 ± 0.38 and 1.3 ± 0.15, respectively) was significantly elevated in MG-63 
cells following treatment with 2%PG when compared to 21%ST (Figure 3.16B). 
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Figure 5.16 The level of HIFs expression in IMR-90 cells cultured in three different 
oxygen conditions. A) The RT-qPCR expression of the HIFs normalized to the expression 
of β-actin. B) Western blot analysis of HIFs normalized to the expression of GAPDH and to 
1 for 2% oxygen. Data are presented as mean ± standard deviation (SD). n=3 *P<0.05, 
**P<0.01 vs air oxygen (21%ST). 
 
5.5 Discussion 
Over the last two decades, extensive research into cancer epigenetics has come to challenge 
the long-standing view of genetic mutations as the key determinant in tumourigenesis 
(Sharma et al., 2010, Baylin and Jones, 2011). Discoveries of abnormalities in global 
methylation patterns within cancer cells and its effects on gene expression independent of 
genetic mutations has highlighted a role of epigenetics in cancer development (Sharma et 
al., 2010). In contrast, little is known about the impact of changes within the tumour 
microenvironment on the global DNA methylation of cancer cells, particularly hypoxic 
stress. Therefore, in this chapter we aimed to understand how local hypoxic 
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microenvironments can alter cancer cells, triggering abnormal DNA methylation profiles in 
vitro.  
The proliferation of the human cancer cell lines was explored following exposure to different 
oxygen conditions. We observed a significant decrease in the rate of proliferation of cancer 
cells cultured in both hypoxia conditions (Figure 5.1). In addition, our MTT results 
displayed similar effect to growth rate (Figure 5.2). This data is consistent with previous 
studies which have found that cancers cells lost their proliferation ability within hypoxic 
conditions as a result of the modulation of a number of metabolic mechanisms, cell cycle 
regulation as well as development of epigenetic modifications (Gardner and Corn, 2008; Pal 
et al., 2010; Xu et al., 2016). The correlation between proliferation of cancer cells and 
abnormal DNA methylation profiles have been examined in several cancer models (Cui et 
al., 2002; Shahrzad et al., 2007; Gossage and Eisen, 2010). It has been reported that 
disruptions of VHL (von Hippel–Lindau) through hypermethylation of its corresponding 
promotor region in cancer cells results in the up-regulation of hypoxia-inducible factors 
(HIFs) which in turn affect the cellular proliferation and survival. (Gossage and Eisen, 2010).  
We observed that reduced oxygen did not lead to changes in the mRNA levels of NANOG 
and SOX-2, significantly. In contrast, the expression of OCT-4 was significantly increased 
in 2% O2 hypoxia compared to air oxygen (Figure 5. 3). These results are in line with 
previous studies that showed that HIFs induce human pluripotency markers in cancer cells 
(Covello et al., 2006; Mathieu et al., 2011). Covello et al revealed that HIF2A, but not 
HIF1A, binds the OCT-4 promoter directly and activates the expression of OCT-4 which 
correlated to enhanced levels OCT-4 protein (Covello et al., 2006). In addition, it has been 
suggested that increased of OCT-4 expression in cancer cells under hypoxia conditions were 
associated with partial unmethylation of the promoter of OCT4 (Mathieu et al., 2011).  
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Next, we went onto further explore the effects a hypoxic microenvironment on global 5mC 
and 5hmC levels in cancer cells. We did observe an overall decrease in the global 5mC levels 
when cultured in hypoxic conditions (Figure 5.4). Consistent with our findings, genomic 
hypomethylation of 5mC has been observed in both solid tumours such as hepatocellular and 
cervical cancer, in addition to haematological cancers such as chronic B-cell lymphocytic 
leukaemia (Wahlfors et al., 1992; Kim et al., 1994; Sadikovic et al., 2008). In addition, 
hypoxia induces genomic DNA hypomethylation through the activation of HIF1A in vivo 
(Liu et al., 2011). Furthermore, the recent discovery showed the that methylation level was 
decreased statistically in systemic sclerosis (SSc) fibroblasts cells (Hattori et al., 2015). 
We also observed an increase in the global 5hmC levels when incubated at 2% hypoxia 
conditions (Figure 5.5). Our results agree with previous reports that demonstrated that the 
level of 5hmC increased in tumorigenic N-type neuroblastoma cells exposed to 1% O2 
hypoxia (Mariani et al., 2014). In addition, Wu et al found that reduced oxygen led to an 
increased level of global 5hmC in breast cancer MCF7, MDA‑MB‑231 cell lines, as well as 
in primary breast cancer cells (Wu et al., 2015). Hepatoblastoma HepG2 cells cultured in 
1% oxygen for 24 h, had greater levels of 5hmC than those in cells cultured in 21% oxygen 
(Lin et al., 2017). 
To examine the relationship between the global 5mC and 5hmC patterns and the level of 
expression of DNMTs and TETs, we used RT-PCR and Western blot to explore the 
expression of these genes within cancer cells in response to hypoxia. Our results showed a 
decrease in the relative expression of de novo methylation DNA methyltransferase 
DNMT3B and DNMT3L in response to hypoxia. Notably, this may correlate to the decrease 
in global 5mC levels observed in cancer cells. Interestingly, this decrease was associated 
with significant increases in the methylation levels of these genes in cancer cells cultured 
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under hypoxia conditions. However, it has been reported that increased mRNA expression 
of DNMT3B in glioma tumours may have resulted from hypomethylation of its promoter 
regions (Rajendran et al., 2011). In addition, overexpression of the all three DNMTs genes 
resulted in DNA hypermethylation in different cancer cell lines such as stomach, colorectal 
carcinoma, hepatocellular and breast (Sun et al., 1997; Kanai et al., 2001; Girault et al., 
2003). Also, a significant decrease in mRNA levels for DNMT1, DNMT3a and DNMT3b 
has been shown in human colorectal cancer cells cultured under hypoxia conditions 
(Skowronski et al., 2010). Similarly, Waston et al found that DNA methylation levels altered 
in cardiac tissue fibrosis with HIF1A regulating the expression of DNMT1 and DNMT3B 
(Waston et al., 2014). In addition, exposure to severe hypoxic conditions in in vivo xenograft 
cancer, resulted decrease in 5mC levels (Shahrzad et al., 2007). Study of all three DNMTs 
in Hepatoma cells has shown that low oxygen upregulated the expression of DNMT1 and 
DNMT3A but not DNMT3B (Liu et al., 2011). This changes in DNMTs expression could 
be explain via hypoxia inducible factor (HIFs) pathway, which acts through the binding of 
HIFs with specific hypoxia response elements (HRE) present in promoter and enhancer 
regions of hypoxia responsive genes. This is consistent with the fact that the flanking regions 
of HRE are highly variable and critical for HRE function (Kaluz et al., 2008; Liu et al., 2011; 
Geo et al., 2017). 
We found a significant increase in the expression of the ten-eleven translocation 
methylcytosine dioxygenase TET1. As this is one of the enzymes responsible for the 
conversion of 5mC to 5hmC, the increase of its expression by cancer cells in response to 
hypoxia may correlate to the increase in the global 5hmC levels observed in this experiment. 
However, this increase in TET1 levels in hypoxic tumour cells has not revealed any 
association with its promoter methylation status. Low oxygen has been linked to increase 
the TET1 expression in cancer cells, which catalyses the conversion the 5mC to 5hmC 
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(Mariani et al., 2014). Similarly, two recent studies showed that the increased of 5hmC levels 
in cancer cells following exposure to severe hypoxic conditions was associated with up-
regulation of TET1 and TET3 (Wu et al., 2015; Hattori et al., 2015). In addition, other studies 
have found a decrease in the expression of all three TETs in association to a decreased level 
of 5-hmC in human breast, liver, pancreatic and prostate cancer when compared to 
surrounding tissues (Yang et al., 2013). This highlights the importance of further research 
into the expression of TETs and its correlation to DNA methylation in cancer pathogenesis.  
On the other hand, the present study demonstrates that HIF2A protein expression by Western 
blotting was increased in cancer cells subjected to hypoxia (Section 5.4.8). This agrees with 
results that have shown the expression of HIF2A at protein level increases significantly when 
cells are cultured for long term under hypoxic condition (Gordan et al., 2007; Forristal et al., 
2010). However, Cameron et al suggested that HIF1A protein is only transiently expressed 
for two days after exposure to hypoxia (Cameron et al. 2008). Our results also in agreement 
with Forsyth et al and Westfall et al results that showed there was no significant increase in 
the mRNA expression of the HIFs subunits under low oxygen tensions (Forsyth et al., 2008; 
Westfall et al., 2008). This finding suggesting that changes at the protein levels could be due 
to posttranscriptional regulation (Huang et al. 1998; Lang et al. 2002).  
Finally, we explored the effect of modulating hypoxia on levels of DNA methylation (5mC 
and 5hmC) and the expression of DNMTs/TETs. We found that removal hypoxia caused 
significant changes in the level of 5mC and 5hmC and their DNMTs/TETs when compared 
to 2% hypoxia conditions in HIF2A-dependent regulation. However, RNA-Seq showed that 
about 369 genes were changes significantly in the hypoxic cells when the effect of hypoxia 
stress was removed in compared to control cells (Hartley et al., 2013). Interestingly, we 
found that the transition between hypoxia and normoxia induced changes in the level of 
DNMT3L at mRNA and methylation levels. This recent result strongly supports the 
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hypothesis that DNMT3L plays a role in alter DNA methylation and potential role of reduced 
oxygen in regulation the DNMT3L expression (Heo et al., 2017). 
In conclusion, this study has highlighted the significant effect a hypoxic microenvironment 
can have on epigenetic changes within cancer cells as well as the importance of further 
research into the expression of DNMTs/TETs and its correlation to DNA methylation in 
cancer pathogenesis. 
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Chapter 6: Summative discussion, conclusions, 
and further work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
203 
 
6.1 Summative discussion 
Low oxygen induces the activation of several pathways within the cell, some being HIF-
mediated and some HIF-independent. Many studies have reported that reduced oxygen is an 
essential factor in the maintenance, proliferation, differentiation and functions of stem cells 
(Yin and Li, 2006; Abdollahi et al., 2011; Zhi et al., 2018). At the same time, a significant 
progression has been considerable in understanding the molecular mechanisms responsible 
for the hypoxic tumour microenvironment that has opened a new area in the discovery of 
potential targets for cancer treatment (Adamaki et al., 2012). Also, many studies have linked 
reduced oxygen to increased epigenetic instability, which may also contribute to cancer 
development (Perez-Perri et al., 2011; Chen and Sang, 2012). However, whereas many 
investigators agree that the low oxygen tension promotes proliferation, inhibits senescence, 
and maintains properties of several cells including embryonic stem cells and mesenchymal 
stem cell but data on the effect of low oxygen culture conditions on genomic stability are 
rare and conflicting (Yin and Li, 2006; Bentivegna et al., 2013). However, enhanced 
knowledge of enzymatic function and the role of hypoxia in control the DNA methylation 
present new approaches for arising therapeutic strategies designed to reverse transcriptional 
aberrations that are inherent to the cancer epigenome (Baylin and Jones, 2012).  
The principal aim of this thesis was to identify epigenetic changes potentially associated 
with the changes in oxygen level in different cell lines including stem cells and cancer. It 
was, however, essential to first study the effect of low oxygen in various functions of cells 
such as proliferation, metabolic activity and differentiation. In addition, the study of 
functional characterisation of cells was vital to ensure the quality and status of the cells 
before the survey these investigations. In this study, two different oxygen conditions (2%PG 
and 2%WKS) were used to describe the 2% oxygen culture where mimics the native oxygen 
level in vivo environment. The 21%ST was used to describe the 21% air oxygen condition 
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that is used in many standard laboratories culture as described in chapter 2. Flow cytometry 
technique, fluorescence image-based analysis and the tri-lineage differentiation potential 
showed that both stem cells (hPSCs and BM-hMSCs) have typical characteristics of the 
surface antigen of stem cells along with typical results of positive and negative of tri-lineage 
differentiation of BM-hMSCs. Also, there was no significant difference between low oxygen 
and air oxygen condition. These results agree with many studies that showed the low oxygen 
tension did not affect the typical characterisation of stem cells during normal passaging 
(Forsyth et al, 2006; Forristal et al., 2010; Basciano et al., 2011; Narva et al., 2013). In vitro 
studies, it is important to confirm the pluripotent nature of our cells before the continue to 
further investigations. Furthermore, the expression of pluripotent markers OCT-4, NANOG, 
SSEA-4 and ALP gradually reduced over the time course of hPSCs differentiation which 
indicates that cells gradually lost their pluripotency across all time points.  
As early as 1958, Cooper et al found that animal cells grow more rapidly in low oxygen 
tension than air oxygen (Cooper et al., 1958). Since that time, many researchers have studied 
the effect of low oxygen in proliferation and metabolic activity of several cells including 
stem cells and cancer (Forristal et al., 2010; Rajala et al., 2011; Xu et al., 2016). However, 
A variety of studies showed that cells grow more efficiently under reduced oxygen 
conditions when compared to air oxygen (Ivanovic et al., 2000; Studer et al., 2000). 
However, our results showed that physiological normoxia conditions (2%PG and 2%WKS) 
increased the proliferation and metabolic activity of hPS cells as compared with air oxygen. 
On the other hand, hypoxia treated cancer cells showed distinct changes in proliferation and 
metabolic activity. The variability of these differing responses of cells to reduced oxygen 
may be due to the different oxygen concentrations that used during experiments as well as 
the cell type (Abdollahi et al., 2011). Moreover, Heyman et al reported that different cells 
types shown the distinct ability to cope with reduced oxygen during a long term of culture. 
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In addition, the degree of their adaptive capacities may reflect their native oxygen 
microenvironments. (Heyman et al., 2012). However, it has reported that changes of HIFs 
stabilisation under different oxygen levels may participate in control the activity of some 
genes that involved in regulate of mitochondrial oxidative metabolism such as pyruvate 
dehydrogenase complex (PDC) (Semenza, 2007; Natarajan and Becker, 2012). Interestingly, 
the changes in proliferation and metabolic activity that we found was associated with 
changes in 5hmC but not 5mC. However, Bachman et al reported that increases in cell 
proliferation might be due to reducing of 5hmC level (Bachman et al., 2014). Recently, Zhu 
et al found that knockdown of TET1 led to decrease the migration, invasion and proliferation 
of the trophoblast-like cell line JEG3 exposed to low oxygen concentration (Zhu et al., 2017). 
On the other hand, hypermethylation of TET1 did not affect the proliferation rate of cells 
that culture under hypoxia conditions (Thienpont et al., 2016). However, further study is 
needed to delineate the effects of DNA methylation on proliferation and metabolic activity 
of cells under low oxygen conditions. 
Next, because changes in pluripotent markers such as OCT-4, NANOG and SOX-2 were 
relevant with the changes in oxygen concentrations (Forristal et al., 2010), we investigated 
whether this was competing with DNA methylation changes. However, the study of 
pluripotent markers can provide central insights into the understanding of transcriptional 
circuitry responsible for supporting the self-renewal and stemness of stem cells (Han et al., 
2014). We found that exposed our cells to low oxygen conditions (2% O2) led to increasing 
the expression of OCT-4 and SOX-2 but not NANOG in most cell types investigated. These 
results are in line with previous studied that showed that HIFs induce human pluripotency 
markers in both stem cells (hPSC and hMSC) and cancer cells (Covello et al., 2006; Mathieu 
et al., 2011; Barbosa et al., 2012; Han et al., 2014). Covello et al revealed that HIF2A, but 
not HIF1A, binds the OCT-4 promoter directly and activates the expression of OCT-4 which 
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correlated to enhance the levels of OCT-4 protein (Covello et al., 2006). Importantly, we 
observed that the increases of pluripotent markers in our cells were associated with DNA 
hypomethylation, indicating that increases pluripotent markers underlie 5mC reduction. 
Furthermore, these results suggested that the catalytic activity of TET1 does not affect the 
gene activity of pluripotent markers in cancer cells. However, Tsai et al found that DNMT1 
regulate OCT-4 and NANOG in MSC through binding to their promoter leading to the 
repressed the expression of genes associated with the development and lineage 
differentiation and maintain self-renewal and undifferentiated State (Tsai et al., 2014). In 
addition, it has been suggesting that increases of OCT-4 expression in cancer cells under 
hypoxia conditions were associated with partial unmethylation of the promoter of OCT-4 
(Mathieu et al., 2011). Moreover, our re-oxygenation results suggest that oxygen can 
regulate the activity of cancer cells through HIF2A/ DNMT3B mediated control of OCT-4 
expression. However, it has reported that inhibiting HIF2A activity can regulate stem cell 
function through reducing the expression of genes that involved in regulating stem cells 
including OCT-4 (Covello et al., 2006).  
Additionally, Oxygen is an essential factor for several cellular processes in various 
organisms and, any alternative in its availability can produce significant changes in cellular 
quantities (Melvin and Rocha, 2012). Hypoxia-inducible factors (HIFs) is a crucial mediator 
of the adaptive cellular response to hypoxia and is involved in regulating the expression of 
many genes that affect cell survival and metabolism (Eliasson and Jonsson, 2010). However, 
HIFA consists of three isoforms: HIF1A, HIF2A and HIF3A, whereas HIF-β, also known as 
ARNT (aryl hydrocarbon receptor nuclear translocator), has only one isoform, HIF1β. Three 
alpha subunits (HIF1A, HIF2A, and HIF3A) all bind to subunit HIF1β (Gordan and Simon, 
2007). Our results showed that that HIF2A protein expression by Western blotting was 
increasing in most our cells subjected to reduced oxygen. These results agree with previous 
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reports that have demonstrated the expression of HIF2A at protein level increases 
significantly when cells are cultured for a long term under low oxygen conditions (Gordan 
and Simon., 2007; Forristal et al., 2010). Recently, two studies revealed that the expression 
of HIF1A was significantly increased under low oxygen condition within 24 h and before 
they dropped down. On the other hand, the expression of HIF2A consistently remained at a 
high level (Cameron et al. 2008; Zhi et al., 2018). Also, different Western blotting studies 
indicated that HIF2A was upregulated under hypoxic conditions compared with 21% oxygen 
(Grayson et al., 2007; Forristal et al., 2010; Lin et al., 2011; Narva et al.,2013). This finding 
suggests that changes of HIFs at the protein levels could be due to posttranscriptional 
regulation (Huang et al. 1998; Lang et al. 2002).  
However, routine culture of cells in low oxygen conditions resulted in a significant decrease 
in levels of 5mC and 5hmC, accompanied by transcriptional-translational down-regulation 
of DNMT3B and TET1 in most cell types investigated except the levels of TET1 and 5hmC 
in cancer cells. Interestingly, analysis of methylation status of specific gene promoters by 
measuring CpG promoter methylation levels indicated that low oxygen alters the DNMT3B 
promoter methylation levels, but not TET1. These results suggest that modest hypoxia (2% 
O2) did not affect TET activity at promoter regions, indicating that TET enzymes are HIF-
independent in line with previous reports (Laukka et al., 2016; Thienpont et al., 2016). In 
addition, these results showed that increases in 5hmC did not translate into global 5mC 
increases, probably because TETs do not target 5mC at many sites (Williams et al., 2011; 
Thienpont et al., 2016). Hoffner et al found that no association between 5mC and 5hmC and 
the reduction in 5hmC can occur independently from 5mC decrease (Hoffner et al., 2011). 
Many studies indicate that 5hmC is functionally distinct from 5mC and there is evidence for 
5hmC being a stable derivate of 5mC, rather than just an intermediate of demethylation 
(Ecsedl et al., 2018). 
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Furthermore, our results showed there is no linking between increases the activity of TET1 
at mRNA level and its promoters CpG content. These results support strongly the hypothesis 
that the expression of the gene depends on promoters CpG level, with methylated high CpG 
level promoters being usually inactive, whereas methylated low CpG level promoters can be 
active or inactive (Berdasco and Esteller, 2011; Bentivegna et al., 2013). Also, low oxygen 
reduces DNMT3B activity with accompanied 5mC in most cells’ types investigated. 
Interestingly, decreases in the expression of DNMT3B was associated with a high 
methylated pattern in the CpG regions of its promoters. Consistent with our findings, 
genomic hypomethylation of 5mC has been observed in many cells that culture under 
reduced oxygen levels (Liu et al., 2011). Most importantly, cancer cells that returned from 
hypoxic condition to air oxygen showed that levels of HIF2A were decreased significantly 
compared to hypoxic conditions. Furthermore, reduces the level of HIF2A under (2%WKS-
21%ST) condition was associated with the changes in DNMT3B levels at mRNA gene and 
their methylation CpG promoter levels. These results indicate that HIF2A is driving the 
changes in 5mC level through DNMT3B. However, cells maintained at reduced oxygen 
revealed decreases in the global levels of 5mC, whereas in the absence of HIF1A, the global 
level of DNA methylation increased accompanied by increases in DNMT3B expression 
(Waston et al., 2009; Waston et al., 2010). Skowronski et al reported that a possible 
mechanism for the observed changes in DNMTs expression might be due to the hypoxia 
inducible factor (HIFs) pathway, which acts through the binding of HIFs to the hypoxia 
response element (HRE) DNA recognition sites (Skowronski et al., 2010). In addition, 
changes in DNA methylation can impact the control of HIFs binding to target genes directly 
by methylation of a specific CpG dinucleotides within the hypoxia response elements (HRE) 
which are present in promoters, introns, and 3´ enhancers (Rossler et al., 2004; Waston et 
al., 2010). 
  
209 
 
Interestingly, we found that the transition between hypoxia and air oxygen-induced changes 
in the levels of DNMT3L at mRNA and its promoters methylation levels. These recent 
results strongly support the hypothesis that DNMT3L plays a role in altering DNA 
methylation and the potential role of reduced oxygen in regulation the DNMT3L expression 
(Heo et al., 2017). In addition, recent studies have reported that DNMT3L (DNA 
methyltransferase 3-like) does not possess methyltransferase activity itself but interacting 
with DNMT3A and DNMT3B to stimulate their catalytic activity. However, the precise 
function of DNMT3L in these cells is not known (Bourc'his, 2001; Margot et al., 2003). 
In addition, our results showed that data of continuous hypoxic culture (2%WKS) are more 
consistent in compared to semi-continuous hypoxic culture (2%PG). This variation between 
two hypoxic conditions might due to fluctuation of oxygen at cellular level during seeding, 
changing media or passaging or opening and closing incubator doors that associated with 
2% O2 model (intermittent hypoxia).These results are in line with previous studied that 
showed the  fluctuations in oxygen concentration can affect cell growth, differentiation, 
signalling, and free radical production (Place et al., 2017).  In addition, the adapt of cells to 
reduced oxygen over extended periods of incubation and culture is very important factors to 
the reduce of variations (Ahmed et al., 2016). For example, there is evidence that HIF-PHD 
enzymes can adapt to chronic oxygen depletion by changing their “set point” or sensitivity 
with regard to their response to local oxygen concentrations. However, a state of constant 
change (i.e. in cell culture) would preclude a new set-point from being reached and signalling 
through the oxygen-sensing pathways is inconstant ﬂux (Hirsila, 2004; Koivunen et al., 
2005; Abaci et al., 2010). 
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6.2 Conclusions 
The main aim of this study was to identify the DNA methylation changes that potentially 
associated with the changes in oxygen level in different cell lines including stem cells and 
cancer. Also, to study of the effect of reduced oxygen in many functions of cells such as 
proliferation, metabolic activity, stemness and differentiation. The results presented in this 
work show that low oxygen enhances the function profiles of stem cells including 
proliferation, metabolic activity and stemness. In contrast, the culture of cancer cells with 
2% oxygen causes the significant decrease in growth profiles in comparison to air oxygen 
21% O2. In addition, low oxygen induces HIF2A but not HIF1A, at protein levels in most 
cell types investigated. However, evaluation of common genes (DNMTs and TETs) that 
involved in regulating DNA methylation demonstrated similar patterns of expression most 
of these genes in all three oxygen conditions. However, only DNMT3B and TET1 were 
found to be changed significantly. HIF2A stimulates downregulation of DNMT3B, which is 
necessary for genome-wide 5mC decreases. Interestingly, this downregulation in gene 
expression of DNMT3B was associated with increases in their CpG promoter methylation 
levels. Furthermore, our results suggest that low oxygen (2% O2) can affect the TET1 at 
mRNA and protein levels but not at promoter regions, indicating that TET enzymes are HIF-
independent. Most importantly, we found that the transition between hypoxia and air oxygen 
in cancer cells induced the changes in the level of DNMT3B at mRNA and of their promoter 
methylation levels. Together these data suggest that the level of 5mC is reduced by HIF2A, 
via DNMT3B- mediated methylation. However, Table 6.1 provides a summary of the effects 
of reduce oxygen in up-regulation or down-regulation of DNMT3B and TET1 at gene 
expression and methylation levels, which are associated with increase and decrease the 5mC 
and 5hmC levels in different cell types. 
  
211 
 
Table 6.1 Summary involvement of DNMT3B and TET1 in the regulation of 5mC and 
5hmC in different cell types under hypoxia effects. 
Cell types DNMT3B 5mC TET1 5hmC 
Gene 
expression 
Gene 
methylation 
Gene 
expression 
Gene 
methylation 
Embryonic stem 
cells     
N/A 
 
Induced 
pluripotent stem 
cells 
    
N/A 
 
Mesenchymal 
stem cells       
A549 
    
N/A 
 
COV362 
    
N/A 
 
MG-63 
    
N/A N/A 
SH-SY5Y 
    
N/A 
 
Jurkat cells N/A N/A N/A 
 
N/A N/A 
IMR-90 
  
N/A 
 
N/A N/A 
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6.3 Further work 
Despite the results that presented in this thesis enhances our understanding of the effect of 
low oxygen on different types of cytosine modification, it will be important to extend follow-
up studies upon these areas.  
1. Continuation of the current analysis in other cell lines to minimise the variation, 
improve confidence and to compare the effect of oxygen at different time points 
and different oxygen concentrations (e.g. 3% O2, 5% O2 and 10% O2) in different 
cell types. 
2. Further investigation of the role of DNA methylation in development and cell 
differentiation as well as to analysis and compare the effect of oxygen on 
epigenetic DNA inside live system to obtained better knowledge.  
3. Further work also can examine the impact of chemical compounds having 
hypoxia-mimic action (HMAs) and what are the main difference between oxygen 
cultured cells and these cultured by chemical compound in DNA methylation 
marks (e.g. DMOG, Deferoxamine). 
4. More insight may be gained by the investigation of associations between 
methylation and gene expression and potential functional roles of low oxygen by 
applying another assay such as second-generation methylation array technology 
will permit the identification of aberrant DNA methylation in hypoxic cells 
relative to air oxygen.  
5. Investigation the role of the individual HIFs factors in both 5mC and 5hmC and 
their enzymes by knockdown and overexpression techniques. 
6. Confirmed the results of DNMT3B and TET1 by knockdown and overexpression 
techniques of these enzymes. 
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7. Further work also can do by examine the impact of 3D microenvironment cell 
culture in DNA methylation marks and their enzymes in compare to 2D culture 
technique. 
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